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Abstract 
Research and development into the production of novel antimicrobials is greatly needed due to 
the current global threat that antimicrobial resistance is presenting. In the present study, modern 
and ancient forestlands, Friston Forest, (Sussex, UK), and New Forest, (Hampshire, UK), and 
Dawes Farm, (Warnham, West Sussex, UK) were sampled in the hope of isolating organisms with 
inhibitory activity and/or similar morphology to that of the Streptomyces spp. for further 
assessment of antagonistic activity against selected test bacteria. Perpendicular screening, and 
the newly developed starvation method, were used to characterise the inhibitory ability of 
organisms isolated against sensitive test strains of Escherichia coli, Staphylococcus aureus, 
Staphylococcus epidermidis, Pseudomonas aeruginosa, and Proteus mirabilis. Organisms 
displaying inhibitory activity towards sensitive organisms were further tested using clinically 
isolated test organisms from the same genus. Perpendicular screening confirmed 11 (15.9%), 5 
(14.7%), and 13 (30.2%) of the total organisms isolated from Friston Forest, New Forest and 
Dawes Farm respectively, with inhibitory activity towards one or more of the test organisms used, 
with eight of these displaying further inhibition of at least one of the clinical test organisms used 
in this method. The starvation method, used for further antibacterial screening, involving the 
incubation of the potential antimicrobial producing organisms in minimal media for long 
incubation periods, confirmed 21 (30.4%) 12 (35.3%), and 9 (20.9%) isolates from Friston Forest, 
New Forest, and Dawes Farm vets with inhibitory ability. 
All organisms isolated were tested using Gram staining, with those displaying resemblance to the 
Streptomyces spp. selected for further determinative identification using the polymerase chain 
reaction, with primers specific to the 16S rRNA gene of the Streptomyces genus. Nineteen isolates 
were determined as belonging to this genus, with 42.1% of the confirmed Streptomyces spp. 
displaying inhibitory activities. 
The same soil samples were used for the cultivation of potentially pathogenic bacteria, with 
biochemical testing used to determine the identity of each of the 222 organisms isolated, to a 
genus level. Across the three locations three isolates were identified as belonging to Salmonella 
spp., 21 as Staphylococcus aureus, nine Pseudomonas spp., two Staphylococcus epidermidis, four 
Klebsiella spp. and four Escherichia coli. The screening carried out in this study confirmed the 
ability for the isolation of pathogenic organisms as well as soil organisms with antibiotic producing 
capability, from the previously untested farm and forestland sampled.  
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1.1 Antibiotic resistance 
Antimicrobials cover a wide range of natural as well as synthetic agents that can be used to 
combat infections in both humans and animals, which are often produced by microorganisms 
themselves, primarily to better their niche exploitation in their given environment (Van Hoek et al., 
2011; Hibbing et al., 2010).  Antibiotics are one example of an antimicrobial, defined as a natural 
substance produced itself by a microorganism, with the ability to kill or inhibit the growth of other 
microorganisms (CDC, 2017). However, these antimicrobial drugs are increasingly being classified 
as ineffective for the treatment of various microorganisms, due to the ability of these resistant 
pathogens to overcome the action of particular antimicrobials. This increasing resistance has 
caused the development of multiple drug resistant strains of certain organisms, including those 
with resistance mechanisms towards several of the current last line antibiotics, presenting a major 
global, and indeed, ‘one health’ concern (WHO, 2014). In some pathogens, resistance has been 
observed against the carbapenem class of antibiotics by carbapenem-resistant Enterobacteriaceae 
(CRE), which has been linked with high mortality in human infections (>50%) (Zarkotou et al., 2011). 
Vancomycin-resistant Staphylococcus aureus (VRSA) has also been isolated, with vancomycin being 
one of the last resort treatments for serious infections caused by Gram-positive bacteria (Hu et al., 
2016; Rice, 2006; Whitener et al., 2004). As well as this, resistance towards the polymyxin group of 
antibiotics, including colistin, has been seen in recent years, by organisms belonging to the 
Enterobacteriaceae group (Laxminarayan et al., 2013; Olaitan et al., 2014). These polymyxins are 
used as the last line of defence against infections, caused by pan-drug resistant Gram-negative 
organisms, hence maintaining the effectiveness of these drugs is crucial (Gao et al., 2016; Olaitan 
et al., 2014). This emergence and increasing frequency of resistant bacteria is apparent all over the 
world, with it currently causing around 700,000 deaths every year, which is estimated to increase 
to 10 million deaths in 2050 if antimicrobial resistance (AMR) is not tackled (O’Neill, 2016). 
Antimicrobial resistance (AMR), defined by the Centres for Disease Control and Prevention 
(CDC), and European Centre for Disease Prevention and Control (ECDC), using the displayed 
effectiveness of several drugs against bacterial strains (Figure 1.1 and Table 1.1), can occur in 
multiple ways allowing bacteria and other microbes to overcome the action of an antimicrobial, 
making it no longer effective (Magiorakos et al., 2011). De novo mutations in microbes can directly 
affect targets or pathways targeted by antimicrobials, or cause the upregulation of efflux pump 
mechanisms or enzymes that affect the antimicrobial’s structure, providing an advantage for the 
mutated strain, enabling the organism to overcome the action of particular antimicrobials 
(Laxminarayan et al., 2013; Levy, 1992; Török et al., 2012). The acquisition of these mutations 
conferring resistance (resistance genes) can also be, in some cases, transmitted between the same 
or different bacterial species (Von Wintersdorff et al., 2016). This often involves the use of plasmids 
or other mobile genetic elements in horizontal gene transfer (HGT), allowing resistance to spread 
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and hence increasing the prevalence of particular resistance genes (Török et al., 2012; Mazel and 
Davies, 1999). 
 
Figure 1.1: The relationship between the terms Multidrug-resistant (MDR), Extensively drug-
resistant (XDR) and Pandrug-resistant (PDR) used to define the drug sensitivity of specific bacterial 
organisms (taken from Magiorakos et al., 2011). An example of these definitions of antimicrobial 
resistance is given for Pseudomonas aeruginosa in Table 1.1. 
 
However bacterial resistance, due to naturally occurring antibiotic resistance genes (ARG), 
is an ancient mechanism that has occurred in bacteria before antibiotics were of major use in the 
medical industry. Perron and colleagues (2015) demonstrated that bacteria samples taken from 
ancient permafrost soils harboured several different resistance genes that conferred resistance to 
such antibiotic classes as the β-lactams and tetracyclines, as well as the non-naturally occurring 
antibiotic amikacin, with great genetic similarity to those resistance genes seen in pathogenic 
bacteria.   
Although AMR has been seen to be developed amongst organisms in natural ecosystems, 
it is clear that exaptation and evolution leading to the development of resistant organisms, which 
have undergone favourable de novo mutations or acquired ARG, is the consequence of selective 
pressure, created by the vast number of antimicrobials in use in recent years (Martinez, 2012; Mazel 
and Davies, 1999; Rice, 2006; Wellington et al., 2013). With the use of HGT, these now 
advantageous genes can be passed between bacteria, including different strains and species, 
allowing resistance genes to spread and be maintained, while rendering certain antibiotics 
ineffective (Laxminarayan et al., 2013).  
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Table 1.1: The antimicrobial susceptibility profile of Pseudomonas aeruginosa that fits the 
definitions used by the European Centre for Disease Prevention and Control (ECDC) and the Centres 
for Disease Control and Prevention (CDC). Multidrug-resistant (MDR) is defined as non-
susceptibility to at least one antimicrobial in three or more classes/categories. Extensively drug-
resistant (XDR) is defined as susceptibility towards only two classes/categories of antimicrobials (or 
non-susceptibility to at a minimum of one agent in all but two categories). Pandrug-resistance (PDR) 
is defined as a strain that is no longer susceptible to all agents in all antimicrobial classes/categories 
(Magiorakos et al., 2011). The relationship of the differing resistance terms can be seen in Figure 
1.1. 
Antimicrobial agent (antimicrobial 
category) 
Isolate no 1 (PDR) Isolate no 2 (XRD) Isolate no 3 (MDR) 
gentamycin (aminoglycoside) X X  
tobramycin (aminoglycoside) X   
amikacin (aminoglycoside) X   
netilmicin (aminoglycoside) X   
imipenem (carbapenem) X X X 
meropenem (carbapenem) X X  
doripenem (carbapenem) X X  
ceftazidime (cephalosporins) X  X 
cefepime (cephalosporin) X X  
ciprofloxacin (fluoroquinolones) X X X 
levofloxacin (fluoroquinolones) X   
piperacillin-tazobactam (penicillin + b-
lactamase inhibitors) 
X   
ticarcillin-clavulanic acid (penicillin + b-
lactamase inhibitors) 
X X  
aztreonam (monobactam) X X  
fosfomycin (phosphonic acid) X   
colistin (polymyxin) X   
polymyxin B (polymyxin) X   
 
 
Antimicrobial resistance presents several important consequences, affecting both the 
medical and agricultural sectors. Rising resistance levels of a variety of bacteria increases the 
likelihood of infections becoming untreatable, whilst simultaneously increasing mortality rates, 
especially among immunocompromised patients (Bhatt et al., 2014). As well as this, overall 
expenditure required for treatment, is increased, as alternative, more expensive last resort drugs 
are used (Bhatt et al., 2014; Gebreyohannes et al., 2013). Additionally, increased hospital stays due 
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to prolonged infection, and potential lengthened monitoring of patients, due to increased toxicity 
of treatment/antibiotics to overcome this infection, further increases the overall expenditure 
(Laxminarayan et al., 2013; Santajit and Indrawattana, 2016). A recent review by O’ Neill (2016) 
highlighted the dire consequences of AMR, including the effect it will have on the ability to perform 
simple surgical procedures, such as caesarean sections and joint replacements, due to an increased 
likelihood of resistant post-operative infections and hence an increased likelihood of mortality 
(Bhatt et al., 2014; Bala Chandrasekhar et al., 2015; Mangram et al., 1999).  
Certain bacterial species, known as the ESKAPE pathogens, have also been highlighted as a 
key risk, calling for the urgent development of new antimicrobials (Rice, 2008). This acronym 
includes the bacteria Enterococcus faecium, Staphylococcus aureus, Klebsiella pnuemoniae, 
Acinetobacter baumannii, Pseudomonas aeruginosa, and the Enterobacter species, which are 
mainly associated with nosocomial infections and are increasingly seen to be resistant towards 
antimicrobials (Rice, 2008; Santajit and Indrawattana, 2016). The World Health Organisation 
(WHO), who have defined critically important antimicrobials for use in human medicine, also 
recently highlighted the urgency of this issue, and released a list, prioritising drug resistant 
organisms that require urgent research and development into new antibiotic treatments (WHO, 
2016; WHO 2017). Carbapenem resistant A. baumannii, P. aeruginosa and Enterobacteriaceae, that 
also have the ability to produce Extended Spectrum Beta Lactamases (ESBLs), are detailed as a 
critical priority, and are top of the list of organisms that require desperate research into novel 
antimicrobials against them (WHO, 2017). 
1.2 Overcoming this antibiotic resistance 
WHO (2016) have provided several objectives for a global action plan against AMR, working 
to raise awareness of this resistance and its effects on the health system, as well as on the 
prevention of infections and unnecessary use of antimicrobials in both human and veterinary 
medicine. In a final report tackling AMR, O’Neill (2016) also highlighted 10 means of reducing the 
demand of antimicrobials, including increasing global awareness as well as surveillance of drug 
consumption, and resistance, among others. In addition, there remains a great need for the 
research and development of novel antimicrobials, necessary in the fight against AMR, which could 
include the chemical manipulation of antibiotics currently in use, as well as seeking new products 
from natural sources (Shore and Coukell, 2016; The PEW Charitable Trust, 2016). 
Chemical modification of already known antibiotics has proven useful in providing further 
antibiotics, but completely new classes of these drugs are needed to overcome resistance (Zinner, 
2005).  This is, however, a major challenge, due to the current ‘discovery void’, with a severe lack 
of novel antimicrobials reaching the market. No new major antibiotic classes were discovered 
between 1987 and 2015, with teixobactin, an antibiotic with action against Gram-positive bacteria, 
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being the first new class in over 30 years (Silver, 2011; Ling et al., 2015).  There have only been two 
new antimicrobial classes developed and released for use from the pharmaceutical market since 
1985, linezolid, an oxazolidinone, in 2000 and daptomycin, a lipopeptide, in 2003, however these 
classes were reported much earlier in 1978 and 1987 respectively, demonstrating just how slow the 
development of novel antimicrobials has been in recent years (Butler and Buss, 2006; Silver, 2011).  
This lack of research is mainly due to the large cost of research and development of new 
antimicrobials, which outweighs the money returned from these drugs. Courses of these antibiotics 
are often short (days), compared to drugs used for treatment of chronic conditions such as 
diabetes, hence research for chronic conditions is favoured by pharmaceutical companies (Zinner, 
2005; O’Neill 2016). 
Isolation of natural resources plays a significant role in the discovery of new drugs and have 
been essential for innovation and production of compounds for use in clinical settings (Gullo et al., 
2006). Between the years 1981 and 2002, over half the antibacterial drugs approved for use were 
developed from natural compounds (Newman et al., 2003). An example of the significance of 
natural products is the antibiotic mupirocin, produced by the soil bacterium Pseudomonas 
fluorescens, which was initially isolated in 1971 and introduced into a clinical setting in 1985 
(Newman et al., 2003; Sutherland et al., 1985). The majority of antimicrobials that have been 
synthesized and are commonly seen today in medical practices, originated from secondary 
metabolites produced by soil microorganisms, with the antibiotic mupirocin being one example 
(Kavitha et al., 2010). 
Teixobactin, mentioned above, is produced by the Gram-negative bacterium Eleftheria 
terrae, which was recently isolated in 2015 from soil, using an iChip device (Ling et al., 2015). This 
device allowed bacterial organisms to be cultivated in their natural environment, enabling the 
growth of more bacteria that are unculturable under laboratory conditions (Ling et al., 2015). This 
novel antimicrobial, whose mechanism of action targets bacterial cell wall synthesis, was shown to 
have good activity against Gram-positive organisms, with inhibitory effects even being seen against 
vancomycin-resistant Enterococci. This discovery highlights soil as a valuable source of novel 
secondary metabolites, that could potentially help overcome AMR (Ling et al., 2015). Teixobactin is 
an example of a new antimicrobial reaching the market, however due to its ineffectiveness against 
Gram-negative organisms, such as those belonging to the Enterobacteriaceae family, it further 
emphasizes the need for additional research and development into novel antimicrobials. Additional 
new antimicrobials are needed in this fight against AMR, as the overuse of this one new antibiotic 
will again lead to development of resistance towards it (Ling et al., 2015).  
The search for new antimicrobials is therefore of significant importance. As such, searching 
out potentially inhibitory compounds from new and unexploited settings is a possible area of 
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interest in the early stages of drug discovery. The current study focusses on returning to more 
natural resources, in the hope of locating antimicrobial producing organisms (APO), and hence 
begin to remedy the major threat affecting both the pharmaceutical industry and the medical 
sectors, that is, the increasing amount of resistance being seen by varied species of bacteria. 
1.3 Actinomycetes and Streptomyces spp. 
Actinomycetes, a class of Gram-positive filamentous bacteria, are often located in soil and 
marine environments. They are known to be great producers of natural secondary metabolites, 
including antimicrobials, of which several are currently in use today (Gebreyohannes et al., 2013; 
Kavitha et al., 2010).  Several of the bioactive compounds produced by genera in the Actinomycetes 
group have been seen to act on organisms such as methicillin-resistant S. aureus (MRSA), and 
vancomycin-resistant Enterococci (VRE), among others, showing further potential of Actinomycetes 
for the production of compounds able to overcome the bacterial resistance currently being seen 
(McArthur et al., 2008). More than 70% of all known antibiotics originated from soil microorganisms 
from the Actinomycetes group, with the majority of these being produced from the Streptomyces 
genus (Sanglier et al., 1996; Ganesan et al., 2016). 
The Streptomyces spp. have been shown to be a reliable producer of active metabolites, 
with around 75% of antibiotics produced by organisms within the Actinomycetes group alone, and 
currently in commercial use, derived from this Streptomyces genus (Sharma et al., 2016; Miao and 
Davies, 2010). Table 1.2 displays several antimicrobial compounds that have been isolated from the 
Streptomyces spp., among other bacteria within the Actinobacteria class (Miao and Davies, 2010). 
Due to geographical variation in the overall ecosystems and microorganisms present in soil, 
it is likely the presence of antibiotic-producing Actinomycetes within this microbiome is also 
variable, and hence returning to the study and isolation of Actinomycetes and other 
microorganisms in supposed unexplored soil ecosystems, allows the potential for novel inhibitory 
compounds to be found (Singh et al., 2012). 
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Table 1.2: Commercial therapeutic drugs, originally produced by organisms belonging to the 
Actinobacteria class (adapted from Miao and Davies, 2010). 
Compound Medical application Antimicrobial-Producing 
organism 
tetracycline Antibacterial Streptomyces aureofaciens 
streptomycin Antibacterial Streptomyces griseus 
kanamycin Antibacterial Streptomyces kanamyceticus 
cefoxitin Antibacterial Streptomyces lactamdurans 
vancomycin Antibacterial Amycolatopsis orientalis 
chloramphenicol Antibacterial Streptomyces venezuelae 
ivermectin Antihelminthic Streptomyces avermitilis 
nystatin Antifungal Streptomyces noursei 
bleomycin Anticancer Streptomyces verticillus 
 
 
A study by Iliĉ and colleagues (2007), characterised the antibacterial, as well as antiviral 
activity of secondary metabolites produced specifically by Streptomyces spp. isolated from soil from 
southeast Serbia. A total of 20 different Actinomycetes were isolated, with the five most active 
isolates being identified as Streptomyces hygroscopicus, which were seen to have antimicrobial 
activity against all the test organisms used; this included P. aeruginosa, Enterobacter aerogenes, 
Candida albicans, as well as anti-viral activity against the Herpes Simplex virus. A more recent study 
by Ganesan and colleagues (2016), aimed to locate Actinomycetes in soil samples from Tamil Nadu, 
India, and determine inhibitory activity towards fungi, as well as bacteria. Forty-four out of a total 
of 106 Actinomycetes strains isolated, displayed antimicrobial activity against at least one of the 
different pathogenic microbes, with five of these showing broad inhibitory activity against the 
majority of the 24 microbes used, including inhibitory action against Proteus vulgaris, Klebsiella 
pneumoniae and the fungi Candida tropicalis. One of these five highly inhibitory strains also showed 
inhibition towards all 24 of the test organisms used, which was identified to have 98% similarity to 
Streptomyces rimosus, using DNA sequencing results. This study, combined with the findings by Ilic 
and colleagues (2007), display that novel compounds with a broad range of inhibitory activity are 
still being produced and isolated from the Streptomyces genus, and that the Actinomycetes group 
have immense potential in the search for new antimicrobial compounds.   
Further studies have also isolated extracellular metabolites from Actinomycetes, focusing 
on those with antifungal potential (Sharma and Parihar, 2010). Kavitha and colleagues (2010) 
isolated four different Actinomycete strains, three of which were from the Streptomyces genus, 
with one of these producing metabolites with strong antifungal activity against such fungi as 
Aspergillus flavus and Aspergillus niger. Microorganisms from the Streptomyces genus only, have 
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also been seen to produce compounds with antifungal activity. Twenty-seven (6.8%) out of the 396 
Streptomyces isolates obtained from soil samples, collected from the rhizosphere of 16 medicinal 
plants in Thailand by Khamna and colleagues (2009), were seen to produce antifungal activity 
towards at least one of the six pathogenic fungi tested. One Streptomyces strain obtained, was seen 
to strongly inhibit all the test fungi. This study focussed on inhibitory activity towards fungi that 
were pathogenic towards plants, which demonstrates the need for inhibitory compounds to work 
against crop pathogens in the agricultural industry, as well as the research needed for the 
production of novel antimicrobials for use in the medical sector, to overcome the ever-increasing 
resistance being seen.  
1.4 Factors affecting antimicrobial compound production 
As well as sampling areas of soil alone, areas where animals and livestock influence the soil 
microbiome may affect the presence of organisms with the ability to produce inhibitory 
compounds. Farmlands could be especially resource-rich in the hunt for novel antimicrobials, due 
to the effect the local environment and farm animals may have on the ecosystem, as well as the 
increased likelihood of antimicrobial use, that is likely to affect the resulting microorganisms in the 
samples (Hyde et al., 2017). Few of the studies on the isolation of soil microorganisms have 
focussed on the isolation of organisms from areas where significant numbers of livestock reside. 
One study by Sharma and colleagues (2016) investigated the antimicrobial potential of a Nocardia 
strain they isolated from a wildlife sanctuary in India, finding that it had strong inhibitory activity 
against Gram-positive and Gram-negative bacteria, as well as yeasts. Bizuye and colleagues (2013) 
also investigated the isolation of Actinomycetes for the production of antibiotics in soils, in North 
West Ethiopia, with a cattle breeding area being one of the five sites from where soil was sampled. 
Ten out of 30 Actinomycetes isolated, originated from this breeding area, with two of these 
displaying antimicrobial activity against one of the test bacteria and fungi used. Upon further 
screening it was determined that both the isolated Actinomycetes from the breeding ground had 
activity against both Gram-positive and Gram-negative bacteria, with one of them having further 
activity against fungi (Bizuye et al., 2013). These studies may highlight that the collection of samples 
where the soil microbiome is affected by the presence of animals, is a promising area for the 
location of antimicrobial producing Actinomycetes, and other organisms of interest.  
The isolation of Actinomycetes/Streptomyces spp. from soil and natural environments can 
be seen to still be a viable method for the isolation of inhibitory compounds with a vast range of 
activity towards differing organisms. However, the mechanisms behind which antibiotics are 
produced by these organisms are still not completely understood, but it is known that there are 
several intermediate stages and molecules/metabolites involved, which are influenced by the 
external environment conditions, as well as several methods of regulation including precursor 
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accumulation, transport of nutrients and regulation of gene expression (Rokem et al., 2007). It has 
been noted that adverse or stressful growth conditions encourage microorganisms such as 
Streptomyces spp. to produce antibiotics. Hayes and colleagues (1997) showed that Streptomyces 
coelicolor produced methylenomycin, an antibiotic, under alanine-limited conditions, and/or a 
triggered acidic pH shock, through increased transcription of the mmy gene and hence increased 
production of methylenomycin. However, heat and alkali pH shock, as well as the addition of 
alcohol had no effect on triggering the production of methylenomycin, and hence it was shown that 
the antibiotic production occurs as a specific stress response to particular conditions, not any 
general stress conditions (Hayes et al., 1997). This displays that environmental factors, such as 
nutritional availability and pH, play a major role in the production of antibiotics. 
The need for discovery and development of new antimicrobials is a growing concern in both 
the world of human and veterinary medicine. This study aims to continue this search for novel 
secondary metabolites by using forestry and farmland sampling for the isolation of APO, and 
Streptomyces spp. using active selection. As far as it is known Friston Forest, New Forest, and the 
farmland areas sampled are unexplored, and hence could lead to the isolation of potential APO. 
 
1.5 Hypothesis 
It has been hypothesized that the untested forestry and farmland areas selected, contains 
soil microorganisms with the ability to produce novel inhibitory compounds, able to inhibit the 
growth of pathogenic strains of bacteria, including both Gram-negative and Gram-positive 
organisms. Within these isolated organisms, designated as antimicrobial producing organisms, a 
large quantity is theorised to belong to the Streptomyces genus, a common soil bacterium with a 
known ability to produce a vast amount of secondary metabolites. 
The isolation of pathogenic bacteria, from the same soil samples collected for the isolation 
of the microorganisms with inhibitory ability, has also been hypothesized, due to the varying 
microbiomes. As far as is known, these forestry and farmland areas have not yet been tested for 
the presence of microorganisms, both pathogenic as well as those presenting antimicrobial 
activities, and hence it is hypothesised that isolation of novel compounds is more likely.  
 1.6 Aims 
The present study aims to use the soil samples collected from Friston and New forest, as 
well as Dawes Farm, to isolate and determine the prevalence of organisms with the ability to 
produce compounds, able to inhibit the growth of selected test bacteria. Using sensitive and 
resistant test bacteria within the perpendicular streak method, as well as a newly developed 
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starvation method, the extent of the inhibitory activity of these compounds and their producers 
can be determined. 
Using the same soil samples, this study also aimed to isolate and determine the prevalence 
of selected pathogenic bacteria in the soil samples collected, using a range of biochemical tests to 
identify organisms isolated to a genus level, and allow comparative analysis to organisms with 
inhibitory ability isolated from the same locations. 
Using determinative PCR (polymerase chain reaction), and primers specific to the 16S rRNA 
gene of the Streptomyces spp., this study’s final aim is to determine the extent of organisms 
belonging to this genus, with all isolated bacteria, from the 3 locations, presenting morphological 
resemblance to this genus, being tested. 
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2.0 Materials and Methods 
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2.1 Materials 
All broth and agar media were autoclaved at 121°C at a pressure of 15 psi for 15 minutes 
for sterilisation.   
2.1.1 Media 
Several agar and broth media were prepared using the instructions provided. These 
included Nutrient agar (Oxoid, CM0003), Mannitol Salt Agar (Oxoid, CM0085), Edwards modified 
medium (Oxoid, CM0027), Simmons Citrate agar (Oxoid, CM0155), and MacConkey, both with and 
without crystal violet (Sigma, M8302, and Oxoid, CM0007 respectively), Mueller-Hinton agar 
(Oxoid, CM0337), Nutrient broth (Oxoid, CM0001), and Tryptone soy broth (Oxoid, CM1016). 
2.1.1.1 Oat agar 
Oat agar was used for the cultivation and isolation of APO, specifically Streptomyces spp. 
(Shepherd et al., 2010). Fine oats (60 g) were added to 1 L of distilled water and left to steep for 30 
minutes, before passing through a cheesecloth to remove solid matter. Bacteriological agar (12.5 
g) (Oxoid, LP0011) was added to the oat mixture before the volume was made up to 1 L using 
distilled water, before autoclaving as above in section 2.1. 
2.1.1.2 Potato starch agar 
Potato starch agar was used for the cultivation and isolation of APO, specifically 
Streptomyces spp. Potato starch (10 g) (Fisher Sci, 15413047), gelatin peptone (5 g) (Oxoid, LP0008), 
beef extract (3 g) (Oxoid, LP0029) and bacteriological agar (15 g) (Oxoid, LP0011), was added to 1 L 
of water before autoclaving as described in section 2.1. Post-autoclaving 50 µg/ml anti-fungals, 
cyclohexamide (Sigma 01810) and nystatin (sigma N4014), was aseptically added to cooled oat and 
potato starch agar. Both potato starch and oat, as well as nutrient agar plates and slopes were used 
for storage of the APO, and all other isolates.  
2.1.1.3 Mannitol soy agar 
Mannitol soy agar was used for the cultivation and sporulation of potential Streptomyces 
spp. isolates. Soya flour (20 g), Mannitol (20 g), bacteriological agar (20 g) (Oxoid, LP0011) and 
Magnesium (5 mM) were added to 1 L of distilled water, before autoclaving as stated in section 2.1. 
2.1.1.4 Plate count broth and agar  
Plate count broth, was made using 5 g peptone (0.5%) (Sigma, 70169), 2.5 g yeast extract 
(0.25%) (Sigma, 92144) and 1 g of glucose (0.1%) (Sigma, G8270) in 1 L of distilled water. Plate count 
agar was made using the same concentrations of products with the addition of 15g of 
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bacteriological agar (1.5%) (Oxoid, LP0011) to this mixture. Both plate count broth and agar were 
autoclaved as described in section 2.1. 
2.1.2 Biochemical characteristic testing products 
Tryptone water was made for use in indole testing using 10 g of Tryptone (Sigma, T9410) 
and 5 g of sodium chloride (Sigma, S7653) in 1 L of distilled water, before being autoclaved as stated 
in section 2.1, and Kovacs reagent (SLS, CHE2280) was used according to instructions. Urea broth 
(Sigma, 51463) was made according to instructions, and sterilised using filtration. Ringers solution 
(Sigma, 96724) was made according to instructions for McFarland standardisation of bacteria; one 
tablet was dissolved in 500 ml of distilled water and autoclaved as stated in section 2.1. Other media 
including Phosphate Buffered Saline (PBS) (Thermofisher, 003002) and selective agar (see section 
2.1.1) were made according to instructions and autoclaved as described in section 2.1.  
Oxidase reagent was made by mixing 0.01 g of N,N,N′,N′-tetramethyl-p-phenylenediamine 
(TMPD) (Sigma, 87890) in 1 ml of distilled water. Catalase reagent (2% Hydrogen peroxide (v/v)) 
was made by mixing 1 ml of 20% Hydrogen peroxide into 9ml of sterile distilled water. Analytical 
Profile Index (API) testing was carried out using the API 20E kit, following instructions for correct 
use (bioMérieux). Coagulase test was carried out according to instructions stated in the Staphylase 
test kit (Oxoid, DR0595).  
2.1.3 Bacterial cultures 
Test bacteria Escherichia coli (NCTC 11954), Staphylococcus aureus (NCTC 6571), 
Staphylococcus epidermidis (NCTC 13360), Pseudomonas aeruginosa (NCTC 13359), Proteus 
mirabilis (NCTC 13376), Streptococcus pneumoniae (NCTC 7465), and Salmonella Typhimurium 
(NCTC 10787) were obtained from Kingston University Culture Collection, London.  
Clinical strains of test bacteria, stored at Kingston University, were isolated from differing 
locations. P. mirabilis, and E. coli were obtained from Dr Brian Jones at the University of Brighton, 
UK, and from Dr Jackie Kenny at the Royal Marsden hospital, Sutton, London, UK.  NCTC control 
strain of Methicillin-Resistant S. aureus (MRSA) was also used (NCTC 12493).  
Streptomyces coelicolor, strain M145, used as a positive control in PCR and gel 
electrophoresis for the identification of Streptomyces spp. was kindly provided by Dr Paul Hoskisson 
from the University of Strathclyde, UK. All isolates were stored at -80°C using cryovials. 
2.1.4 Genomic DNA 
DNA isolated from Streptomyces coelicolor, M145, also provided by Dr Paul Hoskisson at a 
final concentration of 13 ng/µl, was used as a positive control in the Polymerase Chain Reaction 
(PCR), and gel electrophoresis for the identification of Streptomyces spp. (see section 2.2.3.3). 
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2.1.5 Polymerase chain reaction and gel electrophoresis 
Primers specifically targeting the 16S rRNA gene belonging to the Streptomyces spp. were 
provided from Dr Paul Hoskisson from the University of Strathclyde (Kirby et al., 2011) (Table 2.1). 
Tris-Borate-EDTA (TBE) buffer was made prior to PCR for use as gel material, and for the running of 
the gel, using   10.8 g Tris base, 5.5 g Boric acid, and 0.75 g Ethylenediaminetetraacetic acid in 1 L 
of distilled water, at a final pH of 8.0. 
 
Table 2.1: Forward and reverse primers used for the amplification of the 16S rRNA gene, for the 
detection of Streptomyces spp. designed by Dr. Paul Hoskisson (Kirby et al., 2011). 
Forward  Reverse 
27S (5’ – AGAGTTTGATCCTGGCTCAG – 3’) 1492R (5’ – TACGGCTACCTTGTTACGACTT – 3’)  
 
 
2.2 Methods 
2.2.1 Sample collection 
Samples were aseptically collected to fill sterile 50 ml falcon tubes using gloves, at several 
areas in duplicate within the Friston Forest (Modern Forest) and New Forest (Ancient Forest) areas, 
with soil disturbed using a clean trowel and collected using the falcon itself. Samples were also 
taken at several sites at Dawes Farm, (Warnham, UK) using the same method, with geographical 
coordinates (longitude and latitude), and area information noted down at location (see appendix 
tables A1, A3 and A8). Forty-two samples were collected from New Forest (Hampshire, UK), in 
November 2016. Twenty samples were taken from Friston Forest (East Sussex, UK), and 22 samples 
were taken from Westpoint Farm Vets, Dawes Farm, in April 2017 and May 2017 respectively.  All 
samples were labelled and transported to the lab for further testing, and stored at 4°C.  
 
2.2.2 Isolation of microorganisms from the soil samples 
2.2.2.1 Optimisation of the isolation of microorganisms from the soil samples 
Initially, soil samples were directly streaked onto all agars used: MSA; Nutrient; 
MacConkey; and Edwards agar. However, to make isolation less complex, and prevent the 
specificity of the different selective agar having an effect on the organisms isolated, soil samples 
were initially plated onto nutrient agar and further cultured onto selective agar, according to Gram 
stain. Both 1/10 and 1/100 dilutions of soil diluted in Ringer solution were tested, with a 1/100 
dilution being deemed as optimal, due to the denser cultures a 1/10 dilution presented. 
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2.2.2.2 Isolation of pathogenic organisms 
Previously selected pathogenic strains were targeted to be isolated from soil samples if 
present: E. coli; Salmonella spp.; Klebsiella spp.; and Streptococcus faecalis were highlighted as 
important in the isolation of bacteria from all forest and farmland soil samples. 
A 1/100 dilution of the soil samples was made by adding 0.25 g of soil to 24.75 ml of 
sterilised Ringers solution and vortexed to resuspend the soil in the solution.  Samples were spread 
over nutrient agar, using a sterile cotton swab, before being incubated for 24 hours at 37°C.  
Bacterial isolates were then subcultured onto one half of nutrient agar plates, according to 
differences in morphology to achieve pure cultures on nutrient agar, which was confirmed via Gram 
stain.  
2.2.2.3 Isolation of Antimicrobial Producing Organisms and Streptomyces spp. 
Five grams of each soil sample was placed into empty sterilised petri dishes and dried for 
5-7 days in the incubator at 45°C. The aim of this was to reduce the levels of Gram-negative bacteria 
in the sample to aid the isolation for Streptomyces spp. (Chaudhary et al., 2013). 
Dried soil samples were diluted to 1/100 and spread on agar using the same method as 
above (see section 2.2.2.2). The farm and Friston Forest samples were streaked onto both potato 
starch and oat agar plates. New Forest samples were streaked onto potato starch agar only, due to 
the further optimisation of agar, and development of methodology after the New forest samples 
were initially tested. All plates were incubated for 7-10 days at 25°C for optimal growth of the 
Streptomyces spp. Bacteria presenting areas of growth inhibition towards other organisms, grown 
from the same soil sample, and/or similar colony morphology to that of Streptomyces spp. were 
selected and sub-cultured onto nutrient agar until pure cultures were obtained. All APO were 
numbered according to the total amount obtained from the three locations in total. Pure samples 
were maintained using the cultivation agar of choice (potato starch or oat agar). Samples were also 
stored using cryovials and nutrient agar slopes at -80°C and room temperature respectively.  
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2.2.3 Identification and characterisation of isolated bacteria  
2.2.3.1 Optimisation of the identification and characterisation of isolated bacteria 
PCR was optimised for the identification of Streptomyces spp. from the APO isolated using 
the amplification of the 16S rRNA gene from this genus. Streptomyces coelicolor and its previously 
extracted DNA, provided by Dr Paul Hoskisson, was used to allow the optimisation of the reaction 
mixture, before performing the protocol on DNA extracted from APO. Varying concentrations of 
both DNA and primers were tested; 4 ng/µl, 2 ng/µl, 1 ng/µl, and 0.5 ng/µl, concentrations of DNA 
were tested, as well at the use of 1 µM/µl, 500 nmol/µl, 100 nmol/µl, 10 nmol/µl, 1 nmol/ µl, and 
100 pmol/µl, concentrations of primer in the final reaction mixtures. Test DNA was chosen to be 
standardised at ~2 ng/µl, with a primer concentration of 1 µM/µl used in the final reaction mixtures.  
Both final concentrations of 5% and 0.2% (v/v) DMSO we also tested in the final 25 µl reaction 
mixture, with 5% being optimal. Both a 1% as well as a 2% (w/v) agarose gel were tested for optimal 
separation of the DNA, with a 2% gel detailing better band separation. 
2.2.3.2 Identification and characterisation of pathogenic bacteria of interest 
 ‘Pure’ cultures of different bacterial isolates collected from the soil were subjected to 
various biochemical tests, to allow further identification of the bacterial species present (Table 2.2). 
Initial Gram staining allowed identification of the shape and Gram reaction of the individual isolates, 
as well as confirming cultures were pure. Using a sterile metal loop, the bacterial samples were 
added to 10µl of distilled water already placed on a slide, with the cells then being fixed using a 
Bunsen flame. Stains were added accordingly to samples using the minute method; in order Crystal 
violet, Gram’s iodine, alcohol solution (80% methanol and 20% acetone (v/v)), and Carbol fushin 
were added, with distilled water used to rinse slides between stains (Yazdankhah et al., 2001). It 
should be noted that the alcohol solution however was left on slides for 30 seconds only. Slides 
were then dried using paper towel and were viewed under the microscope at x1000 oil immersion 
magnification. Apparent mixed cultures were further streaked, and again Gram stained. Cell shape, 
Gram stain, and colony morphology was noted alongside isolate numbers. 
Isolates were plated onto selective media according to their Gram stain. Gram-positives 
were plated on Mannitol salt agar, and Edwards modified medium for the detection of the 
Staphylococcus spp. and Streptococcus spp. respectively (Abiola and Oyetayo, 2016). Gram-
negative bacteria were streaked onto MacConkey agar, both with and without crystal violet, to 
confirm the presence of Gram-negative bacteria; the inclusion of crystal violet renders the medium 
more selective for Gram-negative bacilli (See section 2.1.1) (Abiola and Oyetayo, 2016). Biochemical 
tests were used to identify the isolated pathogens from the soil. Results from catalase, oxidase, 
citrate, indole, urea, and API testing were used to identify isolates collected from the non-dried 
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soils samples, to a species level (see sections 2.1.1 and 2.1.2) (Cowan and Steel, 2003; Abiola and 
Oyetayo, 2016). Positive and negative controls were used in each individual biochemical test to 
confirm the accuracy of results, according to table 2.2, using the test organisms stated in section 
2.1.3.  
 
Table 2.2: The several biochemical tests used for the identification of organisms isolated from the 
wet soil samples. The test organisms used as positive and negative controls for the individual tests 
are given, with the test strains used stated in section 2.1.3 used (Abiola and Oyetayo, 2016). The 
individual biochemical testing products can be seen in section 2.1.2. 
Biochemical 
test 
Biochemical test analysis Positive biochemical test 
result 
Test organisms used to confirm positive 
(+VE) and negative (-VE) results for 
biochemical test. 
   +VE -VE 
Gram Stain Determination of the cell 
wall structure and shape 
(Gram-positive or Gram-
negative bacterium). 
Purple stain retained by the 
cell wall – visualised by 
microscope. 
Staphylococcus 
spp. 
Enterobactericeae 
 (e.g E. coli, Salmonella 
spp. etc) 
Catalase 
test 
Determination if the 
bacterial isolate contains 
the catalase enzyme. 
Bubbles are seen upon the 
addition of the bacteria to 
hydrogen peroxide. 
Staphylococcus 
spp. 
Streptococcus 
pneumoniae 
Oxidase test Positive result indicates 
the presence of the 
cytochrome C oxidase 
enzyme (indicates the 
bacteria is aerobic). 
The appearance of a blue 
colour after the addition of 
bacteria to filter paper 
coated with TMPD. 
Pseudomonas 
aeruginosa 
Escherichia coli 
MacConkey 
agar 
Growth of Gram-negative 
bacteria only. 
Determination of Lactose 
fermentation. 
Positive lactose 
fermentation result is 
indicated by growth of pink 
colonies. 
Escherichia coli Proteus mirabilis 
Simmon’s 
citrate test 
Positive result for 
organisms with the ability 
to use citrate as a carbon 
source. 
Visible bacterial growth 
and/or a colour change of 
the agar to blue. 
Salmonella 
Typhimurium 
Escherichia coli 
Urease test Positive result indicates 
the presence of the 
urease enzyme and 
ability to utilise urea. 
Presence of the urease 
enzyme indicated by the 
colour change of the media 
to pink. 
Proteus 
mirabilis 
Escherichia coli 
Coagulase 
test 
Differentiation of 
Staphylococcus spp. using 
the ability of the 
organism to convert 
fibrinogen to fibrin. 
Agglutination of the plasma 
added indicates a positive 
result. 
Staphylococcus 
aureus 
Staphylococcus 
epidermidis 
Indole test Ability of the organism to 
convert tryptophan to 
Indole. 
A pink colouring of the liquid 
is produced. 
Escherichia coli Staphylococcus aureus. 
Mannitol 
Salt agar 
Selective for Gram-
positive bacteria. 
Distinguish between 
Staphylococcus spp. using 
mannitol fermentation. 
Colour change of pink/red 
agar to yellow indicates a 
positive result for the ability 
to ferment mannitol. 
Staphylococcus 
aureus. 
Staphylococcus 
epidermidis. 
Edwards 
modified 
medium. 
Specific for the isolation 
of Streptococcus spp. 
Growth on agar indicates a 
positive result for the 
presence of Streptococci spp. 
Streptococcus 
pnuemoniae. 
Escherichia coli 
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2.2.3.3 Identification and characterisation of Antimicrobial Producing Organisms and 
Streptomyces spp. 
Gram staining was again used for confirmation of pure cultures, of the organisms isolated 
from the dried soil samples, selected due to seen inhibition and/or similar colony morphology to 
that of Streptomyces spp. Actinomycetes (e.g. Streptomyces spp.) were selectively identified 
according to its known long rod shape using the Gram stain method, as well as its colony 
morphology; on nutrient agar they often present thick, hard to move colonies, with pigmentation 
often seen. Different aerial and substrate mycelium colours were also used to selectively isolate 
those potentially belonging to the Streptomyces genus.  
The identification of Streptomyces spp., was confirmed using Polymerase Chain Reaction 
(PCR) and primers specific for the 16S rRNA gene, found within Streptomyces spp. (Table 2.1).  
Prior to the PCR protocol, a sterile loop was used to inoculate the potential Streptomyces 
spp. onto mannitol soy agar before incubation for 5-7 days at 25°C, allowing time for sporulation. 
The agar plates were then flooded using 20 ml of 20% (v/v) glycerol solution, (diluted using distilled 
water before autoclaving as above), and a cotton bud was used to swab the agar surface to dispense 
the potential Streptomyces spores into solution. Two millilitres of this glycerol solution was then 
placed into 100 ml of Tryptone soy broth before incubating with shaking at 25°C for ~ 2 days ready 
for DNA extraction. One millilitre of each sample in tryptone soy broth was then placed into sterile 
Eppendorf tubes in duplicate and centrifuged at 10,000 x g for 5 minutes. The supernatant was 
discarded before resuspension in 1 ml of PBS, by vortexing. Centrifugation and resuspension was 
again repeated as above in PBS, before placing Eppendorf’s in a heat block at 105°C for 10 minutes. 
Eppendorf tubes were then centrifuged again for 5 mins at 10,000 x g, before measuring the DNA 
concentration and purity of the supernatant in triplicate using the Nanovue spectrophotometer. 
The mean DNA results were recorded for each of the isolates tested from the 3 locations. The 
supernatant was further diluted 1/10 (v/v) using PBS, in preparation for PCR.  
The DNA extracted as above, was added alongside correct volumes of the primers, water, 
Dimethylsulfoxide (DMSO) (Sigma, D2650) and DreamTaq (Fisher Scientific, 11813933) (Table 2.3), 
into a sterile 0.2 ml Eppendorf tube before being placed into a thermal cycler. A no DNA negative 
control was used, with the DNA volume of the reaction mixtures replaced with sterilised water. 
Table 2.4 details the PCR conditions, provided by Dr Paul Hoskisson, for amplification of the 16S 
rRNA gene in Streptomyces spp. Five microliters of each sample or 100bp plus DNA ladder 
(Thermofisher, SM0321) were added to each well in a 2% agarose gel (see below) and run at a 
voltage of 65V (PowerPacTM Biorad) for ~105 minutes. DNA band visualisation was then achieved 
using the Gbox, with clear bands at ~1500bp indicating organisms belonging to the Streptomyces 
genus, ensuring no band was present in the no template DNA well.  
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For the separation of DNA, a 2% (w/v) agarose gel was made by mixing 1.50 g of agarose in 
75 ml of TBE buffer (see section 2.1.5), and heating until a homogenous clear liquid state is reached. 
After slight cooling, nine microliters of SYBR safe (Fisher Scientific 10328162) was added to the gel 
before pouring into cassette and placing in the well comb, leaving the gel to set. Once set, combs 
were removed, and gels were placed into a horizontal Sub-Cell electrophoresis cell (Biorad) before 
being immersed in ~250 ml TBE buffer, ensuring the gel was well covered.  
 
Table 2.3: The reaction mixture used in PCR for the detection of Streptomyces spp. 
Component Volume (µl) 
Dream Taq 12.5 
Forward primer  1.00 
Backwards primer 1.00 
Template DNA 1.00 
Nuclease free water 8.25 
100% DMSO (5% final concentration) 1.25 
Total volume (µl) 25 
 
 
 
Table 2.4: The PCR conditions used for the amplification of the 16S rRNA gene within the 
Streptomyces spp. 
Step Temperature (°C) 
Time 
(mins) 
No. of 
Cycles 
Initial Denaturation 95 10 1 
Denaturation 95 1 
30 Annealing 50 0.75 
Extension 72 1.5 
Final Extension 72 10 1 
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2.2.4 Further testing of Antimicrobial Producing Organisms 
Inhibitory activity exerted by the APO isolated from Friston Forest, New Forest, and Dawes 
Farm samples, was established using several methods against a range of both sensitive laboratory 
strains and clinical isolates of test bacteria. 
2.2.4.1 Optimisation of novel antimicrobial screening (perpendicular streak method) 
Initially, potential APO were incubated for 0, 2, 5 and 7 days, before the addition of the test 
bacteria to the Mueller-Hinton plates, used for perpendicular screening, However, due to time 
constraints, incubation of the potentially inhibitory bacteria for 5 and 7 days prior, was determined 
as unnecessary and was not continued in the final experiment.  
2.2.4.2 Novel antimicrobial screening against sensitive strains of test bacteria (perpendicular 
streak method) 
Perpendicular streak method was used to determine antagonistic activity of the APO 
against sensitive strains of both Gram-negative (E. coli, P. aeruginosa and P. mirabilis) and Gram-
positive (S. aureus and S. epidermidis) bacteria (Singh et al.,2016; Gebreyohannes et al., 2013). Both 
test bacteria and APO of interest were diluted to 0.5 McFarland (1.5 x 108 CFU/ml) in Ringer’s 
solution, vortexing to mix (see section 2.1.3). 
Diluted test bacteria were added, in duplicate, to diluted APO of interest, that had no prior 
incubation and 2 days previous incubation, at both 25°C and 37°C on Mueller-Hinton agar, at a 90° 
angle, (perpendicular streak), before further incubation at original growth temperature (Singh et 
al.,2016; Gebreyohannes et al., 2013). Figure 2.1 displays the layout of the agar plates used to test 
APO in the perpendicular screening method. The APO were incubated with the test bacteria for up 
to 7 days, with routine checks for any inhibition occurring every other day. Inhibition by the APO 
against any of the test bacteria was recorded, and repeat experiments were carried out using the 
same APO for confirmation of inhibitory action. Isolates displaying inhibition against sensitive 
strains of bacteria were further tested using clinical isolates, including some that conferred 
resistance to differing antibiotics. 
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Figure 2.1: Displays an example of the layout of the Mueller-Hinton agar plates used to test the 
inhibitory activity of the APO against sensitive strains of test bacteria in novel antimicrobial 
screening. The red line indicates where the APO being tested was streaked, with the blue line on 
the right displaying the starting point at which the sensitive test organisms were streaked from 
towards the edge of the agar plate, causing the heaviest inoculum to be closer to where the APO 
was streaked. 
 
2.2.4.3 Antimicrobial screening against clinical strains of test bacteria (perpendicular streak 
method) 
Clinical strains of Proteus spp., E. coli and MRSA, were used to further test the inhibitory 
activity of APO of interest (see section 2.1.3). Prior to testing antibiograms were initially run to 
determine the sensitivity of the clinical strains used. Clinical strains of bacteria were diluted to 0.5 
McFarland standard (1.5 x 108 CFU/ml), before being streaked as a lawn onto plates of Mueller-
Hinton agar of ~4 mm in thickness, by swabbing in three directions across the plate. Selected 
antibiotic discs (see below) were then placed onto the surface of the plate using an antibiotic 
dispenser before being incubated at 37°C for 24 hours. Zones of inhibition were then recorded, and 
sensitivity of the strains was determined. P. mirabilis and E. coli were tested against amoxicillin and 
clavulanic acid (30μg), imipenem (10 μg), cefotaxime (5 μg), ciprofloxacin (5 μg) and gentamycin 
(10 μg). MRSA was tested using erythromycin (5 μg), oxytetracycline (30 μg), gentamycin (10 μg), 
ciprofloxacin (5 μg), and cefoxitin (30 μg) discs. Susceptibility was determined using the European 
Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoint tables from 2017 (EUCAST, 
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2017). The data for oxytetracycline however was not available using this table, and hence results 
were reported for reference purposes. 
Clinical strains of test bacteria were then exposed to APO of interest, in accordance to prior 
inhibition seen against specific test bacteria, using the same method as above (see section 2.2.4.2). 
2.2.4.4 Optimisation of the starvation method 
In pilot experiments centrifugation of the APO cultures in plate count broth occurred at 
8000 x g for 5 minutes, however after transfer to plates large amounts of bacterial growth produced 
by the APO was seen, displaying a need for higher speed centrifugation to ensure more of the cells 
are pelleted. 
2.2.4.5 Starvation method 
All APO were further tested using the starvation method after initial screening above. APO 
were inoculated in the minimal medium of plate count broth (see section 2.1.1.4), for 7, 10 and 14 
days in duplicate, at both 25°C and 37°C. One day prior to the end of the incubation of the APO of 
interest, sensitive strains of test bacteria (E. coli, S. epidermidis, and S. aureus) (section 2.1.3), were 
diluted in Ringer solution to 0.5 McFarland standard (1.5 x 108 cfu/ml) and streaked as a lawn using 
a sterile cotton swab, on both Mueller-Hinton and plate count agar plates, and incubated for 24 
hours at 37°C.  Using this same method P. mirabilis was also prepared for use in the starvation 
method, however plates were streaked only for APO that had previously displayed inhibition 
towards this organism (Friston Forest and Farm APO only). P. aeruginosa was not used in this 
method due to lack of inhibition seen towards this organism, and time constraints. After incubation, 
1 ml of each organism was placed into an Eppendorf tube and centrifuged at 13,500 x g for 5 
minutes to pellet the cells. Ten microliters of this supernatant was then added to plates containing 
lawns of test bacteria, in duplicate, and incubated for 7 days at both 25°C and 37°C. Figure 2.2 
displays the layout of the agar plates used for further testing of the APO in the starvation method.  
Plates were monitored within this 7 day period and any inhibition caused by the supernatant was 
recorded. A further 2 ml of each broth inoculated with APO was centrifuged as above, allowing ~3 
ml of each supernatant to be collected and stored at 4°C, for further use in testing. Repeats were 
carried out on isolate’s that displayed inhibition against test bacteria on New Forest isolates only; 
for accuracy and reproducibility, the whole method was repeated, as well as a repeat using the 
stored supernatant collected from the initial round of experiments.  
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Figure 2.2: The layout of agar plates, either plate count agar, or Mueller-Hinton agar used 
to test inhibitory activity of APO supernatant in the starvation method. These plates were used to 
for standardised growth of the test bacteria (see section 2.2.4.5). A central line was drawn on the 
backs of the agar plates to distinguish between different broth cultures of the same APO which 
were grown in duplicate. Each duplicated growth of an APO was centrifuged and plated in duplicate 
again on one half of each agar plate.  
 
2.2.5 Chemical analysis of potential novel antimicrobials- pilot study 
The following methods were carried out in collaboration with Dr Adam LeGresley and Mr 
Rob Warren. Following the growth cycles reported in the starvation method (see section 2.2.4.5), 
the collected supernatant containing potential antibacterial components, was further analysed. 
2.2.5.1 Solvent extraction 
 The supernatants, from the bacterial cultures of interest were harvested using 
centrifugation (5000 rpm) and using a 1:1 (v/v) volume of supernatant vs. solvent, liquid – liquid 
extraction was performed. To facilitate extraction a total of 3 solvents were used including 
petroleum ether, dichloromethane and acetonitrile. The samples were cleaned to remove 
impurities such as protein residue that may interfere with analysis, by acidification of the samples 
to pH2 using HCl (1 M) and incubated at 4oC for 18 hrs. Following this incubation an equal volume 
of chilled acetone was added followed by filtration and neutralisation with NaOH (1 M). The 
residual acetone was removed by rotary evaporation before continuing with extraction. 
 The extraction was started using the least polar solvent, namely petroleum ether and 
stirred for two hours before performing the extraction. This was then followed by a 
dichloromethane extraction, shaking thoroughly, then finally an acetonitrile extraction. Due to 
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acetonitrile being miscible in water the salting out technique was used on this mixture (as 
described below in section 2.2.5.2). The individual fractions were then evaporated to dryness and 
NMR examination was carried out using a solvent of suitable polarity. 
2.2.5.2 Salting out 
The miscible layers in the solution were salted out using a 1:1 (v/v) volume of acetonitrile, 
and water and 1 M NaCl. This has shown to be a successful method for the extraction of 
erythromycin, having superior extraction efficacy and rapid phase separation compared to 
traditional liquid-liquid extraction (Le et al., 2001).  
2.2.5.3 Thin layer chromatography bioassay 
The separated fractions from the solvent extraction (see section 2.2.5.1), were run on TLC 
plates for the separation of compounds, using optimised TLC solvent systems, that differed for 
each fraction and determined using trial and error (see results section 3.2.3.3). Spots were 
detected under ultraviolet light by spraying TLC plates with water and ninhydrin for the detection 
of hydrophilic compounds, and compounds containing free amino groups (Alajlani et al., 2016). 
Each band was scraped off and extracted with MeOH 1M (methanol) to give a single compound 
for antibacterial testing and NMR analysis.  
 Plates containing 10 ml of yeast agar (Sigma, 01497) were prepared before the addition of 
the TLC plate, which was faced upwards. Nine millilitres of Mueller-Hinton agar (see section 2.1.1) 
and 1 ml of 1.5 x 108 CFU suspension of sensitive strains of either E. coli or S. aureus (see section 
2.1.3) in Ringers solution, were mixed and poured over the TLC plate. The plates were left in an 
incubator set at 37°C for 12 hours then coated in a 2.5 mg/ml solution of MTT (methyl thiazolyl 
tetrazolium) and allowed to incubate over 2 hours (Kagan et al., 2014).  
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Results 
The following 3 chapters discuss the results of both the APO, and the potentially pathogenic 
organisms isolated, from the 3 differing locations selected. This includes the New Forest, selected 
due to its classification as an ancient forest (section 3.0), as well Friston Forest (section 4.0), which 
is classified as a modern forest. Chapter 3, (section 5.0), discusses the results obtained from 
organisms isolated at Dawes Farm, providing a wider perspective on the effect a higher interaction 
rate of animals and humans have on the soil microbiome, and the hence resulting inhibitory activity 
seen. 
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3.0 Investigation of soil samples from the New Forest 
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3.0 Investigation of soil samples from New Forest  
Sampling of ancient woodland took place at New Forest, Hampshire, for the cultivation of 
both potentially pathogenic bacteria, as well as APO. The New Forest is well known for the vast 
amounts of differing wildlife, including free-roaming deer, ponies and birds, as well as being a 
recognisable tourist attraction, all capable of affecting the soil microbiome (Forestry Commission, 
2004). This consequently may affect the presence of organisms, including potential APO, within the 
soil, allowing the effects of an increased amount of human and animal interaction, and the forest’s 
known great history, to be compared to the other sample locations. The New Forest is classed as 
being an ‘ancient’ forest, due to it originating before 1600 A.D, with it also mentioned in the 
Domesday book, completed in 1086, also confirming the forest was not established due to tree 
planting (National Archives, 2017; Spake et al., 2016). 
Several different samples of the 219 square mile area of the New Forest, were taken and 
studied, in collaboration with the Forestry Commission, to increase the chances of isolating APO, as 
well as pathogenic bacteria, and to allow comparison between the samples collected at the New 
Forest, due to differing location characteristics.  
 
3.1 Methods 
3.1.1 Isolation and characterisation of microorganisms within the soil 
Soil samples were collected at several varying areas of the New Forest using methods stated 
in section 2.2.1, with all locations and their characteristics noted (see Appendix Table A1). Isolation 
of pathogenic organisms from the non-dried (wet) soil samples, was carried out according to section 
2.2.2.2, and characterised using the several biochemical tests as stated in section 2.2.3.2. Isolation 
of APO was carried out according to section 2.2.2.3, using potato starch agar only, and characterised 
as seen in section 2.2.3.3, which included DNA extraction for PCR based identification of 
Streptomyces spp., however PCR itself was not carried out due to time constraints, hence APO could 
only be presumed as belonging to this genus. 
3.1.2 Further testing of the Antimicrobial Producing Organisms isolated 
Perpendicular screening and the starvation method were carried out with sensitive strains 
of test bacteria, according to sections 2.2.4.2, and 2.2.4.5 respectively. P. aeruginosa and P. 
mirabilis were not further used in the starvation method, due to lack of inhibition towards these 
organisms in initial screening, and time constraints. The readdition of supernatants was carried out 
according to the methodology as written in 2.2.4.5, plates of sensitive strains of E. coli, S. 
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epidermidis and S. aureus were streaked and incubated 24 hours prior to the readdition of APO 
supernatants, stored from the previous round of the starvation method. 
 The several supernatants produced from isolate 26, over several of the differing days 
incubation in the starvation method (see above), were combined and further analysed due to the 
displayed antibacterial capabilities. Due to the inhibition of the same test organisms by isolate 26, 
the combined supernatants were assumed to contain the same compounds. Solvent extraction, TLC 
and NMR were carried out according to sections 2.2.5.1, 2.2.5.2. and 2.2.5.3. Note that NMR was 
run for both of the compounds separated from the acetonitrile fraction, with a Rf value of one, to 
check if they were the same compound.    
The solvent systems were used as followed; chloroform: acetic acid (29:1) for the precipitate, 
chloroform: methanol (19:1) for both petroleum ether and dichloromethane fractions, and ethyl 
acetate: methanol: water (13:2:1) for the acetonitrile fraction. 
 
3.2 Results 
Forty-two soil samples were collected in November 2016 from differing areas of the New 
Forest, with Appendix Table A1 displaying the coordinates and sample area information.  
3.2.1 Isolation of pathogenic microorganisms 
Seventy-seven microorganisms were isolated and identified from the 42 non-dried soil 
samples, collected at the New Forest in November 2016 (Tables 3.1 and A1). One isolate (1.3%) was 
identified as belonging to Salmonella spp., three (3.9%) identified as belonging to the Pseudomonas 
spp. and two (2.6%) were identified as S. epidermidis, using the range of biochemical tests and API 
results. Cultivation of other isolates included Streptomyces spp. (11 isolates) (14.3%), Acinetobacter 
spp. (11 isolates) (14.3%), Kurthia spp. (10 isolates) (13.0%), and the Bacillus spp. (31 isolates) 
(40.3%), all shown to be prevalent at the New Forest (Table 3.1). Kurthia spp. was noted as above, 
due to its irregular shape of colony morphology resembling that of a ‘birds feather’.         
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Table 3.1: The Characteristics and presumptive identities of 77 isolates from the even numbered soil samples from the New Forest. (+VE) indicates 
a positive result, and (-VE) indicates a negative result to the individual biochemical tests used. A lack of growth seen by the individual organisms is 
also noted (No growth) Gram stain, oxidase, lactose fermentation, mannitol fermentation, catalase, citrate, indole, coagulase and urease results are 
detailed, as well as colony size and morphology for differing isolates. Colony morphology is noted as the organism is seen on nutrient agar. Coagulase 
tests were carried out on Gram-positive cocci only. Blank results in the biochemical test sections, indicate that the specific test was not carried out 
on the corresponding isolate. (API), indicates the presumptive spp. was determined using the API test as stated in section 2.1.2. 
Isolate 
number 
Colony 
size (mm) 
Colony morphology Gram Stain Oxidase 
test 
Lactose 
fermentation 
Mannitol 
fermentation 
Catalase Simmon’s 
Citrate test 
Indole test Coagulase 
test 
Urease 
test 
Presumptive spp. 
2.1 3 Glossy, white, risen. Long Gram-positive 
rods. 
-VE   +VE +VE -VE   Streptomyces spp. 
2.2 1 Cream, circular, matte. Gram-negative rods. +VE +VE  +VE +VE -VE   Pseudomonas spp.  
2.3 3 White, irregular shape, 
matte. 
Gram-positive rods -VE  -VE +VE +VE    Bacillus spp. 
2.4 1 Cream, circular, matte. Gram-negative rods. -VE -VE  +VE     Acinetobacter spp. 
4.1 5 Cream, irregular shape, 
glossy. 
Gram-negative rods. -VE +VE  +VE -VE -VE   Cedecea spp. 
4.2 10 White, circular, matte. 
 
Gram-positive rods. -VE  No growth +VE +VE    Bacillus spp. 
4.3 2 Yellow, circular, glossy. Gram-negative rods. -VE -VE  +VE -VE -VE   Acinetobacter spp. (API) 
4.4 <1 White, circular, glossy.  Gram-negative rods. +VE -VE  -VE -VE -VE   Moraxella spp. 
6.1 <1 Pale white, circular, matte. Gram-negative rods. -VE -VE  +VE -VE   -VE Shigella spp.  
8.3 1 White, circular, matte. Gram-positive rods -VE    +VE +VE -VE   Bacillus spp. 
8.4 <1 White, circular, matte. Gram-negative rods. +VE +VE   +VE -VE   Acinetobacter spp. 
10.1 3 White, circular. Gram-positive rods 
with spores. 
+VE -VE   +VE +VE -VE   Bacillus spp. 
10.2 3 White, irregular shapes, 
matte. 
Gram-positive rods 
with spores. 
-VE   +VE +VE    Bacillus spp. 
10.3 3 White, irregular shape, 
matte. 
Gram-positive rods 
with spores. 
+VE   +VE +VE    Bacillus spp. 
10.4 1 White, circular, matte. Gram-positive rods 
with spores. 
+VE   +VE +VE    Bacillus spp. 
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Isolate 
number 
Colony 
size (mm) 
Colony morphology Gram Stain Oxidase 
test 
Lactose 
fermentation 
Mannitol 
fermentation 
Catalase Simmon’s 
Citrate test 
Indole test Coagulase 
test 
Urease 
test 
Presumptive spp. 
12.1 4 White, glossy, circular- 
rough edges. 
Long Gram-positive 
rods  
+VE -VE -VE +VE +VE -VE   Streptomyces spp. 
12.2 2 Cream, circular, glossy. Gram-positive rods. +VE  +VE +VE +VE    Bacillus spp. 
12.4 <1 White, glossy, circular. Long Gram-positive 
rods. 
+VE  -VE +VE +VE    Streptomyces spp. 
12.5 7 White, circular, matte. Gram-positive rods 
with spores. 
-VE  +VE +VE +VE    Bacillus spp. 
12.6 5 White, irregular shape 
with extensions, matte. 
Gram-positive rods. -VE  -VE  +VE -VE    Kurthia spp. 
12.7 2 Cream, circular, glossy. Gram-negative rods. +VE +VE  +VE +VE -VE   Pasteurella spp. (API) 
14.1 15 Cream, irregular shape 
with extensions, matte. 
Gram-positive rods  -VE -VE  +VE -VE -VE   Kurthia spp. 
14.2 2 White, irregular shape, 
matte. 
Long Gram-positive 
rods 
+VE   +VE +VE -VE   Streptomyces spp. 
14.3 4 White, irregular shape, 
matte. 
Gram-negative rods. +VE -VE  +VE -VE -VE   Moraxella spp. 
14.4.1 4 Large, glossy, circular. Gram-negative rods. -VE -VE  +VE     Acinetobacter spp. (API) 
14.4.2 4 White, circular, glossy. Gram-negative rods. -VE -VE  +VE     Acinetobacter spp. (API) 
14.6 1 White, circular, glossy. Long Gram-positive 
rods  
-VE -VE  +VE +VE -VE   Streptomyces spp. 
14.7 1 White, circular, glossy. Long Gram-positive 
rods 
-VE -VE  +VE +VE -VE   Streptomyces spp. 
16.1 15 White, irregular shape, 
matte. 
Gram-positive rods. -VE -VE -VE +VE -VE    Kurthia spp.  
16.2 5 White, rough-edged 
circular, matte. 
Gram-positive rods. -VE No growth No growth +VE +VE    Bacillus spp. 
16.3 2 Cream, circular, glossy. Gram-negative rods. -VE -VE  +VE +VE   -VE Salmonella spp. 
16.5 <1 White, circular, glossy. Long Gram-positive 
rods  
+VE No growth    -VE   Streptomyces spp. 
16.6 4 Cream, circular, glossy. Gram-negative rods. +VE -VE  +VE +VE -VE   Pseudomonas spp. 
18.1 30 Cream, irregular shape 
with extensions, matte. 
Gram-positive rods. -VE  -VE +VE -VE    Kurthia spp. 
18.3 4 Cream, circular, glossy. Gram-negative rods. +VE -VE   -VE -VE   Moraxella spp. 
18.4 2 Small, white colonies. Gram-negative rod +VE +VE  +VE +VE -VE   Pasteurella Spp. (API)  
18.5.1 3 Matte, rough circular. Gram-positive rods. -VE +VE  +VE +VE -VE   Bacillus spp. 
18.5.2 2 Glossy, circular. Gram-positive rods. +VE +VE -VE +VE +VE -VE   Bacillus spp. 
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Isolate 
number 
Colony 
size (mm) 
Colony morphology Gram Stain Oxidase 
test 
Lactose 
fermentation 
Mannitol 
fermentation 
Catalase Simmon’s 
Citrate test 
Indole test Coagulase 
test 
Urease 
test 
Presumptive spp. 
18.5.3 3 White, circular, glossy. Gram-negative rods. -VE -VE  +VE     P. paucimobilis (API) 
18.6 <1 White, circular, glossy. Gram-negative rods. -VE -VE  +VE     Acinetobacter spp. (API) 
20.1 12 White, irregular shape, 
matte. 
Gram-positive rods. -VE  -VE +VE -VE    Kurthia spp. 
20.2 8 White, circular, matte. Gram-positive rods. -VE  -VE +VE +VE    Bacillus spp. 
20.4 2 Cream, circular, glossy. Long Gram-positive 
rods. 
+VE   +VE +VE -VE   Streptomyces spp. 
20.5 4 Cream, irregular shape, 
glossy. 
long Gram-positive 
rods. 
+VE  -VE +VE +VE    Streptomyces spp. 
20.6 2 White, irregular shape, 
matte. 
Gram-positive rods. -VE -VE -VE +VE -VE -VE   Kurthia spp. 
20.7 1 Yellow, circular, glossy. Gram-negative rods.  -VE +VE No growth +VE -VE -VE   Acinetobacter spp. (API) 
20.9 <1 White, circular, matte. Gram-positive rods. -VE   +VE +VE    Bacillus spp. 
22.1 1 White, matte, irregular 
shape. 
Gram-positive rods 
with spores. 
-VE  +VE +VE +VE    Bacillus spp. 
22.2 2 White, circular, matte. Gram-positive rods 
with spores. 
-VE +VE +VE +VE +VE    Bacillus spp. 
22.3.1 2 Cream, irregular shape, 
matte. 
Gram-positive rods 
with spores. 
-VE  +VE +VE +VE    Bacillus spp. 
22.3.2 1 White, little, circular. Gram-positive rods 
with spores. 
-VE  +VE +VE +VE    Bacillus spp. 
24.1 12 White, irregular shape 
with extensions, matte. 
Gram-positive rods. -VE  -VE +VE -VE    Kurthia spp. 
24.3 3 White, circular, matte. Gram-negative rods. -VE -VE  +VE -VE -VE   Acinetobacter spp. (API) 
24.4 <1 White, circular, glossy Gram-negative rods. -VE -VE   -VE -VE   Acinetobacter spp. 
26.1 1 Grey, glossy. Gram-positive rods 
with spores. 
+VE  +VE +VE +VE    Bacillus spp. 
26.2 1 Cream, glossy. Gram-positive rods 
with spores. 
+VE  +VE +VE +VE    Bacillus spp. 
26.3.1 1 White, circular, matte. Gram-positive rods 
with spores. 
+VE  +VE +VE +VE    Bacillus spp. 
26.3.2 1 Grey, glossy. Gram-positive rods. +VE  +VE +VE +VE    Bacillus spp. 
26.3.3 1 Small, white, glossy. Gram-positive cocci. -VE  -VE +VE +VE  -VE  Staphylococcus 
epidermidis  
26.4 2 Grey, small, glossy. Gram-negative rods. -VE +VE  +VE +VE -VE   Acinetobacter spp. (API) 
28.1 10 White, circular with rough 
edges, matte. 
Gram-positive rods. +VE  -VE +VE +VE    Bacillus spp. 
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Isolate 
number 
Colony 
size (mm) 
Colony morphology Gram Stain Oxidase 
test 
Lactose 
fermentation 
Mannitol 
fermentation 
Catalase Simmon’s 
Citrate test 
Indole test Coagulase 
test 
Urease 
test 
Presumptive spp. 
28.2 4 White, irregular shape, 
matte. 
Long Gram-positive 
rods  
+VE  -VE -VE +VE    Streptomyces spp. 
28.3 1 Cream, circular, glossy. Long Gram-positive 
long rods 
+VE +VE   +VE -VE   Streptomyces spp. 
28.4 1 White, circular, glossy Gram-negative rods. -VE -VE  +VE     Pasteurella spp. (API) 
30.1 2 White, circular, matte. Gram-positive rods 
with spores. 
+VE  +VE +VE +VE    Bacillus spp. 
30.2.1 1 White, circular, glossy. Gram-positive cocci. -VE  -VE +VE +VE  -VE  Staphylococcus 
epidermidis 
30.2.2 1 Pale white, small, circular. Gram-positive rods 
with spores. 
+VE  -VE +VE +VE    Bacillus spp. 
32.1 3 White, circular with rough 
edges, matte. 
Gram-positive rods 
with spores. 
+VE -VE  +VE +VE    Bacillus spp. 
34.3 4 White, circular with 
extensions, matte. 
Gram-positive rods 
in chains. 
-VE  No growth +VE +VE    Kurthia spp. 
36.1 25 Cream, irregular shape 
with extensions, matte. 
Gram-positive rods 
in chains. 
-VE  No growth +VE +VE    Kurthia spp. 
36.2 5 Cream, circular, glossy. Gram-negative rods. +VE -VE   +VE -VE   Acinetobacter spp. (API) 
36.3 6 White, circular with 
extensions, matte. 
Gram-positive rods 
in chains. 
-VE  No growth +VE +VE    Kurthia spp. 
36.4 <1 White, circular, matte. Gram-positive rods. +VE +VE   +VE -VE   Bacillus spp. 
38.1 1 Cream, circular, matte. Gram-positive rods 
with spores. 
+VE  +VE +VE +VE    Bacillus spp. 
38.2 1 Grey, circular, matte. Gram-positive rods 
with spores. 
+VE No growth       Bacillus spp. 
38.4 1 White, circular, matte. Gram-positive rods 
with spores. 
+VE   +VE +VE    Bacillus spp. 
42.1 <1 White, circular, matte. Gram-positive rods 
with spores. 
+VE  +VE +VE +VE    Bacillus spp. 
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3.2.2 Identification of Streptomyces spp. from APO isolated 
One out of the 34 (2.9%) APO isolated using dried soil samples, isolate 20, was 
identified as potentially belonging to the Streptomyces spp. due to Gram stain (see appendix 
Table A2), and colony morphology representative of the genus. DNA extraction however 
resulted in too low a value for DNA concentration, and hence due to time constraints, the 
DNA was not tested using determinative PCR, meaning the genus of isolate 20 could not be 
confirmed. This was also the case for the 11 Streptomyces isolates identified from the wet 
soil samples (Table 3.1). 
3.2.3 Testing of Antimicrobial Producing Organisms 
3.2.3.1 Novel antimicrobial screening against sensitive organisms 
Thirty-four organisms with the ability to produce inhibitory compounds were 
isolated using potato starch agar, from the initial collection of samples from New Forest (See 
appendix table A2).  All 34 isolates, including the potential Streptomyces spp., were then 
subjected to further testing to determine the range of inhibitory activity using several test 
organisms; sensitive strains of E. coli, S. epidermidis, S. aureus, P. mirabilis and P. aeruginosa 
were used for initial screening of the APO. Different isolates showed a range of different 
activity against both Gram-positive and Gram-negative bacteria, however no inhibition 
against P. aeruginosa or P. mirabilis was seen. Five isolates displayed inhibitory ability from 
initial perpendicular screening (14.7%); isolates 9, 10, 11, 16 and 26 showed inhibition at 
varying temperatures (Table 3.2). Isolates 9 and 10 displayed the largest range of activity, 
with inhibition seen against S. epidermidis, S. aureus, and E. coli after being incubated at 25°C 
for 2 days (Figures 3.1 and 3.2).  Isolate 11, also isolated at location 16, showed inhibition 
only against E. coli after both 0 and 2-day incubation at 25°C. Isolate 26 showed ability to 
produce inhibition under a range of conditions against both S. epidermidis and S. aureus due 
to repeated inhibition at both 25°C and 37°C after both 0 and 2-day incubation (Figure 3.3). 
Isolate 16 also showed inhibition against S. epidermidis and S. aureus, with 2-day incubation 
at both 25°C and 37°C (Figure 3.4). Zero-day incubation of isolate 16 at 37°C showed 
inhibition against S. epidermidis and S. aureus (Figure 3.4), with 0-day incubation at 25°C only 
showing inhibition towards S. aureus.  
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Table 3.2: The inhibitory activity shown by five of the 34 isolates, collected from the New 
Forest in November 2016, using the perpendicular screening method. A (-) indicates no 
inhibition of test organisms was apparent under the conditions stated. 
Isolate number Inhibition of test bacteria seen at 25°C Inhibition of test bacteria seen at 37°C 
 0 day 2 day 0 day 2 day 
9 - S. epidermidis, S. 
aureus, and E. coli 
- - 
10 - S. epidermidis, S. 
aureus, and E. coli 
- - 
11 E. coli E. coli - - 
16 S. aureus S. epidermidis and S. 
aureus 
S. epidermidis and 
S. aureus 
S. epidermidis and S. 
aureus 
26 S. epidermidis and 
S. aureus. 
S. epidermidis and S. 
aureus. 
S. epidermidis and 
S. aureus.  
S. epidermidis and S. 
aureus.  
 
 
 
Figure 3.1: Isolate 9 grown for 2 days at 25°C, using the perpendicular screening method, 
displaying inhibition towards E. coli, S. epidermidis, and S. aureus, in duplicate (A and B). Test 
bacteria from top to bottom, P. aeruginosa, E. coli, S. epidermidis, S. aureus and P. mirabilis. 
The arrows displayed on duplicate A indicate the inhibition of test bacterial growth away 
from the APO being tested (9). 
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Figure 3.2: Isolate 10 grown for 2 days at 25°C, displaying inhibition in the perpendicular 
screening method towards E. coli, S. epidermidis, and S. aureus, in duplicate. Test bacteria 
from top to bottom, P. aeruginosa, E. coli, S. epidermidis, S. aureus and P. mirabilis. The 
arrows on duplicate A indicate the extent of inhibition caused by APO 10. 
 
 
 
Figure 3.3: Isolate 26 incubated for 2 days at 37°C, displaying inhibition against S. epidermidis 
and S. aureus in the perpendicular screening method, indicated by the black arrows. Test 
bacteria from top to bottom, P.aeruginosa, E. coli, S. epidermidis, S. aureus and P. mirabilis. 
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Figure 3.4: Isolate 16 incubated for 2 days at 25°C (plate A) and incubated for 0 days at 37°C 
(plate B), using the perpendicular screening method, with both displaying inhibition towards 
S. epidermidis and S. aureus indicated by the black arrows on plate B. No inhibition seen to 
P. aeruginosa, E. coli and P. mirabilis. Test bacteria from top to bottom, P. aeruginosa, E. coli, 
S. epidermidis, S. aureus and P. mirabilis. 
 
 
3.2.3.2 Starvation method 
The starvation method was used for further screening of the inhibitory activity of the 
APO. Twelve of the 34 (35.3%) isolates showed inhibition against one or more of the test 
bacteria used (Table 3.3); 5, 6, 13, 18, 27, 28, 29, 30, 31 and 34, as well as 16 and 26 which 
previously displayed inhibition in initial perpendicular screening, showed inhibition against 
at least one of the test bacteria used (E. coli, S. aureus or S. epidermidis) in the starvation 
method (Tables 3.2 and 3.3). Figures 3.5 and 3.6 display the inhibition against E. coli on plate 
count agar, by isolates 6 and 13 respectively, after both were incubated for 10 days at 25°C. 
Figure 3.7 displays the inhibition seen towards both S. epidermidis and S. aureus on plate 
count agar, by isolate 26 after incubation for 7 days at 37°C. 
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Table 3.3: Results from the first run of the starvation method using New Forest isolates, 
displaying APO with the ability to produce inhibition against the test bacteria at different 
incubation times (7, 10 and 14 days) and temperatures. The agar result in which inhibition 
was displayed on, is recorded in brackets; PC – plate count agar, MH – Mueller-Hinton agar. 
A (-) indicates no inhibition of test organisms was apparent under the conditions stated. 
Isolate 
number 
Days of incubation of isolate at 25°C- 
Inhibition seen - (agar result in bracket) 
Days of incubation of isolate at 37°C- 
Inhibition seen - (agar result in bracket) 
 7 Days 10 Days 14 Days 7 Days 10 Days 14 Days. 
5 - - E. coli, S. 
epidermidis 
and S. 
aureus. 
(PC). 
- - - 
6 S. epidermidis 
and S. aureus 
(MH) E. coli 
(PC) 
E. coli (both) S. 
epidermidis 
and S. 
aureus, (PC). 
- - - 
13 E. coli, S. 
epidermidis 
and S. aureus 
(PC) 
E. coli (MH 
and PC) 
- - - - 
16 - - S. aureus 
and S. 
epidermidis 
(PC) 
- - - 
18 - - - - - S. epidermidis 
and S. aureus 
(PC) 
26 S. epidermidis 
and S. aureus 
(PC) 
- S. aureus 
(PC) 
S. epidermidis 
and S. aureus 
(PC) 
S. aureus 
(PC) 
S. epidermidis 
and S. aureus 
(PC) 
27 - S. epidermidis 
and S. aureus 
(MH) 
- - - - 
28 - - - - S. aureus 
(MH and 
PC) 
- 
29 - - - - S. aureus 
(PC) 
- 
30 - S. epidermidis 
and S. aureus 
(MH) 
- - - - 
31 - E. coli (PC) - - - - 
34 - E. coli and S. 
epidermidis 
(PC). 
- - - - 
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Figure 3.5: Isolate 6 that was isolated from New Forest, and incubated for 10 days at 25°C, 
before displaying inhibition against E. coli streaked onto plate count agar, from the initial 
starvation method. 
 
 
Figure 3.6: Isolate 13 initially isolated from New Forest, displaying inhibition against E. coli 
on plate count agar, after incubation for 10 days at 25°C, using the starvation method. 
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Figure 3.7: Displays the inhibition seen towards test bacteria S. epidermidis and S. aureus on 
plate count agar, after New Forest isolate 26 was incubated for 7 days at 37°C in the 
starvation method. The two arrows detail the diameter of the inhibition presented by isolate 
26. 
 
The starvation method was repeated using the supernatant of isolates that produced 
inhibition prior, which was stored at 4°C and collected from the first round of testing. Results 
were seen to differ from that of the original starvation method data, when the supernatant 
was added directly to the test bacteria, after the centrifugation of incubated samples (Table 
3.4). Isolates 5, 6, 13, 27, 28, 29, 30, 31 and 34 displayed less/no inhibition than seen prior. 
Isolate 26 was shown to display the same level of inhibitory activity and isolates 16 and 18 
displayed higher amounts of inhibitory action than seen previously towards the 
Staphylococcus spp. and E. coli respectively. 
The reincubation of the New Forest APO that had previously shown inhibition in the 
starvation method, detailed differing results (Table 3.5). Isolates 5, 6, 13, 16, 18, 26, 28, 29, 
30, 31 and 34 all showed less range of inhibitory activity and/or less inhibition towards test 
bacteria than previously (Table 3.3). Near identical inhibition was seen by isolate 26 with 
inhibitory activity displayed at similar incubation times and temperatures. Isolates 27, 28, 29, 
30, 31 and 34 displayed no evidence of inhibition in either duplicates of the starvation 
method (Tables 3.4 and 3.5).  
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Table 3.4: Inhibition seen from the reuse of the supernatants obtained from the first round 
of the starvation method using prolonged incubation of the New Forest APO. Note that N/A 
indicates that a supernatant was not available for repeat testing. The agar in which inhibition 
was seen, is placed in brackets; PC – plate count agar, MH – Mueller-Hinton agar. A (-) 
indicates no inhibition of test organisms was apparent under the conditions stated. 
Isolate 
number 
Days of incubation of isolate at 25°C - 
Inhibition seen (agar result in bracket) 
Days of incubation of isolate at 37°C – 
inhibition seen (agar result in bracket) 
 7 days  10 days  14 days 7 days 10 days 14 days 
5 - - E. coli (PC) - - - 
6  - S. epidermidis 
(PC) 
- - - - 
13 N/A E. coli, S. 
epidermidis and 
S. aureus (PC) 
N/A N/A - N/A 
16 S. epidermidis 
and S. aureus 
(PC) 
N/A N/A S. epidermidis and 
S. aureus (PC). 
N/A S. epidermidis 
and S. aureus 
(PC). 
18 E. coli (PC) N/A S. 
epidermidis 
an E. coli 
(PC). 
N/A N/A - 
26 S. epidermidis 
and S. aureus 
(PC). 
N/A S. 
epidermidis 
and S. aureus 
(PC). 
S. epidermidis and 
S. aureus (PC). 
N/A S. epidermidis 
and S. aureus 
(PC). 
27 - N/A - - N/A - 
28 N/A - - N/A - - 
29 N/A - - - N/A - 
30 - N/A - - N/A - 
31 - - - - - - 
34 - - - - - - 
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Table 3.5: Inhibition displayed in the repeat of the whole starvation method, using prolonged 
incubation at varying days (7, 10 and 14 days), of New Forest APO that had shown inhibition 
previously. The agar in which inhibition was seen is presented in brackets; PC – plate count 
agar, MH – Mueller-Hinton agar. A (-) indicates no inhibition of test organisms was apparent 
under the conditions stated. 
Isolate 
number 
Days of incubation of isolate at 25°C- Inhibition 
seen (agar result in bracket) 
Days of incubation of isolate at 37°C – Inhibition 
seen (Agar result in bracket) 
 7 days  10 days  14 days 7 days 10 days 14 days 
5 - - - - S. epidermidis 
(MH) 
- 
6  - - - - - - 
13 - - - - - - 
16 - S. epidermidis 
and S. aureus 
(PC). 
S. epidermidis 
and S. aureus 
(PC). 
- S. epidermidis 
and S. aureus 
(PC). 
S. aureus (PC). 
18 - - - - - - 
26 S. aureus and S. 
epidermidis 
(MH) and S. 
aureus (PC). 
- S. epidermidis 
and S. aureus 
(PC). 
S. epidermidis 
and S. aureus 
(PC). 
S. epidermidis 
(PC). 
S. epidermidis 
(PC). 
27 - - - - - - 
28 - - - - - - 
29 - - - - - - 
30 - - - - - - 
31 - - - - - - 
34 - - - - - - 
 
3.2.3.3 Chemical analysis of potential antimicrobial compounds- pilot study 
Solvent extraction and TLC, for the elucidation of separate compounds was carried 
out using supernatant collected from isolate 26, due to the broad conditions in which 
inhibitory activity was produced by this APO, towards the test organisms used. Several of the 
supernatants produced over the differing days incubation in the starvation method, were 
combined for chemical analysis (see section 3.2.3.2). The compounds and their rf values 
resulting from TLC, using the precipitate as well as solvents petroleum ether, 
dichloromethane and acetonitrile, that were used for solvent extraction, can be seen in 
Tables 3.6, 3.7, 3.8 and 3.9 respectively. These tables also display compounds with seen 
antibacterial activity against the test bacteria used (E. coli and/or S. aureus); only three 
compounds were seen to present inhibitory activity against S. aureus only, with two 
extracted using dichloromethane, and one of the compounds extracted using acetonitrile 
(Tables 3.8 and 3.9). These compounds were then placed through NMR, however the 
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structures of the inhibitory compounds were not determined due to time constraints (see 
Appendix figures A1, A2, A3, A4, A5, A6, A7 and A8). 
Table 3.6: The Rf values of the three compounds separated using TLC from the precipitate 
of the supernatant of isolate 26. The solvent system used in TLC consisted of a 29:1 ratio of 
chloroform: acetic acid. +VE = compound displayed antimicrobial capability, -VE = no 
antimicrobial capability of the compound was seen. Methods and data was collected from 
the work carried out by Mr Rob Warren, and Dr Adam LeGresley. 
Precipitate Rf Antimicrobial activity 
Compound 1 1 -VE 
Compound 2 0.71 -VE 
Compound 3 0.04 -VE 
 
 
Table 3.7: The compounds and their subsequent Rf values and the antimicrobial 
capabilities of isolate 26’s supernatant extracted using petroleum ether. The solvent 
system used consisted of a 19:1 ratio of chloroform: methanol. +VE = compound displayed 
antimicrobial capability, -VE = no antimicrobial capability of the compound was seen. 
Methods and data was collected from the work carried out by Mr Rob Warren, and Dr 
Adam LeGresley. 
Petroleum ether Rf Antimicrobial activity 
Compound 1 1 -VE 
  
 
Table 3.8: The Rf values and antimicrobial capabilities of the three compounds extracted 
from the supernatant of isolate 26 using dichloromethane. The solvent system used 
consisted of a 19:1 ratio of chloroform: methanol. +VE = compound displayed antimicrobial 
capability, -VE = no antimicrobial capability of the compound was seen. Methods and data 
was collected from the work carried out by Mr Rob Warren, and Dr Adam LeGresley. 
Dichloromethane Rf Antimicrobial activity 
Compound 1 1 +VE (S. aureus) 
Compound 2 0.68 +VE (S. aureus) 
Compound 3 0.58 -VE 
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Table 3.9: The Rf values of the compounds that were extracted using two TLC plates, for 
the separation of the acetonitrile fractions of the supernatant originating from isolate 26. 
The solvent system consisted of a ratio of 13:2:1 of ethyl acetate: methanol: water. +VE = 
compound displayed antimicrobial capability, -VE = no antimicrobial capability of the 
compound was seen. Methods and data was collected from the work carried out by Mr Rob 
Warren, and Dr Adam LeGresley. 
Acetonitrile Rf Rf Antimicrobial activity 
Compound 1 1 1 +VE (S.aureus) 
Compound 2 0.74 (missing) -VE 
Compound 3 0.68 0.63 -VE 
Compound 4 0.58 0.55 -VE 
Compound 5 0.25 0.34 -VE 
Compound 6 0.18 0.12 -VE 
Compound 7  0.05 0.03 -VE 
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3.3 Discussion 
The New Forest selected due to its classification as an ancient forest, notably 
different from the other two sample locations, proved to be successful in the isolation of 
APO. Thirty-four APO were isolated and further tested, with five (14.7%) of these displaying 
some form of inhibitory activity towards either E. coli, S. epidermidis, and/or S. aureus in 
initial perpendicular screening (Table 3.2). Isolates 16 and 26 showed great activity at a range 
of temperatures (25°C and 37°C) after both 0 and 2-day incubation using this perpendicular 
screening method, with both APO continuing to produce this inhibition under the range of 
conditions used in the differing repeats of the starvation method (Tables 3.3, 3.4 and 3.5). 
Despite the work to lower the amounts of Gram-negative organisms in the soil samples by 
drying, both these organisms were seen to be Gram-negative rods, which upon further 
investigation as future work, may explain their inhibitory activity towards the Gram-positive 
organisms only, and their ability to produce inhibitory compounds under a range of 
conditions, compared to the other APO with inhibitory ability (Table A2).  
The starvation method, used to induce inhibitory activity by the APO using the 
creation of stressful environments, displayed higher amounts of inhibitory activity compared 
to perpendicular screening, with 12 (35.3%) organisms displaying some form of inhibitory 
action to the test bacteria used, over double the amount seen in initial screening (14.7%) 
(Tables 3.2 and 3.3). However, the repeat of the whole method using the APO that previously 
showed inhibition, only detailed three (8.8%) of these isolates with repeated inhibitory 
activity, showing a great reduction between the repeats of this method (Tables 3.3 and 3.5); 
isolates 6, 13, 18, 27, 28, 29, 30, 31, and 34 showed no inhibitory activity in the repeat of the 
whole method (Table 3.5). As well as this, isolate 5 displayed less inhibition towards test 
bacteria, also presenting this inhibition on differing agars and at different temperatures; in 
the first run of the starvation method, isolate 5 displayed inhibition to both the 
Staphylococcus spp. and E. coli on plate count agar at 25°C, however upon the repeat, 
inhibition was seen against S. epidermidis only, on Mueller-Hinton agar, after incubation at 
37°C (Tables 3.3 and 3.5). This large decrease of activity, by APO previously shown with the 
ability to produce inhibitory compounds, may provide evidence that specific 
environmental/stress conditions are required to be met, before the activation of a series of 
complex pathways, that leads to the production of the antimicrobial compounds of interest 
(Figure 3.8) (Rokem et al., 2007). The conditions, however, were kept the same for both the 
repeats of the experiment, and hence this may further show the sensitivity for the activation 
of the genes involved in the production of antibiotics (Liu et al., 2013).  
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Figure 3.8: The several steps, and proteins required for the production of antibiotics from 
the secondary metabolism in microorganisms. Several different regulatory structures are 
detailed from primary to secondary metabolism, that control potential antibiotic production 
(Taken from Rokem et al., 2007).  
 
Supernatants collected and stored at 4°C from the first round of testing using the 
starvation method, were reapplied to plates of test bacteria according to the method used 
previously (detailed in section 2.2.4.5). Results from the readdition of the several 
supernatants displayed six of the 12 APO to have continued inhibitory activity with the use 
of at least one of the supernatants collected and retested. Isolates 16 and 18 were shown to 
display more inhibitory activity than seen previously, with isolate 16 seen to inhibit the same 
test bacteria as seen in the initial starvation method, however inhibition was further seen at 
both 25°C and 37°C upon the reuse of supernatant. The supernatant collected from isolate 
18, displayed inhibition at 25°C, as well as showing additional inhibition to E. coli, compared 
to the inhibitory effects seen at 37°C only, in the initial starvation method (Tables 3.3 and 
3.4). However, these results again detail a decrease in the amount of inhibitory activity seen 
compared to the initial method, with less/no inhibitory activity of supernatants produced by 
those that had formerly shown inhibition; isolates 6, 13, 27, 28, 29, 30, 31 and 34 all showed 
less inhibition compared to the initial addition of the supernatant (Tables 3.3 and 3.4). This 
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decrease in inhibitory activity may be due to the degradation of the antimicrobial 
compounds, which may be resultant of the time, and conditions, at which the collected 
supernatants were stored. Further work may include increasing the volume of the 
supernatant stored, as well as storage at differing conditions, to ensure the compounds 
remain viable. However, it was noted that some of the supernatants were unavailable for 
retesting, and hence this has a profound effect on the results (Table 3.4). If this method was 
also to be improved, direct analysis of the supernatant using DOSY-NMR, before it is placed 
onto test bacteria, would be used to allow determination of any compounds present, 
preventing the loss of any that maybe potentially useful.  
The pilot study used in the present study is an example of this analysis. The 
supernatant of isolate 26, collected from the starvation method was further analysed due to 
its seen inhibition in this method, as well as initial perpendicular screening (Tables 3.2 and 
3.3). The TLC bioassay detailed three of the separated compounds to have activity against S. 
aureus with two extracted using the solvent dichloromethane, and one extracted using 
acetonitrile (Tables 3.8 and 3.9). However, no inhibition was seen by the separated 
compounds towards E. coli, which further shows the lack of activity by isolate 26 towards 
this organism, previously seen in both the perpendicular screening and starvation method 
(Tables 3.2 and 3.3). Nevertheless, the three compounds were further analysed using NMR, 
however due to time constraints, confirmation of the compound structures could not be 
drawn (see Appendix figures A1, A2, A3, A4, A5, A6, A7 and A8). This hence highlights further 
work, which may include methods to aid in the identification of compounds such as mass 
spectrometry, to identify the molecular weight. As well as this, the continuation of this pilot 
study using other supernatants, collected from New Forest APO with displayed inhibitory 
ability from the starvation method, would increase the likelihood for the identification of 
novel antimicrobial compounds. 
As well as working to isolate potential APO, this study also worked to cultivate 
organisms belonging to the Streptomyces spp., due to their known ability to produce a vast 
number of secondary metabolites, including antibiotics (Selvameenal et al., 2009; Miao and 
Davies, 2010). However, only one organism from the APO isolated from New Forest, was 
identified as potentially belonging to the Streptomyces spp., which was not confirmed due 
to time constraints preventing the PCR procedure for the identification of this genus, being 
carried out. This may highlight the New Forest as a location not favoured by the Streptomyces 
spp., which may be due to the soil conditions and competition of other organisms within the 
same soil microbiome, however samples areas were sparsely taken, and the lack of 
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Streptomyces in the soil samples collected, may not be representative of the Streptomyces 
population of the New Forest area as a whole. However, this is thought to be the first study 
aiming to isolate Streptomyces spp. and APO from the New Forest area, and hence further 
work focussing on the isolation of this genus would be preferable. The lack of Streptomyces 
spp. may also be due to the culture methods; potato starch agar only, was used for the 
cultivation of APO/ Streptomyces spp. compared to both the Friston Forest and Dawes Farm 
methods, for which both potato starch and oat agar were used to isolate APO.  
 However, from the wet soil isolates, 11 of the total 77 organisms isolated were 
presumptive Streptomyces spp. due to Gram stain and morphology (Table 3.1). Of the 
previously selected bacteria, only one organism (1.3%), was identified as belonging to the 
Salmonella spp., with no further organisms cultivated from the New Forest, identified as 
belonging to one of the genus’ previously selected as of importance. Three (3.9%) and two 
(2.6%) isolates however were identified as belonging to the Pseudomonas spp. and as S. 
epidermidis respectively, with the remaining majority of isolates belonging to more known 
soil bacteria including 11 (14.3%) and 10 (13.0%) belonging to the Acinetobacter and Bacillus 
genus’ respectively, as well as a large amount characterised as belonging to the Kurthia spp. 
(40.3%) (Table 3.1). The cultivation of these supposedly pathogenic bacteria was carried out 
to characterise the sample area, as well as to compare to the presence, or lack of APO from 
the same location, however, due to lack of isolation of the previously selected bacteria, 
extensive comparison cannot be conducted. However, the Salmonella spp. was isolated from 
sample site 16, as were the APO 9, 10 and 11, that showed inhibitory activity in initial 
perpendicular screening (Table 3.2), which may indicate a correlation between the presence 
of APO and pathogenic organisms, nevertheless further work sampling the same and 
differing areas of the New Forest would be required to further prove this hypothesis. This 
lack of pathogenic organisms may show their lack of presence in the soil, or the organisms 
themselves maybe hard to cultivate, due to the conditions, and/or the competition between 
the other bacteria in the same sample. 
The New Forest has proven to be successful in the isolation of APO from the sites 
sampled, due to the inhibition seen in both perpendicular screening and the starvation 
method. However further work/sampling is necessary for the isolation of higher amounts of 
APO, and organisms belonging to the Streptomyces spp. Future work could also include the 
confirmation of isolates belonging to the Streptomyces spp., using PCR, of both the 
organisms isolated in the present study, and those isolated from any further sampling. 
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4.0 Investigation of soil samples from Friston Forest 
Friston Forest, another known national forest, is located in East Sussex, and differs 
from the ancient New Forest, due to the more recent planting of trees in the 1950s, 
classifying the forest as modern (Sussex Wildlife Trust, 2017). As a result, Friston Forest is 
less diverse in regard to tree type, with this forest largely made up of pine trees, which hence 
may affect the ecosystem that flourishes there, compared to that of the New Forest, allowing 
the potential for differing organisms, including both pathogenic and antimicrobial producing 
bacteria, to be isolated. As with the New Forest, the Forestry Commission are in charge of 
managing the 688 acres of Friston Forest, which it is also known to be a hotspot for tourists 
and mountain biking (Woodland Trust, 2017; Forestry Commission, 2017). 
Also, compared to the New Forest and Dawes Farm, Friston Forest resides much 
closer to the sea shoreline, meaning the higher salt content in the area may potentially affect 
the salinity of the soil, relative to that of the other two locations; higher soil salinity has been 
shown to affect the microbial activity and metabolism of organisms within the soil, as well 
as changing the overall microbiome structure (Yan et al., 2015; Maganhotto de Souza Silva 
and Fay, 2012). In collaboration with the Forestry commission, several areas within Friston 
Forest were sampled to increase the likelihood of isolating pathogenic organisms, as well as 
APO that are vital in the fight against AMR.  
 
4.1 Methods 
4.1.1 Isolation and characterisation of microorganisms within the soil 
The collection of soil samples from several areas within Friston Forest was carried 
out according to the methods stated in section 2.2.1, with coordinates and characteristics of 
each sample noted (see Appendix Table A3). Isolation and biochemical testing for the 
identification of potential pathogenic organisms within the soil was carried out using the 
methodology stated in 2.2.2.2 and 2.2.3.2. Sample drying, and isolation of APO and potential 
Streptomyces spp. was carried out using the methodology stated in 2.2.2.3, using both oat 
and potato starch agar, with further characterisation using Gram staining, and PCR for the 
identification of isolates belonging to the Streptomyces spp. carried out according to section 
2.2.3.3. 
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4.1.2 Further testing of Antimicrobial Producing Organisms 
All APO were further tested with the perpendicular screening method using both 
sensitive and clinical strains of test bacteria (see sections 2.2.4.2 and 2.2.4.3), as well as the 
starvation method using sensitive strains of E. coli, S. epidermidis, S. aureus and P. mirabilis 
(see section 2.2.4.5). Only repeats of novel antimicrobial using sensitive strains were carried 
out. 
 
4.2 Results 
Twenty soil samples were collected from Friston Forest, Sussex, at varying locations 
with differing characteristics in April 2017 (see appendix Table A3), for the cultivation of both 
APO and pathogenic organisms.  
4.2.1 Isolation of pathogenic microorganisms 
From the 20 soil samples collected (see appendix Table A3), 55 wet soil isolates were 
subcultured and purified ready for further testing and identification. The biochemical test 
results and morphology of each individual isolate can be seen in Table 4.1. No isolates from 
Friston Forest were identified as belonging to the Klebsiella spp. or identified as E. coli. 
Several isolated were seen to belong to the Bacillus, Kurthia, and Acinetobacter spp.; 13 
(23.6%), eight (14.6%), and 12 (21.8%) respectively. Kurthia spp. was noted as above due to 
its irregular colony morphology resembling that of a ‘birds feather’. Two isolates were 
identified as S. aureus with two identified as belonging to the Salmonella spp. (3.6%). One 
and two isolates were identified as Enterococci spp. (1.8%) and Enterobacter spp. (3.6%) 
respectively. Two isolates also had the presumptive identification as belonging to the 
Streptomyces spp. due to the test results (3.6%).
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Table 4.1: The biochemical characteristics, colony morphology and presumed species of the 55 bacteria isolated from wet soil samples from Friston 
Forest. Morphology noted is the isolate as seen on nutrient agar. (+VE) indicates a positive result, and (-VE) indicates a negative result to the 
individual biochemical tests used; Catalase, Oxidase, Lactose fermentation, Mannitol fermentation, Edwards agar growth, Coagulase, Indole, 
Simmons’ Citrate and Urease tests results are seen for the varying isolates. A lack of growth seen on the differing characterisation agar used, by 
isolates, is stated (No growth). Coagulase tests were carried out on Gram-positive cocci only. Blank results in the biochemical test sections, indicate 
that the specific test was not carried out on the corresponding isolate. 
Isolate 
Number 
 
 
 
Colony 
Size (mm) 
Colony Morphology Gram stain Catalase Oxidase Lactose 
fermentation 
Mannitol 
fermentation 
Edwards 
agar growth 
Coagulase 
test 
Indole 
test 
Citrate 
test. 
Urease 
test. 
Presumptive spp. 
1.1 1 Small, White, circular, 
glossy. 
Gram-positive 
rods. 
+VE +VE  No growth No growth  -VE -VE  Rothia spp.   
1.2 3 Cream, circular, 
glossy. 
Gram-negative 
rods  
+VE -VE No growth    -VE   -VE Acinetobacter spp. 
1.3 7 Cream, circular with 
rough edges, glossy. 
Gram-negative 
rods. 
+VE -VE No growth    -VE  -VE Acinetobacter spp. 
1.4 3 Cream, circular 
glossy. 
Gram-negative 
rods. 
+VE -VE -VE     -VE -VE Acinetobacter spp. 
2.1 2 White, Circular, 
glossy. 
Gram-negative 
rods. 
+VE -VE No growth     -VE -VE Acinetobacter spp. 
2.2 4 White, irregular 
shape, glossy. 
Gram-negative 
rods  
+VE 
 
-VE No growth    -VE  -VE Acinetobacter spp. 
3.1 2 Cream, circular, 
glossy. 
Gram-positive 
rods. 
+VE -VE  -VE -VE  -VE +VE  Bacillus spp. 
3.2 1 White, circular glossy. Gram-positive 
rods. 
+VE -VE  -VE No growth  -VE +VE  Bacillus spp. 
4.1 
 
 
 
1 White, clear, circular. Gram-negative 
rods. 
+VE +VE No growth    -VE -VE -VE Moraxella spp.  
5.1 7 Cream, circular with 
slightly rough edges, 
glossy. 
Gram-negative 
rods. 
+VE -VE No growth    -VE -VE -VE Acinetobacter spp. 
5.2 2 White, circular, 
matte. 
Gram-positive 
rods. 
+VE -VE  No growth No growth  -VE -VE -VE Kurthia spp. 
6.1 8 Cream, circular, 
glossy. 
Gram-negative 
rods. 
+VE -VE No Growth    -VE -VE -VE Acinetobacter spp. 
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Isolate 
Number 
 
 
 
Colony 
Size (mm) 
Colony Morphology Gram stain Catalase Oxidase Lactose 
fermentation 
Mannitol 
fermentation 
Edwards 
agar growth 
Coagulase 
test 
Indole 
test 
Citrate 
test. 
Urease 
test. 
Presumptive spp. 
6.2 <1 White, circular, 
matte. 
Gram-positive 
rods. 
+VE -VE -VE +VE   -VE +VE  Bacillus spp. 
6.3 1 Grey, circular, glossy. Gram-negative 
rods. 
+VE +VE No growth     -VE  Moraxella spp. 
7.1 9 Cream, circular, 
matte. 
Gram-positive 
rods. 
+VE -VE  -VE No growth  -VE +VE  Bacillus spp.  
7.2 1 Cream, circular, 
glossy. 
Gram-positive 
cocci. 
+VE -VE  -VE No growth +VE 
 
   Staphylococcus 
aureus. 
7.3 3 Cream, circular, 
matte. 
Gram-positive 
rods. 
+VE -VE  No growth No growth  -VE +VE  Bacillus spp.  
7.4 1 White, glossy, 
circular. 
Gram-positive 
rods. 
-VE +VE  No growth No growth  -VE -VE  Actinomyces spp. 
8.1 6 Cream, circular, 
matte. 
Long Gram-
positive rods. 
+VE -VE  -VE No growth  -VE +VE  Streptomyces spp.  
8.2 7 Cream, glossy. Gram-negative 
rods. 
+VE -VE -VE    -VE +VE -VE Salmonella spp. 
8.3 4 White, irregular 
shape, matte. 
Gram-positive 
rods. 
+VE +VE  No growth   -VE -VE  Kurthia spp. 
9.1 5 Cream, circular, 
matte. 
Gram-negative 
rods. 
+VE +VE. -VE     -VE  Moraxella spp. 
9.2 3 Yellow, circular, 
glossy. 
Gram-positive 
cocci. 
-VE -VE  +VE +VE     Enterococci spp. 
9.3 4 White, matte, 
irregular shape. 
Gram-positive 
rods. 
+VE +VE  -VE No growth  -VE -VE  Rothia spp. 
9.4 1 Cream, circular, 
glossy. 
Gram-positive 
rods with 
spores. 
+VE +VE  -VE No growth  -VE +VE  Bacillus spp. 
9.5 5 White, circular, 
matte. 
Gram-negative 
rods. 
+VE +VE -VE    -VE -VE  Moraxella spp. 
11.1 11 White, irregular 
shape, matte. 
Gram-positive 
rods. 
+VE -VE  No growth No growth   -VE  Kurthia spp. 
12.1 5 Cream, circular, 
matte. 
Gram-positive 
rods. 
+VE -VE  -VE No growth   +VE  Bacillus spp. 
12.2 1 Grey, circular, glossy. Gram-negative 
rods 
+VE -VE +VE    -VE +VE -VE Enterobacter spp.. 
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Isolate 
Number 
 
 
 
Colony 
Size (mm) 
Colony Morphology Gram stain Catalase Oxidase Lactose 
fermentation 
Mannitol 
fermentation 
Edwards 
agar growth 
Coagulase 
test 
Indole 
test 
Citrate 
test. 
Urease 
test. 
Presumptive spp. 
12.3 6 White, matte, 
circular. 
Gram-positive 
rods. 
+VE -VE  No growth No growth  -VE -VE  Kurthia spp. 
13.1 7 Cream, circular, 
matte. 
Gram-negative 
rods. 
+VE -VE No growth     -VE  Streptomyces spp. 
13.3 6 White, irregular 
shape, matte. 
Gram-positive 
rods. 
+VE +VE  No growth No growth  -VE -VE  Kurthia spp. 
14.1 7 Cream, matte, 
circular. 
Gram-negative 
rods. 
+VE -VE No growth    -VE +VE -VE Acinetobacter spp. 
14.2 6 Cream, circular, 
matte. 
Gram-negative 
rods. 
+VE -VE No growth    -VE +VE -VE Acinetobacter spp. 
14.3 2 White, glossy, 
circular. 
Gram-negative 
rods. 
+VE -VE +VE    -VE -VE -VE Erwinia spp. 
14.4 <1 Grey, circular, glossy. Gram-negative 
rods. 
+VE -VE No growth      -VE Acinetobacter spp. 
14.5 1 Grey, circular, glossy. Gram-negative 
rods. 
+VE -VE +VE    -VE +VE (blue 
agar). 
-VE Enterobacter spp. 
15.2 4 White, irregular 
shape. 
Gram-negative 
rods. 
+VE +VE No growth    -VE -VE  Moraxella spp. 
16.1 2 Cream, matte, 
circular. 
Gram-negative 
rods. 
+VE -VE No growth    -VE +VE -VE Acinetobacter spp. 
16.2 3 Cream, matte, 
circular. 
Gram-positive 
rods. 
+VE +VE  +VE  No growth  -VE +VE  Bacillus spp. 
16.3 3 Cream, circular, 
glossy. 
Gram-negative 
rods. 
+VE -VE No growth    -VE -VE -VE Cedecea spp. 
17.1 13 Grey, matte, circular. Gram-positive 
rods. 
+VE +VE  +VE No growth  -VE -VE  Kurthia spp. 
17.2 6 Cream, circular, 
matte. 
Gram-negative 
rods. 
+VE -VE No growth. No growth.     -VE Acinetobacter spp. 
17.3 <1 White, circular, 
glossy. 
Gram-positive 
cocci. 
+VE -VE  -VE No growth +VE    Staphylococcus 
aureus. 
17.4 1 Grey, circular, glossy. Gram-negative 
rods. 
+VE +VE No growth    -VE -VE  Moraxella spp. 
18.1 4 Cream, circular, 
matte. 
Gram-positive 
rods. 
+VE -VE  -VE No growth  -VE +VE  Bacillus spp. 
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Isolate 
Number 
 
 
 
Colony 
Size (mm) 
Colony Morphology Gram stain Catalase Oxidase Lactose 
fermentation 
Mannitol 
fermentation 
Edwards 
agar growth 
Coagulase 
test 
Indole 
test 
Citrate 
test. 
Urease 
test. 
Presumptive spp. 
18.2 49 White, irregular 
shape, matte. 
Gram-positive 
rods. 
+VE +VE  No growth No growth  -VE -VE  Kurthia spp. 
18.3 <1 White, irregular 
shape, matte. 
Gram-positive 
rods. 
+VE +VE  No Growth No growth  -VE -VE  Kurthia spp. 
19.2 2 Cream, circular, 
glossy. 
Gram-negative 
rods. 
+VE -VE -VE    -VE +VE -VE Salmonella spp. 
19.3 9 White, irregular 
shape, matte. 
Gram-positive 
rods with 
spores. 
+VE +VE  +VE No growth  -VE +VE -VE Bacillus spp. 
19.4 12 White, irregular 
shape, matte. 
Gram-positive 
rods with 
spores. 
+VE +VE -VE No growth    +VE  Bacillus spp. 
20.1 5 Cream, circular, 
matte. 
Gram-positive 
rods. 
+VE -VE  -VE No growth  -VE +VE -VE Bacillus spp. 
20.2 7 White, circular with 
rough edges, matte. 
Gram-positive 
rods with 
spores. 
+VE +VE  +VE    +VE  Bacillus spp. 
20.3 2 White, circular, 
glossy. 
Gram-negative 
rods  
+VE +VE -VE    -VE +VE  Pseudomonas spp. 
20.4 1 White, circular, 
matte. 
Gram-negative 
rods. 
+VE +VE No growth    -VE -VE  Moraxella spp. 
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4.2.2 Identification of Streptomyces spp. from APO isolated 
Using the dried soil samples from the 20 samples sites, a total of 69 APO with either 
displayed inhibition and/or similar morphology to that of the Streptomyces genus, were isolated 
using both oat agar (31 isolates) and potato starch agar (38 isolates), before being Gram stained 
and catalase tested (see appendix Tables A4 and A5). Out of these isolates cultivated from Friston 
Forest, 33 isolates were noted to have similar morphology and/or Gram stain to that of the 
Streptomyces spp.; 13 and 20 isolates cultivated using oat and potato starch agar respectively, were 
further tested using PCR for the identification of those belonging to the Streptomyces genus (Table 
A6 and A7).  Seven APO isolated using oat agar was found to presents bands at ~1500bp – indicating 
they belong to the Streptomyces spp. (22.6%) (Table A6). Totally 12 (31.6%) out of the 38 isolates 
obtained using potato starch agar were found to belong to the Streptomyces spp. (Table A7). Figure 
4.1 details a gel containing PCR reaction mixtures of APO 68, 75, 81, 84, 88, and 91, separated using 
gel electrophoresis. From this gel isolates 81, 84 and 91 were confirmed as belonging to 
Streptomyces spp., with isolate 88 determined as belonging to another genus. PCR was repeated 
for those displaying only one band of the two duplicates; 68 and 75 were seen to produce only one 
band at 1500bp, out of the two duplicates (Figure 4.1). 
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Figure 4.1: Agarose gel (2%) run of PCR reaction mixtures using DNA extracted from Friston Forest 
Isolates, cultivated using potato starch agar, for the identification of Streptomyces spp. Bands were 
visualised at ~1500bp, indicating the amplification of the 16S rRNA gene within the Streptomyces 
spp. Wells were filled with PCR reaction mixtures as follows: 1= DNA ladder, 2= No template DNA, 
3=  S. coelicolor (positive control), 4= isolate 68, 5= isolate 68, 6= isolate 75, 7= isolate 75, 8= isolate 
81, 9 = isolate 81, 10 = isolate 84, 11= isolate 84, 12= isolate 88, 13= isolate 88, 14= isolate 91, 15= 
isolate 91. 
 
4.2.3 Testing of Antimicrobial Producing Organisms 
4.2.3.1 Novel antimicrobial screening against sensitive organisms  
All isolates yielded from dry soil screening using oat and potato starch agar (31 and 38 
microorganisms respectively), due to inhibitory properties and/or similarities to Streptomyces spp. 
morphology, were initially tested using the perpendicular screening method. 
Initial screening detailed seven (21.2%) out of the 31 oat agar isolates with antimicrobial 
activity, with isolate 60 displaying inhibitory activity against P. mirabilis, and other isolates 
displaying inhibition against E. coli, S. epidermidis, and/or S. aureus (Table 4.2).  Four out of the 38 
(10.5%) organisms isolated using potato starch agar for initial cultivation, displayed inhibitory 
activity, with inhibition being seen only against E. coli, S. epidermidis and S. aureus (Table 4.4). 
Figure 4.2 displays the inhibition seen towards P. mirabilis by isolate 60, after 2 days incubation 
prior to the addition of test bacteria, at 25°C. Figures 4.4 and 4.5 show the activity of isolates 68 
and 70, displaying inhibition after 2 days incubation at 25°C during initial perpendicular screening; 
68 displayed inhibition towards S. epidermidis and S. aureus, and 70 displayed inhibition against S. 
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epidermidis, S. aureus and E. coli. In total 15.9% of all isolates, cultivated using both agars, from 
Friston Forest were seen to display inhibition. 
 Repeats of perpendicular screening of all isolates, with previously identified inhibition, 
however detailed less and differing inhibition to initial screening results (Tables 4.3 and 4.5 
respectively). Four out of the 7 (57.1%) oat isolates displayed continued inhibition of some form, 
and two out of the four (50%) potato starch agar isolates, again showed inhibition. Out of the 69 
Friston isolates, 11 displayed inhibitory activity against one of the test organisms (15.9%), with six 
displaying repeat inhibitory activity (8.7%).  Figure 4.3 displays the inhibition against E. coli, S. 
epidermidis and S. aureus after 2 days incubation at 25°C of oat isolate 64, in the repeat of 
perpendicular screening. 
 
 
Table 4.2: The seven APO isolated from Friston Forest using oat agar as initial cultivation media, 
that displayed inhibitory activity in initial perpendicular screening. A (-) indicates no inhibition of 
test organisms was apparent under the conditions stated. 
Isolate number Inhibition of test bacteria seen at 25°C Inhibition of test bacteria seen at 37°C 
 0 day 2 day 0 day 2 day 
38 - E. coli, S epidermidis 
and S. aureus 
- - 
49 - E. coli, S. aureus and 
S. epidermidis 
- - 
53 - - - S. epidermidis. 
54 - S. aureus. - - 
57 - - S. aureus. S. epidermidis and S. 
aureus. 
60 - P. mirabilis - - 
64 - E. coli. - - 
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Table 4.3: Inhibition results from the repeat of the perpendicular screening method, of the seven 
Friston Forest APO isolated using oat agar, that showed inhibition previously. A (-) indicates no 
inhibition of test organisms was apparent under the conditions stated. 
Isolate number Inhibition of test bacteria seen at 25°C Inhibition of test bacteria seen at 37°C 
 0 day 2 day 0 day 2 day 
38 - - - - 
49 - S. epidermidis - - 
53 - - - - 
54 - - S. epidermidis and S. 
aureus 
- 
57 - - - - 
60 - P. mirabilis - P. mirabilis 
64 - E. coli, S. epidermidis 
and S. aureus 
- S. aureus 
 
 
Table 4.4: The four isolates from Friston Forest, cultivated using potato starch agar displaying 
inhibitory activity from initial screening using the perpendicular screening method. A (-) indicates 
no inhibition of test organisms was apparent under the conditions stated. 
Isolate number Inhibition of test bacteria seen at 25°C Inhibition of test bacteria seen at 37°C 
 0 day  2 day 0 day  2 day 
68 - S. epidermidis and S. 
aureus. 
- - 
70 S. epidermidis and S. 
aureus. 
E. coli, S. 
epidermidis and S. 
aureus. 
E. coli. - 
100 - S. epidermidis. - - 
101 - E. coli, S. 
epidermidis and S. 
aureus. 
- - 
 
 
Table 4.5: The inhibition seen in the repeat of perpendicular screening, of the four Friston Forest 
APO, cultivated using potato starch agar, that had previously shown inhibition. A (-) indicates no 
inhibition of test organisms was apparent under the conditions stated. 
Isolate number Inhibition of test bacteria seen at 25°C Inhibition of test bacteria seen at 37°C 
 0 day  2 day 0 day  2 day 
68 - S. epidermidis and S. 
aureus. 
- - 
70 - - - - 
100 - - - - 
101 - E. coli, S. epidermidis 
and S. aureus. 
- - 
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Figure 4.2: The inhibition seen by Friston Forest isolate 60, isolated using oat agar, against P. 
mirabilis, after 2 days incubation at 25°C. The arrow indicates where the growth of P. mirabilis has 
been inhibited. From top to bottom, E. coli, S. epidermidis, S. aureus, P. aeruginosa and P. mirabilis 
were tested against isolate 60. 
 
Figure 4.3: The inhibitory action of Friston oat isolate 64 in duplicate (A and B), against E. coli, S. 
epidermidis, and S. aureus, after incubation for 2 days at 25°C, upon the repetition of the 
perpendicular screening method. The arrows indicate where the individual organisms’ growth have 
been inhibited. From top to bottom, E. coli, S. epidermidis, S. aureus, P. aeruginosa and P. mirabilis 
were tested against isolate 64.  
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Figure 4.4: Friston Forest isolate 68 cultivated using potato starch agar, displaying inhibition against 
S. epidermidis and S. aureus after 2 days incubation at 25°C before the addition of the test bacteria 
in the initial perpendicular screening method. The black arrows indicate the extent of the inhibition 
of test bacteria caused by APO 68. From top to bottom, E. coli, S. epidermidis, S. aureus, P. 
aeruginosa and P. mirabilis were tested against isolate 68. 
 
 
 
 
Figure 4.5: Isolate 70 initially cultivated from Friston Forest using potato starch agar, displaying 
inhibition against E. coli, S. epidermidis and S. aureus after 2 days incubation at 25°C, in duplicate 
(A and B), in initial perpendicular screening. From top to bottom, E. coli, S. epidermidis, S. aureus, 
P. aeruginosa and P. mirabilis were tested against isolate 70. 
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4.2.3.2 Antimicrobial screening against clinical strains 
The six APO originally isolated from Friston Forest using oat agar, that showed inhibition 
towards sensitive strains of E. coli, P. mirabilis and/or S. aureus, were further tested against 
clinically isolated strains of the same species of bacteria, using the perpendicular streak method. 
Table 4.6 displays that two APO showed further inhibition towards the clinical strains of test 
bacteria (33.3%).  Isolate 53 previously only displayed inhibition to S. epidermidis, and hence was 
not further tested against any of the clinical isolates (Table 4.2). Figure 4.6 highlights inhibition 
presented towards the clinical strain of P. mirabilis, by APO 60, after it was incubated for 2 days at 
25°C prior to the addition of test bacteria. 
Three of the original four APO isolated from Friston Forest using potato starch agar with 
inhibition seen previously, were further tested using clinical strains; isolate 100 was not further 
tested due to inhibition only being seen against S. epidermidis (Table 4.4). Only one of the three 
potato isolates displayed inhibition to the clinical strains of test bacteria (33.3%) (Table 4.7).  
Inhibition seen towards the clinical strains of E. coli and S. aureus by Friston isolate 101, can be seen 
in Figure 4.7, where the organism was grown for 2 days at 25°C prior to the addition of test bacteria. 
 
Table 4.6: Inhibition seen towards clinical strains of test bacteria by Friston Forest APO isolated 
using oat agar, after both 0 and 2 days incubation at both 25°C and 37°C, using the perpendicular 
screening method. A (-) indicates no inhibition of test organisms was apparent under the conditions 
stated. 
Isolate 
number 
Test Organisms Inhibition of test bacteria 
seen at 25°C 
Inhibition of test bacteria 
seen at 37°C 
  0 day 2 day  0 day  2 day 
38 E. coli, and S. 
aureus. 
- - - - 
49 E. coli, and S. 
aureus 
- - - - 
54 S. aureus. - - - - 
57 S. aureus. - - - - 
60 P. mirabilis. - P. mirabilis. - P. mirabilis. 
64 E. coli, and S. 
aureus 
- E. coli and S. 
aureus. 
- - 
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Table 4.7: Inhibition seen towards clinical strains of test bacteria by APO isolated from Friston 
Forest using potato starch agar, incubated for both 0 and 2 days at both 25°C and 37°C, using the 
perpendicular screening method. A (-) indicates no inhibition of test organisms was apparent under 
the conditions stated. 
Isolate 
number 
Test Organisms Inhibition of test bacteria 
seen at 25°C 
Inhibition of test bacteria 
seen at 37°C 
  0 day 2 day  0 day  2 day 
68 S. aureus. - - - - 
70 S. aureus and E. 
coli. 
- - - - 
101 S. aureus and E. 
coli. 
- E. coli and S. 
aureus. 
- - 
 
 
 
 
 
 
Figure 4.6: The inhibition towards the clinical strain of P. mirabilis, presented by Friston oat isolate 
60, that was incubated for two days at 25°C before the addition of test bacteria. The arrows indicate 
the extent of the inhibition of P. mirabilis caused by isolate 60. 
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Figure 4.7: The inhibition presented by Friston isolate 101, originally isolated using potato starch 
agar, towards resistant clinical strains of E. coli (top) and S. aureus (bottom) from the perpendicular 
screening method. Isolate 101 was incubated for 2 days at 25°C before the addition of test bacteria 
and further incubated for 7 days. The arrows indicate the inhibitory activity by isolate 101 towards 
the test organisms. 
 
4.2.3.3 Starvation method 
Isolates cultivated from Friston Forest using both oat and potato starch agar, were tested 
using the starvation method. Five of the 31 (16.1%) oat isolates displayed inhibition of at least one 
of the test bacteria used at the differing temperatures and timepoints (Table 4.8). Isolate 53 showed 
inhibition at a range of time points, as well as inhibition at both 25°C and 37°C. Figure 4.9 displays 
an example of the inhibitory activity produced by isolate 53 towards S. epidermidis, after it was 
incubated for 10 days at 25°C. Figure 4.8 also shows the inhibition seen towards S. epidermidis on 
Mueller-Hinton agar, by oat isolate 60 that was incubated for 14 days at 37°C. 
Out of the 38 APO isolates from potato starch agar, 16 (42.1%) showed some form of 
inhibition towards the test bacteria used (Table 4.9).  Isolate 78 was seen to display inhibition 
against S. aureus, streaked as a lawn on plate count agar, after incubation for 7 days at 37°C (figure 
4.10). Figure 4.11 displays the inhibition presented towards E. coli on Mueller-Hinton agar, after 
isolate 98 was incubated for 10 days at 37°C. Repeats of this starvation method, using stored 
supernatant, as well as repeat of whole method, did not occur for all Friston Forest isolates, due to 
time constraints. 
In total the number of Friston Forest APO, cultivated using both agars, that displayed 
inhibition towards one of the test bacteria in the starvation method, was 30.4%, with a large 
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majority inhibiting the Gram-positive test organisms used. Ten out of the 16 (62.5%), and three out 
of the five (60%) confirmed APO, isolated using potato and oat agar respectively, were able to 
inhibit at least one of the test Staphylococcus spp. used. 
 
 
Table 4.8: The inhibition seen by APO isolated from Friston Forest using oat agar, tested using the 
starvation method. The agar that inhibition was seen on by individual isolates, is stated in brackets; 
PC – plate count agar, MH- Mueller-Hinton agar. A (-) indicates no inhibition of test organisms was 
apparent under the conditions stated. 
Isolate 
Number 
Days of incubation of isolate at 25°C (agar 
result in bracket) 
Days of incubation of isolate at 37°C (agar 
result in bracket) 
 7 days 10 days 14 days 7 days 10 days 14 days 
47 - - - E. coli (PC). S. aureus 
(PC) E. coli 
(MH). 
- 
53 S. aureus (PC). S. aureus and 
S. epidermidis 
(PC). 
S. 
epidermidis 
and S. 
aureus (PC). 
- - S. aureus (PC). 
54 - - - - E. coli (PC). - 
60 - - - E. coli, S. 
aureus and S. 
epidermidis 
(MH). 
E. coli, S. 
epidermidis 
and S. 
aureus (PC). 
S. epidermidis 
and S. aureus 
(PC and MH) 
and E. coli 
(MH). 
63 - - - - E. coli (MH) - 
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Table 4.9: The inhibition seen by the APO isolated from Friston Forest using potato starch agar, 
using the starvation method. The agar that inhibition was seen on by individual isolates, is stated in 
brackets; PC – plate count agar, MH - Mueller-Hinton agar. A (-) indicates no inhibition of test 
organisms was apparent under the conditions stated. 
Isolate 
number 
Days of incubation at 25°C (agar result in 
bracket) 
Days of incubation at 37°C (agar result in 
bracket) 
 7 days 10 days 14 days 7 days 10 days 14 days 
69 - - - E. coli (MH + 
PC). 
- - 
70 S. 
epidermidis 
and S. 
aureus (PC). 
- - S. epidermidis 
and S. aureus 
(PC) E. coli (MH 
+ PC). 
- E. coli (PC + 
MH). 
71 - - - E. coli (MH + 
PC). 
- - 
73 - S. aureus and 
S. epidermidis 
(PC) 
- - E. coli (MH). S. epidermidis 
and S. aureus 
(MH). 
74 - S. epidermidis 
and S. aureus 
(MH + PC). 
- - - - 
75 - - - - E. coli (MH) E. coli (MH) and 
S. epidermidis 
(PC). 
76 - S. epidermidis 
and S. aureus 
(PC + MH) 
- - - - 
78 S. 
epidermidis 
and S. 
aureus (PC). 
- S. epidermidis 
and S. aureus 
(PC). 
S. epidermidis 
and S. aureus 
(PC). 
S. 
epidermidis 
and S. 
aureus (PC). 
S. epidermidis 
and S. aureus 
(PC). 
82 - - - E. coli (MH). - - 
84 - - - E. coli (PC). E. coli (MH). E. coli (MH + 
PC). 
85 - - - - - E. coli, S. 
epidermidis and 
S. aureus (MH). 
90 - - S. aureus 
(MH+PC) and 
S. epidermidis 
(PC). 
- - - 
96 - S. epidermidis 
and S. aureus 
(PC) 
S. aureus (PC). - - - 
97 - - - - - E. coli (MH) 
98 - - - - E. coli (MH). - 
102 - - S. epidermidis 
and S. aureus 
(PC). 
- - - 
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Figure 4.8: Isolate 60 Isolated from Friston Forest using oat agar, incubated for 14 days at 37°C, 
detailing inhibition against S. epidermidis streaked as a lawn on Mueller-Hinton agar, using the 
starvation method. The arrow provides an example as well as indicating the inhibition of S. 
epidermidis caused by isolate 60. 
 
 
Figure 4.9: The inhibition seen towards S. epidermidis on plate count agar, by Friston Forest oat 
isolate 53, that was incubated for 10 days at 25°C, using the starvation method. The arrow indicates 
an area of inhibition of S. epidermidis caused by isolate 53. 
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Figure 4.10: Isolate 78, initially isolated from Friston Forest using potato starch agar, displaying 
inhibition against S. aureus, on plate count agar, after 7 days incubation at 37°C, using the starvation 
method. An example of the extent of the inhibition towards S. aureus can be seen by the arrows 
used.  
 
 
Figure 4.11: Isolate 98 isolated from Friston Forest using potato starch agar, displaying inhibition 
towards E. coli on Mueller-Hinton agar, in the starvation method, after 10 days incubation at 37°C. 
The arrow indicates the inhibition of E. coli seen, caused by the inhibitory activity of isolate 98. 
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4.3 Discussion 
Friston Forest was selected due to its classification of being a modern forest, allowing the 
results obtained to be compared to that of New Forest, as well as Dawes Farm. From these results, 
it can be seen that APO, can in fact be cultivated from Friston Forest, with 69 organisms initially 
cultivated due to observed inhibition and/or similar morphology to that of Streptomyces spp. Using 
oat agar, 31 APO were initially selected and purified, before testing using perpendicular screening. 
Using this method, it was detailed that seven (21.2%) of these had the ability to produce some form 
of inhibitory action (Table 4.2), including isolate 60 that displayed inhibition against P. mirabilis after 
2-day incubation at 25°C (figure 4.2), with the six other APO showing inhibition towards either E. 
coli, S. epidermidis and/or S. aureus. Upon repeating this method, isolate 60 again showed 
inhibition towards Proteus spp. after 2-day incubation, but this inhibition was seen at both 25°C 
and 37°C, showing increase in inhibitory activity (Table 4.3). As well as this isolate 64 also displayed 
further inhibition to both the Staphyloccocus spp., additional to the inhibition seen towards E. coli, 
in the first run of the method, however from this repeat, four of the APO showed less/no inhibition 
compared to the first run of the method (Tables 4.2 and 4.3). This lack of inhibition was also seen 
in the repeat of this method using the clinical test organisms (Table 4.6). Of the six isolates that 
displayed inhibition to either E. coli, S. aureus or P. mirabilis previously, only two (33.3%) displayed 
the ability to inhibit the clinical strains of the same test organism; isolates 60 and 64 displayed 
inhibition towards P. mirabilis from Brighton hospital, and E. coli and the NCTC strain of MRSA 
respectively. Although, the lack of inhibition seen may be due to the resistance possessed by both 
the E. coli, and MRSA, meaning the compounds being produced by the APO are ineffective.  
Similar results were also seen by the Friston APO cultivated using potato starch agar, with 
less inhibition seen in both repeats of perpendicular screening. Overall 38 APO were isolated using 
this agar, with only four (10.5%), showing some form of inhibitory activity (Table 4.4). This shows 
that just over half the amount of inhibition was seen compared to the oat agar isolates (21.2%), 
with no inhibition seen towards P. mirabilis. The potato starch agar isolates also displayed less 
inhibition upon the first repeat, with only two of the four isolates displaying inhibition; isolates 68 
and 101 continued to produce inhibitory compounds (Table 4.5). Upon the further testing using 
clinical organisms, only one of the three APO tested (33.3%), displayed inhibitory activity; figure 4.7 
shows the inhibition of clinical strains of both E. coli and MRSA, by isolate 101. However, these 
results still show that APO with inhibitory activity against clinical strains, are able to be isolated 
from Friston Forest, with inhibition also seen towards these bacteria by 33.3% of the oat agar 
isolates tested (Tables 4.6 and 4.7). As well as this both isolates 64, and 101, as discussed previously, 
were seen to produce compounds able to inhibit both resistant Gram-positive and Gram-negative 
organisms, displaying that further work on these compounds, including identification of its base 
structure using DOSY-NMR, could allow the production of a novel antimicrobial, able to treat these 
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potentially life-threatening infections in a clinical setting. However, neither of the isolates are seen 
to display inhibition towards, P. aeruginosa, a well-known opportunistic pathogen, and cause of 
urinary tract infections, and ventilator-associated pneumonia (Mittal et al., 2009; Sawa et al., 2016).  
Further inhibition was also seen by potato starch agar isolates in the starvation method, 
with 16 (42.1%) isolates displaying some form of inhibition, much more than seen previously in the 
perpendicular screening method (10.5%) (Tables 4.4 and 4.9). This, however was not seen by the 
isolates cultivated using oat agar, with only five isolates (16.1%) showing some form of inhibitory 
activity in the starvation method, compared to the seven (21.2%) inhibitory isolates seen prior 
(Tables 4.2 and 4.8). This may provide further evidence for the specific conditions required, to 
encourage differing organisms to produce antimicrobial compounds, and it may be noted that these 
stress-induced conditions may, in fact, halt the production of the antimicrobial metabolites, and 
the lack of nutrients may have even caused cell death (Rokem et al., 2007). Although this shows a 
decrease of inhibitory activity from this method, some of the APO that did not display any inhibition 
in the initial perpendicular screening, were seen to inhibit test organisms in the starvation method; 
this was seen by oat isolates 47 and 63, which displayed a lack of inhibition in initial screening, but 
inhibited E. coli and S. aureus, and E. coli only respectively, after prolonged incubation (Tables 4.2 
and 4.8). However, overall from this starvation method, 21 (30.4%) of the 69 APO were seen to 
produce some form of inhibition, compared to the 11 (15.9%) isolates in initial screening, showing 
an overall increase in inhibitory activity of the Friston Forest APO. Using this starvation method, it 
was also concluded that the majority of the inhibition was seen against the Gram-positive 
organisms, with three out of five oat isolates (60%) and 10 out of 16 (62.5%) potato starch agar 
isolates displaying activity against these test organisms (Table 4.8 and 4.9). 
As well as this, certain APO also showed the ability to produce compounds under a range 
of conditions in the starvation method, including inhibition of test bacteria after differing lengths 
of incubations, as well as at both of the test temperatures used. Isolates 70 and 73 displayed the 
ability to produce inhibitory compounds after several of the different days incubations used, at both 
25°C and 37°C, affecting both Gram-positive and Gram-negative bacteria (Table 4.9). This was also 
seen by isolates 53 and 78, which, under a range of conditions showed the ability to inhibit Gram-
positive organisms (Tables 4.8 and 4.9). However, the repeat of this method using samples from 
both the same and differing locations within Friston Forest, may increase the chances of isolating 
APO, as well as allowing further conclusions to be drawn regarding the effectiveness of the 
starvation method.  
From comparison of all APO results, certain organisms can be determined as highly 
effective at producing antimicrobial compounds. Such APO as isolates 53, 60 and 70, which all 
displayed inhibition in both initial perpendicular screening and starvation method, with isolate 60 
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also inhibiting the clinical strain of P. mirabilis, could be selected for further work including analysis 
of the compounds being produced, in the hope of isolating a novel antimicrobial compound (Tables 
4.3, 4.4, 4.6, 4.8 and 4.9). 
As well as the further testing of the APO, PCR was undertaken for the identification of those 
belonging to the Streptomyces genus, from both the oat and potato starch agar isolates with similar 
morphology, and Gram stain to that known of the species. In total 19 (27.5%) of the 69 Friston APO 
isolated were confirmed as belonging to the Streptomyces spp. with eight (42.1%) of these 
displaying some form of inhibitory activity in one or more of the screening methods used. However, 
as well as this an additional ten (14.5%) isolates could only be presumed as belonging to this genus, 
due to time constraints preventing the testing of these isolates using the PCR method. This 
highlights a key area of further research necessary, meaning conclusions regarding the presence 
and likelihood of isolating this genus at certain sample areas can be drawn, as well as allowing 
comparison and optimisation of the culture methods, to increase the likelihood of obtaining larger 
amounts of organisms belonging to the Streptomyces genus.   
Of the 19 confirmed Streptomyces spp. varying inhibition was seen. Isolate 49 produced 
inhibitory activity towards E. coli, S. aureus and S. epidermidis in initial perpendicular screening, and 
S. epidermidis in the repeat of this method (Tables 4.2 and 4.3). However, upon testing of activity 
against clinical isolates, no inhibition was presented, although a strain of S. epidermidis was not 
available for use in this method, meaning future inclusion of this strain may produce differing 
results (Table 4.6). This is similar to isolates 53 and 100, which displayed inhibition towards S. 
epidermidis in the first repeat of perpendicular screening, however it is not known if the activity 
would inhibit the growth of a clinical strain of the same organism (Tables 4.2 and 4.4). Isolate 53 as 
well as 85 also detailed activity in the starvation method, however both these isolates were not 
confirmed as belonging to this genus due to the halting of the PCR procedure (Table 4.8 and 4.9). 
This can also be said for the presumed Streptomyces isolate 60 which displayed a broad range of 
activity, as discussed above (Tables 4.2, 4.3, 4.6 and 4.8). Other presumed Streptomyces spp. were 
seen to produce inhibition in the initial perpendicular screening against both clinical and sensitive 
strains of test bacteria including isolate 64 (Table 4.6), meaning further work, as discussed 
previously, using the PCR method to confirm the genus of these isolates, would provide further 
evidence for the inhibitory ability of compounds produced by the Streptomyces spp. 
(Gebreyohannes et al., 2013). 
Similar to the isolates cultivated using oat agar, from the same samples sites, none of the 
12 confirmed Streptomyces spp., isolated using potato starch agar, showed inhibition spanning the 
differing methods, even though higher amounts of Streptomyces spp. were isolated using this agar 
(Table A7). Isolate 100 displayed inhibition in perpendicular screening as discussed above, and 
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isolates 76, 84, 96, 97, 98 and 102 were all active in the starvation method alone (Tables 4.4 and 
4.9). As well as this, inhibition was also seen by isolate 85 in the starvation method, however this 
isolate was only presumed to belong to the Streptomyces genus, due to its characteristics, as 
discussed previously (Tables 4.9 and A5).  
From the same 20 soil samples, 55 organisms were isolated and characterised using the 
several biochemical tests, for the identification of potential pathogenic bacteria, including those 
previously selected as of importance (see section 2.2.2.2). Two isolates (3.6%) were identified as 
belonging to the Salmonella spp., one of the genus’ selected as of importance. A further two isolates 
(3.6%) were identified as S. aureus and belonging to the Enterobacter spp., as well as Streptomyces 
spp. Additionally, the more well-known soil microorganisms such as Kurthia spp. (14.6%), Bacillus 
spp. (23.6%) and Acinetobacter spp. (21.8%) were isolated. These results hence may display the lack 
of potentially pathogenic organisms within the Friston Forest area. On the other hand, the lack of 
cultivation of these organisms may be due to the soil biochemistry, such as the high acidity, which 
is largely due to the woodland being classed as a pine forest. This may have caused a more hostile 
environment for certain pathogenic bacteria, meaning more prevalent soil organisms were able to 
out compete them and the cultivation of these pathogenic bacteria of interest was less likely. 
Overall, these results show the ability to isolate APO from Friston Forest at the sample 
locations used, as well as the ability to locate organisms belonging to the Streptomyces genus. This 
includes those with the ability to produce inhibitory compounds, affecting both Gram-positive and 
Gram-negative test organisms. As well as this, the lack of pathogenic organisms, of those previously 
selected, from the several areas of Friston Forest sampled, was noted. 
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5.0 Investigation of soil samples from Dawes Farm 
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5.0 Investigation of soil samples from Dawes Farm 
Similar to the New Forest, Dawes Farm was selected to allow for any effects that livestock 
have on the soil microbiome to be studied. In collaboration with Westpoint Farm Vets, who own 
the on-site practice, sampling again occurred at varying areas. This included grazing fields with 
animals, including cattle, present, and those where animals were previously present (relocated), as 
well as areas primarily affected by human activity, including walkways, to allow any differences to 
be noted. Westpoint Farm Vets specialise in the treatment and upkeep of farm animals, and hence 
differences may be seen compared to that of the New Forest results, in both presence of pathogenic 
organisms and APO, due to the differing animals and nature of the sites sampled; this may be due 
to the larger and more dense populations of animals affecting the soil microbiome, as well as the 
higher likelihood of antimicrobial use on Dawes Farm, due to the nature of the site. Several areas 
of Dawes Farm were sampled to increase the chances of isolating both potentially pathogenic 
organisms, as well as APO. 
 
5.1 Methods 
5.1.1 Isolation and characterisation of microorganisms within the soil 
Soil samples were collected from several different locations at Dawes Farm, Warnham, in 
collaboration with Westpoint Farm Vets, and pathogenic organisms were isolated using the 
methods stated in section 2.2.1 and 2.2.2.2 respectively. For further characterisation, using 
biochemical tests, of the potential pathogenic bacteria, methods were carried out as in section 
2.2.3.2. 
 For the isolation of potential APO and Streptomyces spp. methods were carried out as seen 
in section 2.2.2.3, with the use of both oat and potato starch agar as cultivation media. Further 
characterisation occurred using Gram staining and PCR as seen in section 2.2.3.3.  
5.1.2 Further testing of Antimicrobial Producing Organisms 
All APO that were cultivated using both potato starch and oat agar, were further tested 
using the perpendicular screening method, using both sensitive and clinical strains, as stated in 
sections 2.2.4.2 and 2.2.4.3 respectively, and then further tested using the starvation method, 
against sensitive strains of E. coli, S. epidermidis, S. aureus and P. mirabilis as seen in section 2.2.4.5. 
Repeats of perpendicular screening using sensitive strains took place only.  
As well as this, Ms Suzana Haxhia (MSc Biomedical Science Project student) carried out the 
perpendicular method as seen in section 2.2.4.2, on presumed Streptomyces spp. that were isolated 
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from wet soil samples, originating from Dawes Farm only, for further determination of 
Streptomyces activity.  
5.2 Results 
Twenty-two soil samples were collected at Westpoint Farm Vets, Dawes Farm, Warnham, 
in May 2017 (See appendix table A8). 
5.2.1 Isolation of pathogenic microorganisms 
Ninety organisms were isolated and purified from the 22 soil samples taken from farmland 
belonging to Westpoint Farm Vets. Further testing including Gram staining, catalase, indole, 
coagulase, lactose fermentation, oxidase, and citrate, and the identification of isolates was carried 
out with assistance of project student Ms. Suzana Haxhia. From the farm samples 90 isolates were 
identified using biochemical tests; four isolates were identified as belonging to the Klebsiella spp., 
and E. coli (4.4%). Nineteen, 26, and six isolates were identified as S. aureus (21.1%), Bacillus spp. 
(28.9%), and P. aeruginosa (6.7%) respectively. One isolate was identified as S. epidermidis (1.1%), 
due to coagulase result. Eleven isolates were identified as belonging to the Streptomyces genus due 
to Gram stain (12.2%), and 19 isolates were identified as Aureobacterium spp. (21.1%). 
5.2.2 Identification of Streptomyces spp. from APO isolated 
From the 22 dried soil samples, 26 APO were isolated using oat agar, and 17 were isolated 
using potato starch agar (see appendix Tables A9 and A10). Using the Gram stain information of 
APO isolated using oat and potato starch agar, 11 (42.3%) and nine (52.9%) APO respectively were 
selected for further identification using DNA extraction and PCR; appendix Tables A11 and A12 
display the concentration and the purity of the DNA extracted from all isolates. However, isolates 
were not put through conclusive PCR for the identification of Streptomyces spp., due to time 
constraints.  
 5.2.3 Testing of Antimicrobial Producing Organisms 
5.2.3.1 Antimicrobial screening against sensitive organisms 
All 26 and 17 APO isolated and purified from oat and potato starch agar respectively, due 
to apparent inhibitory effects and/or similar morphology to that of Streptomyces spp., were tested 
(see appendix Tables A9 and A10). From initial perpendicular screening ten out of the 26 oat isolates 
displayed inhibition to at least one of the test bacteria used (38.5%) (Table 5.1). Repeats of 
perpendicular screening using the oat isolates, originating from Dawes Farm, that had shown 
inhibition prior, displayed four out of the ten APO with continued inhibition (40%); isolates 112, 
113, 115, 121, 123, and 126 displayed no inhibition upon the repeat of perpendicular screening 
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(Table 5.2).  Repeated inhibition by APO, out of all oat isolates in total, was seen by 15.4% of 
isolates.  
Three out of the 17 (17.6%) APO isolated from Dawes Farm, Warnham, using potato starch 
agar, were seen to present inhibition against at least one of the five test isolates in initial 
perpendicular screening (Table 5.3). All three isolates (100%) again showed inhibition on varying 
days, upon the repeat of this method, but inhibition was seen against less organisms than initially 
(Table 5.4); neither 131 or 132 presented inhibition against P. mirabilis with 132 also lacking 
inhibition against S. aureus. Isolate 142 also displayed inhibition against S. epidermidis only, upon 
repeats (Tables 5.3 and 5.4). 
Of the 43 APO isolated using both agars, 13 (30.2%) displayed some form of inhibition to 
the sensitive strains of test bacteria. No inhibition was seen by either of the groups of isolates 
towards P. aeruginosa. 
 
 
Table 5.1: The ten APO originally isolated using oat agar, from Dawes Farm, that displayed inhibition 
in initial perpendicular screening. A (-) indicates no inhibition of test organisms was apparent under 
the conditions stated. 
Isolate Number Inhibition of test bacteria seen at 25°C Inhibition of test bacteria seen at 37°C 
 0 day 2 day 0 day  2 day 
105 - S. epidermidis, S. 
aureus, and P. 
mirabilis. 
- - 
    112 - P. mirabilis - P. mirabilis 
113 - - - E. coli, S. 
epidermidis and S. 
aureus. 
115 - S. epidermidis and 
S. aureus. 
- - 
116 - S. epidermidis and 
S. aureus. 
- - 
120 - P. mirabilis. - - 
121 - - - P. mirabilis 
123 - - - S. epidermidis and 
S. aureus. 
126 - S. epidermidis and 
S. aureus. 
- - 
128 - S. epidermidis and 
S. aureus. 
- - 
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Table 5.2:  The inhibition seen using the repeat of the perpendicular screening method, by the ten 
APO originally isolated using oat agar, from Dawes Farm, Warnham, that had shown inhibition 
previously. A (-) indicates no inhibition of test organisms was apparent under the conditions stated. 
Isolate Number: Inhibition of test bacteria seen at 
25°C 
Inhibition of test bacteria seen at 
37°C 
 0 day 2 day 0 day 2 day 
105 - S. epidermidis, S. 
aureus and P. 
mirabilis 
- - 
112 - - - - 
113 - - - - 
115 - - - - 
116 - S. epidermidis 
and S. aureus. 
- - 
120 - - - P. mirabilis 
121 - - - - 
123 - - - - 
126 - - - - 
128 - S. aureus - - 
 
Table 5.3: The inhibition seen by the three APO isolated originally from Dawes Farm using potato 
starch agar, when tested using the perpendicular screening method. A (-) indicates no inhibition of 
test organisms was apparent under the conditions stated. 
Isolate Number Inhibition of test bacteria seen at 
25°C 
Inhibition if test bacteria seen at 
37°C 
 0 day 2 day 0 day  2 day 
131 - S. epidermidis, S. 
aureus and P. 
mirabilis 
- - 
132 - S. epidermidis, S. 
aureus and P. 
mirabilis 
- - 
142 - - - E. coli, S. 
epidermidis and 
S. aureus. 
 
Table 5.4: The inhibition seen by the three APO with inhibitory activity seen previously, isolated 
from Dawes Farm, Warnham, using potato starch agar, upon the repeat of the perpendicular 
screening method. A (-) indicates no inhibition of test organisms was apparent under the conditions 
stated. 
Isolate Number Inhibition of test bacteria seen at 
25°C 
Inhibition of test bacteria seen at 
37°C 
 0 day 2 day 0 day 2 day 
131 - S. epidermidis 
and S. aureus  
- - 
132 - S. epidermidis - - 
142 - - - S. epidermidis 
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5.2.3.2 Antimicrobial screening against clinical strains 
Out of 10 APO originally isolated from Dawes Farm, and cultivated using oat agar, that 
showed inhibition prior (Table 5.1), three were seen to have inhibitory activity towards at least one 
of the clinical test bacteria using the perpendicular screening method (30%) (Table 5.5). Isolate 105 
showed inhibition against S. aureus and P. mirabilis, with inhibition towards P. mirabilis shown in 
figure 5.1.  Two of the three (66.6%) potato starch isolates from Dawes Farm, that had shown 
inhibition prior in initial screening, showed activity towards the clinically isolated bacteria used 
(Table 5.6).  Figure 5.2 displays the inhibition towards S. aureus and P. mirabilis by isolate 132, 
however due to the overgrowth of Proteus spp. on this plate, confirmation of inhibitory action 
against MRSA was not confirmed using this replicate. 
None of the APO isolated using the two agars were seen to be effective against clinically 
isolated E. coli; two of the isolates, 113 and 142, had shown inhibition of sensitive E. coli previously 
(Tables 5.1 and 5.3). Totally, inhibition towards clinical strains of test bacteria, was seen by five 
(38.5%) out of the 13 APO, that had previously shown inhibition. 
 
 
 
 
Table 5.5: Inhibition shown towards clinically isolated test bacteria, using perpendicular screening, 
by the ten APO initially isolated from Dawes Farm using oat agar, that showed inhibition previously. 
A (-) indicates no inhibition of test organisms was apparent under the conditions stated. 
Isolate number Test Organisms 
used 
Inhibition of test bacteria seen 
at 25°C 
Inhibition of test bacteria seen 
at 37°C 
  0 day 2 day  0 day  2 day 
105 S. aureus and P. 
mirabilis 
- S. aureus and 
P. mirabilis. 
- - 
112 P. mirabilis - - - - 
113 E. coli and S. 
aureus. 
 -  - 
115 S. aureus - S. aureus. - - 
116 S. aureus - - - - 
120 P. mirabilis - - - P. mirabilis 
121 P. mirabilis - - - - 
123 S. aureus - - - - 
126 S. aureus - - - - 
128 S. aureus - - - - 
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Table 5.6: Inhibition seen by the three APO, that were initially cultivated using potato starch agar 
from Dawes Farm, towards clinically isolated test bacteria in perpendicular screening. A (-) indicates 
no inhibition of test organisms was apparent under the conditions stated. 
Isolate number Test Organisms 
used 
Inhibition of test bacteria seen 
at 25°C 
Inhibition of test bacteria seen 
at 37°C 
  0 day 2 day  0 day  2 day 
131 S. aureus and P. 
mirabilis 
- P. mirabilis 
and S. aureus. 
- - 
132 S. aureus and P. 
mirabilis 
- P. mirabilis 
and S. aureus 
- - 
142 E. coli and S. 
aureus. 
- - - - 
 
 
 
 
Figure 5.1: Isolate 105, isolated from Dawes Farm using oat agar, displaying inhibition against 
clinically isolated S. aureus (top) and P. mirabilis (bottom). Isolate 105 was incubated 2 days prior 
the addition of test isolates at 25°C. The arrows display the inhibitory activity of 105 towards the 
test organisms used. However, from this figure, activity towards MRSA could not be confirmed, due 
to the overgrowth of P. mirabilis. 
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Figure 5.2: The inhibitory activity of isolate 132 isolated using potato starch agar from Dawes Farm, 
against clinically isolated S. aureus (top) and P. mirabilis (bottom) after previous incubation of this 
organism for 2 days at 25°C, using the perpendicular screening method. The arrows indicate where 
the inhibition of the test organisms has taken place. However due to the overgrowth of the Proteus 
spp., the inhibition of S. aureus was not confirmed using this plate replicate. 
 
5.2.3.3 Starvation method 
All 26 and 17 isolates cultivated originally from oat and potato agar respectively, were 
further tested using prolonged incubation at 25°C and 37°C, using the starvation method. Out of 
the 26 oat isolates, five displayed inhibition to at least one of the test bacteria used (19.2%) (Table 
5.7). Figure 5.3 displays the inhibition seen towards E. coli by oat isolate 112 after incubation for 10 
days at 37°C. Figure 5.4 displays inhibitory action towards S. aureus after 7-day incubation of oat 
isolate 120 at 37°C. 
 Four out of the 17 potato isolates were seen to present inhibitory activity towards the test 
bacteria used, after prolonged incubation during the starvation method (23.5%) (Table 5.8). Figures 
5.5 and 5.6 display inhibition against S. aureus by isolates 146 and 136 respectively, after both 
isolates were incubated for 10 days at 37°C. In total nine out of the 43 (20.9%) farm isolates, 
cultivated using both agars, displayed inhibition towards one or more of the test bacteria. 
Within the oat isolates, inhibition was seen against all test bacteria used, including P. 
mirabilis, however isolates initially cultivated using potato starch agar, presented no inhibition 
towards the Gram-negative test bacteria used; no inhibitory activity was seen towards E. coli or P. 
mirabilis within the varying temperatures and incubation periods (Tables 5.7 and 5.8).   
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Table 5.7: The inhibition seen in the starvation method by the APO isolated from Dawes Farm, using 
oat agar as the cultivation media. Agar results in brackets – PC – plate count agar, MH – Mueller-
Hinton agar. A (-) indicates no inhibition of test organisms was apparent under the conditions 
stated. 
Isolate 
Number 
Days of incubation of isolate at 25°C (agar 
result in brackets) 
Days of incubation of isolate at 37°C (agar 
result in brackets). 
 7 days 10 days 14 days 7 days  10 days  14 days 
112 - - - E. coli (MH), P. 
mirabilis (PC). 
E. coli, S. aureus 
and S. 
epidermidis (PC), 
P. mirabilis 
(MH). 
S. aureus and 
S. epidermidis 
(PC) and E. 
coli (MH). 
114 S. aureus and S. 
epidermidis. 
- - - - - 
120 - - - E. coli, S. 
epidermidis and 
S. aureus (MH). 
- S. epidermidis 
and S. aureus 
(PC), E. coli 
and P. 
mirabilis 
(MH). 
121 - - - - E. coli (MH). S. epidermidis 
(PC). 
129 - - - - E. coli, S. 
epidermidis and 
S. aureus (MH). 
- 
 
 
Table 5.8: Inhibition seen by the APO isolated from Dawes Farm, using potato starch agar as initial 
cultivation media, using the starvation method. Agar results in brackets – PC – plate count agar, MH 
– Mueller-Hinton agar. A (-) indicates no inhibition of test organisms was apparent under the 
conditions stated. 
Isolate 
Number 
Days incubation of isolate at 25°C (Agar result in 
brackets) 
Days incubation of isolate at 37°C (Agar result 
in brackets) 
 7 days  10 days  14 days 7 days  10 days 14 days 
136 - - - - S. aureus and S. 
epidermidis 
(PC). 
- 
137 - S. epidermidis 
(PC) 
S. epidermidis 
and S. aureus 
(PC). 
- - - 
144 - S. epidermidis 
and S. aureus 
(MH). 
- - - - 
146 - - - - S. epidermidis 
and S. aureus 
(PC). 
- 
 
 
 
97 
 
 
 
Figure 5.3: Isolate 112 isolated from Dawes Farm, using oat agar, displaying inhibition against E. 
coli, after 10-day incubation at 37°C, using the starvation method. The arrow displays an example 
of the extent of inhibition of E. coli by APO 112. 
 
 
Figure 5.4: Isolate 120 isolated from Dawes Farm using oat, displaying inhibition against S. aureus, 
on Mueller-Hinton agar, after prolonged incubation at 37°C for 7 days, using the starvation method. 
The arrow displays where the growth of S. aureus has been inhibited. 
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Figure 5.5: Inhibition against S. aureus on plate count agar, by Dawes Farm potato isolate 146, after 
incubation for 10 days at 37°C, using the starvation method. The arrow displays the zone of 
inhibition seen against S. aureus.  
 
 
Figure 5.6: Dawes Farm isolate 136 that was initially cultivated using potato starch agar displaying 
inhibition against S. aureus on plate count agar, after incubation at 37°C for 10 days in the starvation 
method. The black arrow displays an area of inhibition of S. aureus. 
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5.3 Discussion 
Dawes Farm was one of the sample locations selected for the isolation of pathogenic 
bacteria, and organisms with the ability to produce inhibitory compounds, effective against other 
bacterial organisms. In collaboration with Dr Tim Potter, and Westpoint Farm Vets, 22 samples of 
soil were taken in and around grazing fields, where animals were or had been present, resulting in 
the isolation of 90 organisms, with further identification carried out by Ms. Suzana Haxhia. From 
this work, several of the pathogenic organisms, that had been previously selected in section 2.2.2.2, 
were isolated including four (4.4%) E. coli and Klebsiella spp. The majority of organisms, however, 
were identified as belonging to the Bacillus spp., with 26 (28.9%) identified as belonging to this 
genus, followed by 19 (21.1%) identified as S. aureus. As well as this one organism (1.1%) was said 
to be S. epidermidis and 11 (12.2%) Streptomyces spp. were isolated. Although these are not 
included in the specific organisms we aimed to locate in section 2.2.2.2, such organisms as S. aureus 
may provide additional information of the sample areas and can still be determined as pathogenic, 
due to their known ability to cause skin and wound infections, with this organism also selected as 
one of the organisms presenting international concern due to its resistance (WHO, 2014). As well 
as the isolation of these organisms, it was also noted that six (6.7%) P. aeruginosa were isolated, 
which provides further evidence of the variety of pathogenic organisms that may be present in the 
soil, due to its known resistance as one of the ESKAPE pathogens (Rice, 2008; Santajit and 
Indrawattana, 2016).  
The location of these pathogenic organisms, including E. coli and P. aeruginosa may be 
explained by the location properties. All samples were collected at the farmland, which included 
areas where cattle resided or were currently present, which may be thought to have an effect on 
the overall soil microbiome, hence increasing the likelihood of certain pathogenic organisms being 
isolated (Table A8). However, the collection of more samples from the same and differing areas 
within Dawes Farm would allow confirmation of this conclusion, as well as allowing further 
assumptions regarding the presence and activities of APO from the same locations to be made. 
As well as the identification of isolates, Ms Haxhia also carried out perpendicular screening 
(as seen in section 2.2.4.2) on the isolates that were identified as belonging to the Streptomyces 
spp., from the wet soil samples, to increase the likelihood for the identification of novel inhibitory 
compounds. However, none of these isolates were seen to present inhibitory activity to the 
sensitive test organisms used, and it hence may be determined that the ability of Streptomyces, for 
the production of novel antimicrobials, has been exhausted.  
As well as the Streptomyces isolated from the wet soil samples discussed previously, PCR 
was intended to be undertaken for the identification of this genus from the APO collected, allowing 
further conclusions to be drawn regarding these isolates inhibitory activity. However, due to time 
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constraints, this method was not carried out, meaning isolates can only be presumed as belonging 
to this genus by morphology, and cell characteristics, including Gram stain. Out of the 43 APO 
isolated from soil samples using both oat and potato starch agar, 20 (46.5%) of these were 
presumed as belonging to the Streptomyces spp.; 11 (42.3%) isolated using oat agar and nine 
(52.9%) isolated using potato starch agar (see appendix tables A11 and A12). From the presumed 
Streptomyces isolated using oat agar, isolates 115, 121, 123, 126 and 128 all displayed inhibition in 
perpendicular screening, with isolate 121 displaying continued inhibition in the starvation method, 
and isolate 115 displaying inhibitory activity against MRSA (Tables 5.1, 5.2, 5.5, and 5.7). However, 
all the presumed Streptomyces from the potato agar isolates, displayed inhibition only in the 
starvation method, with isolates 137, 144 and 146 displaying inhibitory activity (Tables 5.3 and 5.8). 
Future work to confirm these isolates identification however, would allow the further 
determination of antimicrobial activity of the Streptomyces isolates cultivated from Dawes Farm, 
of both those collected as APO, and the 11 isolates collected from the wet soil samples. 
As well as inhibition that was seen by the presumed Streptomyces spp., as discussed above, 
further inhibition was seen by additional isolates in the differing methods. In total, 26 and 17 APO 
were isolated from oat and potato starch agar, with 10 (38.5%) and three (17.6%) displaying 
inhibition respectively, in perpendicular screening (Tables 5.1 and 5.3). Within this screening several 
isolates were also seen to present inhibition towards the sensitive strain of P. mirabilis; three oat 
isolates (11.5%), and two (11.8%) APO isolated using potato starch agar, presented inhibition of this 
organism. A large amount of APO were also seen to present inhibition to the Gram-positive test 
organisms used, with 10 of the 13 (76.9%) confirmed APO from Dawes Farm presenting inhibition 
to one or both of the Staphylococcus spp. However, no inhibition was seen towards the strain of P. 
aeruginosa used, by any of the APO, potentially displaying the lack of antimicrobial compounds 
within the soil with effect on this organism.  
Upon further testing of these isolates using the clinical strains of the test bacteria, further 
inhibition was seen by three (30%) and two (66.6%) APO originally cultivated using oat and potato 
starch agar respectively, with a total of five (38.5%) displaying inhibitory activity towards one of the 
clinical strains (Tables 5.5 and 5.6). Although it was shown that none of the antimicrobial 
compounds being produced were able to inhibit the growth of the clinical E. coli strain, inhibition 
was seen towards the clinical strain of P. mirabilis and MRSA, of which three isolates, 105, 131 and 
132 were seen to present inhibition towards both of these organisms (Tables 5.5 and 5.6). Figure 
5.1 displays the activity of isolate 105 against P. mirabilis, with inhibition towards MRSA also caused 
by this APO, which may highlight this organism as especially useful. Future work may hence focus 
on the determination of this organism’s genus, as well as the active compound being produced, in 
the hope of locating a new antimicrobial, able to contribute to overcoming the resistance currently 
being presented by several organisms, and the existing AMR crisis (WHO, 2014).  
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Additional to the perpendicular screening carried out, the starvation method, using S. 
aureus, S. epidermidis, E. coli and P. mirabilis as test organisms, was used to increase antimicrobial 
activity of the APO isolated. However, this method was not seen to greatly increase the amounts of 
inhibition seen by isolates. Of the 17 APO isolated using potato starch agar, four (23.5%) of the 
isolates were seen to be inhibitory compared to three (17.6%) seen in initial screening (Tables 5.3 
and 5.8), with less inhibition seen by oat isolates in the starvation method; only five of the 26 
isolates (19.2%) displayed inhibitory activity in the starvation method (Table 5.7), compared to 10 
isolates (38.5%) with inhibition in initial perpendicular screening (Table 5.1), showing a decrease of 
inhibition by 50%. This displays an overall decrease of inhibition from initial screening of around 
10%, with 30.2% of organisms displaying inhibition in perpendicular screening compared to only 
20.9% in the starvation method. An explanation for this may be due to the stress-induced conditions 
inhibiting the growth of certain APO and/or preventing them from producing their antimicrobial 
compounds of interest, due to the lack of nutrients available. However, only four test organisms 
were used for the testing of inhibitory activity by these APO in the starvation method, and hence 
for future work the inclusion of more test organisms, both Gram-positive and Gram-negative 
bacteria, as well as the potential for pathogenic fungal strains to be included, would provide more 
conclusions about the antimicrobial activity of the compounds being produced by the differing APO. 
On the other hand, the same sensitive test organisms were used in initial perpendicular screening, 
so the amount of test organisms used, should not have affected the decrease in inhibition seen 
between the methods. 
Although a decrease of overall inhibition was seen, isolates with no prior inhibition were 
seen to be active in the starvation method; APO 114 and 129, detailed inhibition in the starvation 
method against S. aureus and S. epidermidis, and E. coli and both Staphylococcus spp. after 
incubation for 7 days at 25°C and 10 days at 37°C respectively (Tables 5.1 and 5.7). This may 
demonstrate the starvation method as being an effective way to stress the organisms into 
producing novel antimicrobial compounds of interest. These results also again display the large 
amounts of inhibitory activity seen towards the Gram-positive test organisms, as discussed with the 
results seen in initial screening, with all APO presenting inhibition in the starvation method, 
producing inhibitory activity to at least one of the Staphylococcus spp. (Tables 5.7 and 5.8).  
From this further testing of all APO using the methods, some APO can be seen as extremely 
versatile in their ability to produce inhibitory compounds. Isolates 112, 120 and 121, displayed 
inhibitory activity in both perpendicular screening and the starvation method, with APO 112 seen 
to produce inhibition against P. mirabilis at both temperatures, after 2-day incubation in initial 
screening, and 120 displaying the ability to inhibit the clinical strain of P. mirabilis (Tables 5.1, 5.5 
and 5.7).  It may hence be favourable to take forward these isolates for further testing and 
characterisation, as well as determining whether the active compounds being produced, are novel 
 
 
102 
 
and of interest. However, apart from isolate 112, all other isolates lacked the ability to inhibit test 
organisms at both test temperatures used. On the other hand, isolate 112 and others including 
isolates 120, 121 and 137 were able to produce inhibitory compounds after at least two of the 
differing day incubations in the starvation method, at either 25°C or 37°C (Tables 5.7 and 5.8). 
Overall, Dawes Farm, Warnham, can be confirmed as a location from which pathogenic 
organisms, and APO can be isolated from, including those with activity against both the 
Staphylococcus spp. and Proteus spp., as well as the clinical strains of P. mirabilis and MRSA, 
displaying the potential for the isolation of a novel antimicrobial, able to contribute to the fight 
against AMR, from this location.  
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6.0 Discussion  
AMR has been seen to develop all around the world, with several of the last resort 
antibiotics being determined as ineffective (O’Neill, 2016). This has and will continue to 
compromise our healthcare systems as we know it, with it necessary to tackle antibiotic resistance 
using several different approaches (WHO, 2015). Increasing awareness of antibiotic misuse and 
resistance, as well as the research and development of novel antimicrobials to treat organisms 
presenting resistance, are just two examples of those proposed to combat this issue (WHO, 2016; 
O‘Neill 2016). This study focusses on the latter, by forwarding the research needed into the isolation 
and characterisation of Antimicrobial Producing Organisms (APO) from previously untested 
environments.  
The location and identification of Actinomycetes, and the presence of novel inhibitory 
compounds in samples of soil, has been the subject of several studies around the world. Some 
studies have focussed on soils from hot geographical locations. Singh and colleagues (2012), 
isolated seven Actinomycetes from soil samples from several areas in Gwalior, India, with one 
isolate displaying antimicrobial activity against both Gram-negative and Gram-positive bacteria, 
including activity against a vancomycin resistant enterococci test strain. However, the present study 
focusses on a more temperate environment, and as far as it is known is the first study focusing on 
the location of antimicrobial compounds from both Friston Forest and New Forest with the help of 
the Forestry Commission UK, and specific areas of Dawes Farmland at Warnham, West Sussex, in 
collaboration with Westpoint Farm Vet group.  
Soil organisms, including the Streptomyces spp., show great potential in their ability to 
produce novel secondary metabolites, with almost two thirds of antibiotics that are naturally 
occurring, being produced by this genus (Mohanraj and Sekar, 2013). In this study, the cultivation 
of Streptomyces spp., as well as other soil organisms presenting inhibitory ability, was carried out 
with the view of isolating novel antimicrobial compounds. A total of 84 soil samples were taken 
from the New Forest (42), Friston Forest (20), and Dawes Farm (22), greater than the number of 
samples collected by Ganesan and colleagues (2016), who collected soil samples from five different 
places in Tamil Nadu, India. This provided a range of samples and sample locations in which novel 
compounds, and the parent organisms may be isolated. In total 146 APO were isolated for screening 
with 34, 69, and 43 APO isolated from the New Forest, Friston Forest and Dawes Farm, respectively, 
due to displayed inhibitory activity, and/or morphology similar to that of Streptomyces spp.  
Using these APO, it was confirmed through testing that at least one isolate originating from 
each of the differing sample locations showed the ability to inhibit other test organisms of 
importance. From initial screening, five (14.7%) out of the 34 New Forest isolates displayed 
inhibition against S. epidermidis, S. aureus, and/or E. coli, with no inhibition seen towards P. 
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aeruginosa or P. mirabilis (Table 3.2). No inhibition was again seen towards P. aeruginosa by either 
Friston Forest or Dawes Farm APO, however inhibitory activity towards P. mirabilis was presented 
by APO isolated from these locations. This may be due to the known low antibiotic susceptibility of 
P. aeruginosa, as well as the organism’s ability to rapidly develop intrinsic resistance towards 
antibiotics (Hancock and Speert, 2000; Lister et al., 2009). Overall 15.9% and 30.2% of APO isolated 
from Friston Forest and Dawes Farm inhibited sensitive strains of test bacteria in initial 
perpendicular screening respectively, with Friston isolate 60 and five of the APO isolated from 
Dawes Farm inhibiting the growth of the sensitive strain of P. mirabilis a well-known opportunistic 
pathogen in humans and a common cause of urinary tract infections (Tables 4.2, 4.3, 4.4, 5.1 and 
5.3) (Chen et al., 2012). 
Much of the inhibition seen using the perpendicular screening method however, was seen 
against the Gram-positive organisms S. epidermidis and/or S. aureus. Four isolates out of the five 
(80%) confirmed APO from New Forest (Table 3.2) and 10 out of the 11 (90.9%) Friston Forest APO, 
displayed inhibition towards at least one of the Gram-positive test bacteria used as discussed in 
section 3.3 and 4.3. This was a recurring theme also seen from Dawes Farm APO strains discussed 
in section 5.3, with 10 out of the 13 (76.9%) inhibitory APO, showing inhibition to at least one of 
the Gram-positive organisms used.  
Perpendicular screening, has been used by several other studies as a viable method for the 
determination of inhibitory activity of isolated organisms, including those belonging to the 
Actinomycetes order (Bizuye et al., 2013; Singh et al., 2016). Using this method, Gebreyohannes 
and colleagues (2013) found that 13 out of 31 collected Actinomycetes strains displayed inhibitory 
activity to at least one of the test bacteria used, including inhibition seen towards both P. 
aeruginosa and S. Typhimurium. However, their study investigated the antimicrobial activity of 
Actinomycete isolates only. This may highlight a strongpoint of the present study, in which all 
organisms with observable zones of inhibition in initial cultivation, plus those with characteristics 
similar to that of the Streptomyces genus, were selected for further testing, increasing the 
likelihood of novel antimicrobial compounds being discovered.  
Further testing of inhibitory activity of APO isolated from both Friston Forest and Dawes 
Farm, was carried out using the perpendicular screening method, with clinical strains of E. coli, 
MRSA and P. mirabilis used to determine the activity of the APO isolated further. Antibiograms 
were carried out on these clinical strains to identify any resistance they possessed (Table A13). P. 
mirabilis displayed sensitivity to all antibiotics used, however both E. coli and MRSA showed some 
form of resistance to at least one of the antibiotics. E. coli displayed resistance to both amoxicillin 
and clavulanic acid (30µg), and gentamycin (10µg), as well as intermediate sensitively to cefotaxime 
(5µg). MRSA displayed resistance towards erythromycin (5µg) only out of the antibiotics used, with 
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it assumed to confer resistance to the β-lactams class of antibiotics, due to its classification as a 
methicillin-resistant organism (Table A13).  
Similar amounts of inhibition was seen by APO towards the clinical strains of test bacteria 
isolated from Friston and Dawes Farm, with 33% and 38.5% of isolates displaying inhibition towards 
at least one of the strains of test bacteria (Tables 4.6 and 5.5). However, compared to the inhibition 
seen by the Friston Forest isolates, the Dawes Farm APO detailed no activity against E. coli. 
Conversely four isolates did show inhibition towards MRSA, and a greater amount of inhibition 
towards the clinical strain of P. mirabilis was seen, although it should be noted that Dawes Farm 
APO had greater inhibition towards the sensitive Proteus test strain in initial screening compared 
to Friston APO, as discussed in sections 4.3 and 5.3. These results provide further evidence for the 
presence of APO in the soil, as well as confirming the ability to isolate APO from these two locations 
with inhibitory activity against clinical strains of bacteria. A clinical strain of S. epidermidis was not 
available for use in the further testing using the perpendicular screening method, and hence future 
work could include the repeat of this method using this organism. 
Similar to the results seen previously in perpendicular screening, and discussed above and 
in sections, 3.3, 4.3 and 5.3, large amounts of inhibition were again seen against Gram-positive 
bacteria in the starvation method, with 91.7% and 61.9% of confirmed APO from New Forest and 
Friston Forest respectively, displaying inhibition towards at least one of the Gram-positive test 
strains used. As well as this, all Dawes Farm APO confirmed to have inhibitory activity in the 
starvation method, displayed inhibition towards at least one of the Gram-positive test organisms 
used, as discussed in section 5.3. It has been hypothesized that this may be due to membrane 
structure, in which Gram-positive organisms lack an outer cell membrane containing 
lipopolysaccharide (LPS), which is known to make Gram-negative cell walls more hydrophobic and 
impermeable, meaning they are more susceptible to the inhibitory metabolites (Singh et al., 2016; 
Kim et al., 1994).  
The more prominent inhibitory activity seen towards the Gram-positive bacteria in both 
the starvation and perpendicular screening methods, may highlight a lack of inhibitory compounds, 
able to affect the growth of Gram-negative bacteria, available for isolation from the soil. This was 
also seen by Ling and colleagues (2015), who using a device called the iChip, cultivated soil 
organisms, unculturable in lab conditions, within the soil itself, which resulted in the isolation of 
the new antibiotic, teixobactin. This antibiotic displayed good activity against a range of Gram-
positive organisms, such as MRSA and Streptococcus spp. however, little inhibitory activity was seen 
towards Gram-negative organisms, such as P. aeruginosa and Klebsiella pneumoniae (Ling et al., 
2015). This highlights further, the research needed for the production of novel antibiotics, with the 
ability to inhibit the growth of Gram-negative organisms, especially those that are currently 
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presenting problematic high levels of resistance worldwide (Gulland, 2017, Nordmann et al., 2009; 
Chen et al., 2012). 
The production of secondary metabolites, from primary metabolites, key for bacterial 
growth and reproduction in Streptomyces, as well as other organisms, is known to be highly 
complex (Rokem et al., 2007). Several gene products, including those with enzymatic and regulatory 
functions, are involved in the control and production of these potentially antimicrobial metabolites 
(see figure 3.8) (Rokem et al., 2007; Bekker et al., 2015). It has also been shown that the expression 
of genes, involved in control of secondary metabolite production in Actinomycetes, is highly 
dependent on cultivation conditions, and often requires specific environmental changes and/or 
starvation, for certain metabolites to be produced (Liu et al., 2013; Gullo et al., 2006). The starvation 
method presented in this study was employed with the aim of increasing the amount of inhibition 
produced by the APO, compared to initial screening, by varying the cultivation conditions, 
increasing the likelihood of a bacterial stress response, and hence production of novel 
antimicrobials (Gullo et al., 2006).  
The starvation method was shown to be successful in increasing the amounts of inhibitory 
activity produced by APO with both New Forest and Friston Forest isolates as previously discussed 
in sections 3.3. and 4.3. However, overall nearly a 10% decrease was seen in the total amount of 
Dawes Farm APO, presenting inhibition in the starvation method, compared to that seen in 
perpendicular screening as discussed in section 5.3. This decrease of isolates displaying inhibition 
may due to the stress-inducing conditions used, preventing the growth of the APO during 
incubation, or causing cell death due to a lack of nutrients. On the other hand, even with this 
decrease in the number of isolates displaying inhibition, several organisms with no previous 
inhibitory activity displayed in the novel antimicrobial screening method, presented inhibition 
towards test organisms in the starvation method, highlighting the ability of this method at inducing 
the production of inhibitory compounds from certain APO (see sections 4.3 and 5.3). 
 
Using this starvation method, certain isolates also displayed the ability to produce 
inhibitory compounds under a variety of conditions, including production after several days 
incubation, as well as at both of the differing temperatures used. Friston Forest isolates 53, 70, 73 
and 78, as well as New Forest APO 26 were all seen to produce inhibitory compounds towards test 
organisms, under a range of different conditions, used in this method (see Sections 3.3 and 4.3). 
However, none of the APO isolated from Dawes Farm were seen to present inhibition at both 
temperatures used, (25°C and 37°C), in the starvation method (Tables 5.7 and 5.8), displaying a 
large difference in the amount of inhibition presented by farm APO, compared to that seen by APO 
cultivated from the forest samples. This may highlight forest land as a more prolific producer of 
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APO, and hence more favourable in the search of novel antimicrobials. Contrastingly, APO 112 
isolated from Dawes Farm, was seen to show inhibition towards P. mirabilis after 2 days incubation, 
at both temperatures, in initial perpendicular screening (Table 5.1), however this may be 
determined as not comparable to the forest inhibition results, as both locations also detailed APO 
with the ability to inhibit test organisms, at both of the temperatures used in this method, as 
discussed in sections 3.3 and 4.3.  
Correlation of the inhibition seen spanning all methods, details the capabilities of certain 
APO that showed repeated inhibition, for producing inhibitory compounds under a variety of 
conditions. This was seen by APO 16, 26, 53, 60, 70, 112, 120 and 121, isolated from all three sample 
locations, with both 60 and 120 also producing compounds able to inhibit the clinical strain of P. 
mirabilis (see sections 3.3, 4.3 and 5.3). The repeat of the starvation method, as well as the reuse 
of supernatants however, was not repeated for the Friston Forest and Dawes Farm isolates due to 
time constraints. Hence future work would allow for this to be carried out allowing further 
conclusions to be drawn, as well as comparison with the New Forest repeat results (Tables 3.3, 3.4 
and 3.5). Improvements of methodology of the starvation method, as discussed in section 3.3, could 
also be carried out, including correct storage, and direct analysis using DOSY-NMR, of any 
supernatants with displayed inhibitory activity, as well as the addition of further organisms to the 
method, which may include clinical strains, and fungal isolates. To also allow further assumptions 
regarding APO activity, these additional test organisms may also be added to the perpendicular 
screening method, as seen by several other studies (Arifuzzaman et al., 2010; Ganesan et al., 2016). 
Ganesan and colleagues (2016), used 24 differing organisms in their initial perpendicular screening, 
which included both Gram-positive and Gram-negative bacteria, as well as pathogenic fungal 
strains, such as those belonging to the Aspergillus spp., detailing a much larger amount of test 
organisms used, compared to the present study. 
For other future work, it too would then be favourable to take forward these APO, with 
shown prolific inhibitory ability, for further testing and characterisation. This could involve using 
more accurate molecular methods, such as DNA isolation and sequencing, which has been used by 
several other studies, to give a more representative view of the organisms, and their products of 
interest (Ganesan et al., 2016; Ling et al., 2015). This was seen by Kumar and colleagues (2014), 
who used DNA sequencing and phylogenetic analysis to identify the isolated organism presenting 
the most activity, which was confirmed as belonging to the Streptomyces spp. Atta and Ahmad 
(2009), also used DNA isolation and PCR amplification of the 16S rDNA gene, for phylogenetic 
analysis of an Actinomycete isolate which displayed potent anti-fungal activity. Sequencing of this 
16S rDNA gene fragment allowed the organisms identity to be determined, which was confirmed 
as belonging to the Streptomyces genus (Atta and Ahmad, 2009).  Hence, for future work the further 
purification and DNA sequencing of the 16S rRNA fragments, previously amplified in this study, may 
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provide further insights into the APO identity as well as any antibacterial compounds being 
produced.  
 From the dried soil samples, the APO were selected due to displayed inhibition, and/or 
similar morphology to that of Streptomyces spp., with this genus being actively selected for due to 
the initial cultivation media used in the present study.  This was also seen in the study by Kumar 
and colleagues (2014), who actively selected for this genus, and focussed on these organisms for 
the presence of any inhibitory activity against test organisms. However, due to the selection of all 
isolates that displayed any form of any inhibition, this current study worked to identify those 
belonging to the Streptomyces spp. within these APO isolated, using Gram stain as presumptive 
identification, and PCR for confirmation of isolates belonging to this species. Several isolates were 
presumed as belonging to this genus by its long-branched Gram-positive rods, seen using Gram 
stain carried out prior to PCR as discussed in sections 4.3 and 5.3. In total 19 isolates were confirmed 
as belonging to the Streptomyces spp., all identified from Friston Forest samples, with eight (42.1%) 
of them displaying some form of inhibitory activity. However, due to time constraints, this process 
was halted, leaving the identification of some of the Streptomyces spp. as presumptive. 
As discussed previously correlation can be drawn between the isolates confirmed as 
belonging to the Streptomyces spp., and the methods used to encourage the inhibitory activity of 
the APO. For example, isolate 49, that was confirmed as belonging to the Streptomyces spp., was 
seen to produce inhibition in both repeats of the perpendicular screening method, however as 
discussed in section 4.3, isolate 49 displayed no further inhibition towards any of the clinical strains 
of test bacteria used. This may highlight the lack of inhibitory activity, of compounds produced from 
the Streptomyces spp., against clinical and resistant isolates, possibly as a result of pathological 
fitness. Another hypothesis is that the inhibitory compound produced, is one of the vast amounts 
of known antimicrobial compounds, known for being produced by the Streptomyces genus, and 
hence has already been used for the treatment of infections, allowing organisms to have developed 
resistance against it (Miao and Davies, 2010). This too, may highlight that the isolation of novel 
inhibitory metabolites within the soil, has already been exhausted, and a differing approach may 
need to be developed (Rokem et al., 2007).  Confirmed Streptomyces isolates 76, 84, 96, 97, 98, 100 
and 102 also displayed a lack of further inhibitory ability against the clinical strains, as discussed in 
section 4.3, providing further evidence for this hypothesis. It should be noted that isolates 
presumed to belong to the Streptomyces genus were seen to have activity towards the clinical 
strains of test bacteria, as discussed in sections 4.3 and 5.3. However these isolates, as well as other 
APO isolated from both Friston, and New Forest, could only be presumed as belonging to the 
Streptomyces genus, hence continuation of the identification of these isolates using PCR would be 
beneficial in further work, to allow confirmation of whether the inhibitory compounds produced, 
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were a result of Streptomyces spp. known ability to produce vast amounts of biologically active 
secondary metabolites (Selvameenal et al., 2009).   
However, this study also noted that inhibition was additionally seen by isolates, not 
identified as belonging to the Streptomyces spp., including all of the New Forest APO, and several 
of the Dawes Farm, and Friston Forest isolates (see sections 3.3, 4.3 and 5.3). This provides positive 
evidence for the collection of all isolates presenting inhibition, not just those with similar 
morphology to bacteria belonging to the Streptomyces genus. A study by Mashoria and colleagues 
(2014), also selected for all organisms that displayed inhibition, for further testing, from the soil 
samples collected, similar to the present study.   
This study has revealed the presence of APO from Friston Forest, the New Forest, as well 
as Farmland (Dawes Farm). Further study can determine if certain locations are more likely to 
present either APO and/or organisms belonging to the Streptomyces spp. This may help push 
forward the identification of organisms with the ability to produce inhibitory compounds, by 
highlighting specific locations and/or environmental factors, that may increase the probability of 
isolating APO. Using the differing location information, minor conclusions can be drawn. In initial 
perpendicular screening, three of the New Forest isolates from location 16, (isolates 9, 10 and 11) 
presented inhibition, and were initially isolated near cow faeces (Tables 3.2 and A1). Friston Forest 
isolate 64, displayed ability to inhibit clinical strains of test bacteria (Tables 4.2 and 4.6), was also 
cultivated from soil (sample 20) near rabbit faeces (see appendix table A3). As well as both of the 
forest results, it may be noted that any inhibition seen from APO collected from Dawes Farm, may 
have been due to the large amounts of animal activity, including isolate 129, initially isolated from 
a pile of faecal matter, which presented inhibition in the starvation method (Table 5.7). These 
results could indicate the positive effect that animals, and their faecal matter, have on the soil 
microbiome, increasing the likelihood for the isolation of APO, however a repeat collection and 
cultivation of the same, as well as differing areas with the same environmental characteristics, 
would allow further conclusions to be drawn on the effects the surrounding environment has on 
the isolation of APO. As well as studying the effect animals may have at each sample location, the 
collation of all inhibition seen at the three differing locations, could allow determination if farmland 
is more likely to exhibit higher amounts of APO than forest locations, due to the presence of more 
human and animal activity. However, there was not a significant increase in percentage of 
antimicrobial activity presented by Dawes Farm APO, compared to the percentage of total APO 
presenting inhibition from both Friston and New Forest. In the starvation method, only 20.9% of all 
APO isolated from Dawes Farm displayed inhibitory ability, much less than that seen by the APO 
tested from both Friston (30.4%) and New Forest (35.3%). Although nearly double the amount of 
farm APO presented inhibition in the perpendicular screening method, compared to the percentage 
of APO isolated from either of the two forests sampled; 30.2% of APO isolated from Dawes Farm 
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presented inhibitory activity to at least one of the five test bacteria, compared to that of 15.9% and 
14.7% of the total APO isolated from Friston Forest and New Forest APO respectively, meaning 
conclusions cannot be drawn regarding the effect of animals on the microbiome. Most recent 
studies however only detail the antibiotic resistance conferred by pathogenic organisms within 
farmland sourced soil, rather that the ability for the isolation of APO from these farm locations 
(Wellington et al., 2013; O’Neill, 2016; Wang et al., 2016).  
The cultivation and identification of potentially pathogenic bacteria was also carried out for 
further analysis and characterisation of the microbiome, of the differing locations. Large amounts 
of known soil microorganisms were prevalent in cultivation, including isolates belonging to the 
Bacillus spp., Acinetobacter spp., and Kurthia spp., as well as the isolation of organisms displaying 
similar characteristics to that of the Streptomyces spp. (see sections 3.3, 4.3 and 5.3). In total, 77 
and 55 organisms were isolated from the New Forest and Friston Forest, with one (1.3%) and two 
(3.6%) organisms identified as belonging to the Salmonella spp., from these locations respectively. 
Organisms identified as Streptomyces were also isolated from these locations, with 11 (14.3%), 
identified from the New Forest, and two (3.6%), identified from the Friston Forest samples (See 
sections 3.3 and 4.3). Due to the location of Streptomyces from the wet soil samples, the testing of 
these isolates against test bacteria using the methods presented in this study, could be highlighted 
as further work, and would increase the amounts of isolates screened and the likelihood of locating 
novel antimicrobial compounds.  However, as discussed in section 5.3, no inhibition was seen by 
the 11 (12.2%) Streptomyces isolates from Dawes Farm, that were tested further using the 
perpendicular screening method, meaning this further screening of Streptomyces isolates, from the 
wet soil samples, may be determined as unnecessary.  
Further pathogenic organisms were also isolated from Dawes Farm, with 90 organisms 
isolated altogether, including those identified as E. coli (4.4%) and belonging to the Klebsiella spp. 
(4.4%), as well a large amount identified as belonging to the Bacillus spp. (28.9%), as discussed in 
section 5.3. However, overall a lack of organisms, of which were previously selected (see section 
2.2.2.2), were isolated, from the three locations sampled, which may detail either the lack of these 
organisms in these environments, or that the organisms themselves are hard to culture. Further 
sampling however, would allow further characterisation of the sample locations, allowing 
conclusions to be drawn regarding the effects extended human, and animal activity, has on the soil 
microbiome, and whether this bares correlation to the presence of APO. As well as this, the majority 
of these organisms, were identified using biochemical tests only, with few being tested using API 
20E. Other future work would include further biochemical tests, such as gelatin and carbohydrate 
utilisation, and genome sequencing to confirm the identification of these isolates, not used in the 
present study due to the high cost of sequencing, as well as time constraints. This confirmation 
would also allow the use of antibiograms to provide sensitivity results, and resistance profiles for 
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these pathogenic organisms, further allowing correlation to the activity of any APO isolated from 
the same sites. It should also be noted that the identification of these soil organisms is less specific 
than that seen for clinical isolates, due to the specificity of biochemical testing for the 
determination of well characterised clinical organisms, the vast amount of soil microorganisms, as 
well as the lesser known information on the characteristics of these soil organisms (Mazel and 
Davies, 1999; Abiola and Oyetayo, 2016). 
 
Future work 
The current study has demonstrated the ability to isolate APO from the New Forest, Friston 
Forest, and Dawes Farm, with activity against both sensitive and clinical strains of test bacteria. 
Several areas however, have been highlighted in need of further research, with the potential for 
further development of the study in various areas. In hindsight, it may be favourable to carry out 
future work on single locations, to allow a more in-depth analysis of the microbiome of the 
particular area being studied, as well as permitting time for repeat sampling at differing time points 
for further comparative analysis of the changes in the microbiome. This may also include further 
assessment of the soil biochemistry, in relation to the presence of APO, in partnership with the 
Forestry Commission. 
Other future work focussing on the isolates cultivated in the present study includes the 
continuing of the identification of Streptomyces using PCR, as well as the potential use of genomic 
sequencing of both the APO and supposed pathogenic bacteria, to allow conclusive identification 
and correlation, between the isolated strains. The completion of testing of all APO from the three 
locations, as well as carrying out further repeats of both perpendicular screening, and the starvation 
method, including tests against clinical organisms, would also be favourable to be carried out, to 
allow further conclusions to be drawn, as well as determining if the stress induced environment, 
used in the starvation method, encourages bacterial organisms to inhibit clinical, as well as sensitive 
strains. This further testing may also include the addition of isolates discussed above, as well as the 
inclusion of both multi-drug and pan-drug resistant organisms, to further determine the inhibitory 
ability of the compounds produced. As well as this, the collection of further samples, from the three 
locations used in this study, at differing times of the year, would also allow the effects of seasonal 
changes on the microbiome, to be studied. The completion of this further work would also allow 
additional statistical and comparative analysis to be carried out on the data produced from the 
three locations, and for the determination of the significance of the location on the likelihood for 
the isolation of APO.  
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  Further work could also include the extraction and purification of inhibitory compounds, 
allowing pure antibiotic substances to be obtained, which will likely increase the inhibitory action 
and inhibition zones seen, as well as allowing the active structures to be determined using such 
methods as NMR and/or mass spectrometry (Bizuye et al., 2013). This was trialled in the pilot study 
discussed in sections 2.2.5 and 3.2.3.3 using the supernatant produced by isolate 26 in the 
starvation method for chemical analysis, involving the use of a TLC bioassay, as well as NMR. 
However, as discussed in section 3.3, the true structure of the three supposed antibacterial 
compounds could not be determined due to time constraints in the current project, and it was 
highlighted that further methods, including mass spectrometry, would aid in the determination of 
structures. Continuation of this pilot study, using other supernatants produced by inhibitory APO 
in the starvation method, as well as carrying out the additional methods discussed, would allow the 
elucidation and confirmation of compound structures, and determination of those that are novel.  
The present study is thought to be the first study isolating APO from Friston Forest, New 
Forest and Dawes Farm, however it may be likely that any inhibition seen is by compounds that 
have already been discovered. It is also known that around 99% of soil microorganisms, cannot be 
grown in laboratory conditions and differing techniques are required for the cultivation of these 
organisms, such as those discussed by Ling and colleagues (2015). This may indicate that the APO 
identified in this study have already been isolated and examined (Mazel and Davies, 1999). This also 
highlights the need for differing methods, such as those discussed by several other studies, that 
focus on altering metabolic pathways, in already known organisms, to induce the production of 
inhibitory secondary metabolites from the primary metabolism (Bekker et al., 2015). This is known 
as metabolic engineering, which considers the connections between gene expression and 
secondary metabolite production allowing control mechanisms within the cell to be understood 
and manipulated (see figure 3.8) (Rokem et al., 2007). This has allowed the improvement of cellular 
activities, as well as increased efficiency, and yield of secondary metabolites of interest from certain 
organisms (Rokem et al., 2007; Bekker et al., 2015). This engineering may seem favourable over the 
starvation method, as this altering of biosynthetic pathways, also allows the optimisation of 
environmental and growth conditions, for the production of antimicrobial compounds of interest. 
Whereas the starvation method, used in this study, relies on the creation of generalised stress 
conditions, in the hope it causes a stringent response in APO, leading to a production of inhibitory 
metabolites. However, genetic engineering requires a vast amount of previous knowledge on the 
biochemistry, physiology and genetics of the APO of interest, which may present problems due to 
the vast amounts of differing, potentially rare, soil organisms isolated (Rokem et al., 2007). In the 
future, this molecular work could be carried out on the confirmed Streptomyces strains, due to the 
use of the StreptomeDB database, which contains information for over 2500 different strains of 
Streptomyces spp. and their products providing sufficient information for the determination of 
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engineering strategies for the production of secondary metabolites of interest (Lucas et al., 2013; 
Klementz et al., 2016). 
However as discussed previously, one novel antibiotic is not enough to overcome the AMR 
crisis. The research and development, of novel antimicrobials is an ongoing process, necessary to 
ensure pathogenic infections remain treatable (Laxminarayan et al., 2013). Several objectives have 
been put into place, including antibiotic stewardship, conservation and surveillance, as well as 
increasing global awareness, to maintain sensitivity in pathogenic bacteria, allowing antimicrobial 
treatment to remain effective, and actively combat antibiotic resistance (O’Neill, 2016). 
Nevertheless, this study forwards the research of the isolation and production of novel 
antimicrobials necessary as part of the fight against AMR. 
 
 
 
 
7.0 Conclusion 
In conclusion, this study confirms that APO can in fact be isolated from both Friston (a 
modern forest), New Forest (an ancient forest), and Dawes Farm (a working farmland). Inhibitory 
activity was seen from all locations, against at least one of the clinical strains of test bacteria. The 
results seen in the present study highlight the potential of soil microorganisms, for the isolation of 
potentially novel antimicrobial compounds, which could largely contribute to the fight against AMR, 
as a promising source of new antibiotics, that are desperately needed. 
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9.0 Appendix 
Table A1: Geographic coordinates, and area description of the soil samples taken from the New 
Forest, in November 2016. 
Soil Sample 
Number 
Description of area Latitude Longitude 
1 Hatchpond car park by tree  50.812026 -1.477028 
2 Hatchpond car park by tree  50.812026 -1.477028 
3 Hatchpond car by pond 50.812026 -1.477028 
4 Hatchpond car by pond 50.812026 -1.477028 
5 Balmer lawn by river 50.826604 -1.540752 
6 Balmer lawn by river 50.826604 -1.540752 
7 Balmer lawn under tree 50.826604 -1.540752 
8 Balmer lawn under tree 50.826604 -1.540752 
9 Setthorns by tree 50.796523 -1.616355 
10 Setthorns by tree 50.796523 -1.616355 
11 Setthorns on path  50.79644.0 -1.616447 
12 Setthorns on path  50.79644.0 -1.616447 
13 Setthorns by tree and horse faeces. 50.805486 -0.1641835 
14 Setthorns by tree and horse faeces. 50.805486 -0.1641835 
15 Wilverley Scout campsite by cow faeces. 50.806488 -1.643814 
16 Wilverley Scout campsite by cow faeces. 50.806488 -1.643814 
17 Wilverley Scout campsite by tree 50.806887 -1.643917 
18 Wilverley Scout campsite by tree 50.806887 -1.643917 
19 Longbeech by tree 50.913909 -1.642163 
20 Longbeech by tree 50.913909 -1.642163 
21 Longbeech on grass 50.913874 -1.642141 
22 Longbeech on grass 50.913874 -1.642141 
23 Shavewood by car park 50.908014 -1.58358 
24 Shavewood by car park 50.908014 -1.58358 
25 Shavewood by tree 50.907906 -1.584144 
26 Shavewood by tree 50.907906 -1.584144 
27 Bolderwood arboretum by tree 50.907906 -1.584144 
28 Bolderwood arboretum by tree 50.907906 -1.584144 
29 Bolderwood arboretum near road (lot of moss) 50.867698 -1.654995 
30 Bolderwood arboretum by tree 50.867698 -1.654995 
31 Knightwood oak by car park near tree 50.856119 -1.626748 
32 Knightwood oak by car park near tree 50.856119 -1.626748 
33 Knightwood oak open 50.856119 -1.626748 
34 Knightwood oak open 50.856119 -1.626748 
35 Bolton bench near tree 50.87288.0 -1.568326 
36 Bolton bench near tree 50.87288.0 -1.568326 
37 Bolton bench near faeces in open 50.872728 -1.568315 
38 Bolton bench near faeces in open 50.872728 -1.568315 
39 Shatterford near tree 50.855284 -1.506576 
40 Shatterford near tree 50.855284 -1.506576 
41 Shatterford open 50.85587.0 -1.506766 
42 Shatterford open 50.85587.0 -1.506766 
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Table A2: The catalase and Gram stain result of all 34 APO, isolated using potato starch agar from 
the New Forest soil samples. 
Isolate 
Number 
Sample 
location 
Catalase test Gram Stain 
1 7  +VE Gram-positive rods with spores. 
2 7  +VE Gram-positive rods. 
3 7  +VE Gram-positive rods with spores. 
4 11 +VE Gram-positive rods 
5 11  +VE Gram-positive rods 
6 11  +VE Gram-negative rods 
7 16  +VE Gram-positive rods 
8 16  +VE Gram-positive rods 
9 16  +VE Gram-positive rods 
10 16  +VE Gram-positive rods 
11 16  +VE Gram-positive rods with spores. 
12 19  +VE Gram-positive rods 
13 20  +VE Gram-positive rods 
14 20  +VE Gram-positive rods with spores. 
15 22  +VE Gram-positive rods. 
16 22  -VE Gram-negative rods. 
17 22  +VE Gram-positive rods. 
18 22  +VE Gram-positive rods. 
19 22  +VE Gram-positive rods. 
20 22  -VE Long Gram-positive rods. 
21 22 +VE Gram-Negative rods. 
22 22  +VE Gram-positive rods. 
23 24  +VE Gram-negative rods. 
24 27  +VE Gram-negative rods 
25 27  +VE Gram-positive rods. 
26 36  -VE Gram-negative rods. 
27 36  +VE Gram-negative rods. 
28 37  +VE Gram-negative rods. 
29 37  +VE Gram-positive rods. 
30 39  +VE Gram-positive rods. 
31 39  +VE Small Gram-positive rods. 
32 39  +VE Gram-positive rods with spores in chains. 
33 39  +VE Gram-negative rods. 
34 39  +VE Gram-positive rods. 
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Table A3: Sample location and information of soil samples collected from Friston Forest, in April 
2017. Note that the location results were converted to latitude and longitude, from the original 
results, taken using grid reference coordinates. 
Sample number Latitude  Longitude Description of area 
1 50.782627 0.153862 Outer forest 
2 50.782627 0.153862 Outer forest 
3 50.782986 0.160057 Roadside 
4 50.782986 0.160057 Within forest 
5 50.777509 0.193268 Roadside 
6 50.777509 0.193268 Within forest 
7 ~50.777509 ~0.193268 Roadside 
8 ~50.777509 ~0.193268 Within forest 
9 50.784134 0.192958 Picnic area 
10 ~50.784134 ~0.192958 Within Forest 
11 ~50.784134 ~0.192958 Within Forest 
12 ~50.784134 ~0.192958 Near tree (acidic) 
13 ~50.784134 ~0.192958 Near tree (acidic) 
14 ~50.784134 ~0.192958 Within Forest 
15 50.784769 0.200585 Within Forest 
16 50.784769 0.200585 Within Forest 
17 50.776317 0.171040 Within Forest 
18 50.776317 0.171040 Within Forest 
19 50.776073 0.189068 Within forest 
20 50.776073 0.189068 Near cycle path and Rabbit 
faeces. 
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Table A4: Catalase and Gram stain of the 31 APO isolated from Friston Forest using oat agar. (S) 
indicates the presence of a potential Streptomyces spp., due to morphology and/or Gram stain 
result, which were selected for further identification using DNA extraction, PCR and Gel 
electrophoresis. 
Isolate number Sample location Catalase test Gram stain 
35 1 +VE Long Gram-positive rods (S) 
36 1 +VE Gram-positive rods with spores 
37 4 +VE Long Gram-positive rods (S) 
38 4 +VE Gram-negative rods 
39 5 -VE Hollow Gram-positive rods 
40 5 +VE Gram-positive rods 
41 6 +VE  Gram-positive rods 
42 6 -VE Long Gram-positive rods (S) 
43 6 -VE Long Gram-positive rods (S) 
44 8 +VE Gram-positive rods with spores 
45 8 +VE Long Gram-positive rods (S) 
46 8 +VE Long Gram-positive rods (S) 
47 8 +VE Gram-positive rods 
48 8 +VE Gram-positive rods 
49 9 +VE Long Gram-positive rods (S) 
50 9 +VE Gram-positive rods with spores 
51 9 +VE Gram-positive rods with spores 
52 10 +VE Gram-positive rods with spores 
53 13 +VE Long Gram-positive rods (S) 
54 14 +VE Gram-positive rods with spores 
55 14 +VE Gram-positive rods 
56 14 +VE Gram-positive rods with spores 
57 16 +VE Gram-negative rods 
58 17 +VE Long Gram-positive rods (S) 
59 17 +VE Long Gram-positive rods (S) 
60 17 +VE Long Gram-positive rods (S) 
61 18 -VE Gram-positive rods with spores 
62 18 +VE Long Gram-positive rods (S) 
63 19 +VE Gram-positive rods with spores 
64 20 +VE Long Gram-positive rods (S) 
65  20 +VE Gram-positive rods 
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Table A5: Catalase and Gram stains results of the 38 APO isolated from Friston Forest using potato 
starch agar. (S) indicates the presence of a potential Streptomyces spp. due to morphology and/or 
Gram stain result, and those selected for further identification using DNA extraction, PCR and Gel 
electrophoresis. 
Isolate 
number 
Sample 
location 
Catalase test Gram stain 
66 2 +VE Gram-positive rods 
67 2 +VE Long Gram-positive rods (S) 
68 2 +VE Long Gram-positive rods (S) 
69 2 +VE Gram-positive rods 
70 3 +VE Gram-positive rods 
71 3 +VE Gram-positive rods with spores 
72 4 +VE Long Gram-positive rods (S) 
73 4 -VE Gram-positive rods 
74 4 +VE Gram-positive rods 
75 4 +VE Long Gram-positive rods (S) 
76 5 +VE Long Gram-positive rods with (S) 
77 5 +VE Gram-positive rods 
78 5 +VE Gram-negative rods 
79 6 +VE  Long Gram-positive rods (S) 
80 6 +VE Gram-positive rods 
81 6 +VE Long Gram-positive rods (S) 
82 7 +VE Gram-positive rods with spores 
83 7 +VE Gram-positive rods with spores 
84 8 +VE Long Gram-positive rods (S) 
85 8 +VE Long Gram-positive rods (S) 
86 8 +VE Long Gram-positive rods (S) 
87 8 +VE Gram-positive rods 
88 10 +VE Long Gram-positive rods (S) 
89 10 +VE Gram-positive rods 
90 10 +VE Gram-positive rods 
91 10 +VE Long Gram-positive rods (S) 
92 13 +VE Long Gram-positive rods (S) 
93 13 +VE Gram-positive rods with spores 
94 13 +VE Gram-positive rods 
95 13 +VE Long Gram-positive rods (S) 
96 14 +VE Long Gram-positive rods (S) 
97 16 +VE Long Gram-positive rods (S) 
98 18 +VE Long Gram-positive rods (S) 
99 19 +VE Gram-positive rods 
100 19 +VE Gram-negative rods (S) 
101 19 +VE Gram-positive rods 
102 20 +VE Long Gram-positive rods (S) 
103 20 +VE Long Gram-positive rods (S) 
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Table A6: The DNA concentration and purity results of the 13 isolates, in duplicate, with similar 
morphology and/or Gram stain to Streptomyces spp. from Friston Forest initially cultivated using 
oat agar. Also details the identification of Streptomyces spp. within these isolates using the DNA 
extracted results shown. 
Oat agar 
Isolate 
number 
DNA concentration (ng/ µl) A260/A280 A260/A230 Streptomyces 
spp.? (+/-) 
35 167 1.988 1.777 +VE 
35 166 1.953 1.431 +VE 
37 - - - - 
37 - - - - 
42 115 1.769 1.075 +VE 
42 169 1.742 1.174 +VE 
43 43 1.706 0.606 +VE 
43 51 1.686 0.586 +VE 
45 21 1.798 0.934 +VE 
45 12 1.347 0.539 +VE 
46 74 1.682 1.156 +VE 
46 52 1.905 1.677 +VE 
49 109 1.758 1.313 +VE 
49 188 1.725 1.190 +VE 
53 30 1.606 0.487 - 
53 48 1.553 0.738 - 
58 - - - - 
58 - - - - 
59 193 1.804 1.451 +VE 
59 63 1.818 1.400 +VE 
60 233 1.739 0.975 - 
60 211 1.744 1.185 - 
62 - - - - 
62 - - - - 
64 - - - - 
64 - - - - 
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Table A7: The purity and concentration of DNA extracted from 20 APO isolated from Friston Forest 
using potato starch agar, selected due to similar morphology and/or Gram stain to that of the 
Streptomyces spp. Also details the identification of Streptomyces spp. confirmed by use of the DNA 
shown, PCR and Gel electrophoresis. 
Potato agar 
Isolate number 
DNA concentration 
(ng/ µl) 
A260/A280 A260/A230 Streptomyces 
spp.? (+/-) 
67 102 1.729 1.259 -VE 
67 118 1.873 1.356 -VE 
68 333 1.673 0.856 -VE 
68 496 1.710 0.934 -VE 
72 329 1.848 1.437 +VE 
72 306 1.877 1.286 +VE 
75 119 1.322 0.254 -VE 
75 120 1.319 0.254 -VE 
76 12 1.732 1.522 +VE 
76 34 1.802 1.877 +VE 
79 - - - - 
79 - - - - 
81 118 1.229 0.263 +VE 
81 113 1.215 0.259 +VE 
84 212 1.514 0.400 +VE 
84 160 1.416 0.406 +VE 
85 - - - - 
85 - - - - 
86 - - - - 
86 - - - - 
88 131 1.323 0.287 -VE 
88 126 1.273 0.294 -VE 
91 145 1.368 0.302 +VE 
91 145 1.355 0.298 +VE 
92 31 1.373 0.282 +VE 
92 32 1.330 0.285 +VE 
95 25 1.380 0.296 +VE 
95 21 1.359 0.275 +VE 
96 595 1.740 1.068 +VE 
96 588 1.740 1.083 +VE 
97  10 1.944 0.901 +VE 
97 18 1.897 0.664 +VE 
98 41 2.158 1.343 +VE 
98 38 2.188 1.221 +VE 
100 31 1.374 0.313 +VE 
100 32 1.491 0.347 +VE 
102 39 1.501 0.406 +VE 
102 42 1.547 0.433 +VE 
103 189 1.835 0.871 - 
103 183 1.830 0.906 - 
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Table A8: The sample locations at Dawes Farm, where soil was aseptically sampled in May 2017. PP 
was the name of one sample location, due to it being sampled from faecal matter, within the cow 
field. One sample location was noted for samples 13-22 (and PP), due to the collection of the 
samples in differing areas within in the same field. 
Soil sample 
number 
Location information Longitude Latitude 
1 Cow field -0.376818 51.108043 
2 Cow field -0.376818 51.108043 
3 Cow field -0.376818 51.108043 
4 Cow field -0.376818 51.108043 
5 Cow field- near tree -0.377956 51.106778 
6 Cow field- near tree -0.377956 51.106778 
7 Cow field – near water trough. -0.375476 51.106483 
8 Cow field – near water trough. -0.375476 51.106483 
9 Cow field – near different water 
trough. 
-0.374799 51.107715 
10 Cow field – near different water 
trough. 
-0.374799 51.107715 
11 Footpath between fields. -0.374501 51.107662 
12 Footpath between fields. -0.374501 51.107662 
13 Cow field – with cow’s present. ~ -0.375397 ~ 51.109048 
14 Cow field – with cow’s present. ~ -0.375397 ~ 51.109048 
15  Cow field – with cow’s present. ~ -0.375397 ~ 51.109048 
16 Cow field – with cow’s present. ~ -0.375397 ~ 51.109048 
17 Cow field – with cow’s present. ~ -0.375397 ~ 51.109048 
18 Cow field – with cow’s present. ~ -0.375397 ~ 51.109048 
19 Cow field – with cow’s present. ~ -0.375397 ~ 51.109048 
21 Cow field – with cow’s present 
near tree. 
~ -0.375397 ~ 51.109048 
22 Cow field – with cow’s present 
near tree. 
~ -0.375397 ~ 51.109048 
Faecal matter 
(PP) 
Cow field – with cow’s present. ~ -0.375397 ~ 51.109048 
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Table A9: Catalase and Gram strains of the 26 APO isolated from Dawes Farm using oat agar. (S) 
indicates the presence of a potential Streptomyces spp., due to morphology and/or Gram stain 
result, and hence those selected for further identification using DNA extraction, PCR and Gel 
electrophoresis. 
Isolate number Sample location 
 
Catalase test Gram Stain 
104 2 +VE Gram-negative rods 
105 4 +VE Gram-negative rods 
106 5 +VE Gram-positive cocci 
107 6 +VE Long Gram-positive rods (S)  
108 7 +VE Gram-positive rods and spores 
109 9 +VE Long Gram-positive rods (S) 
110 9 -VE Gram-negative rods 
111 9 +VE Gram-negative rods 
112 9 +VE Gram-negative rods. 
113 10 +VE Gram-positive rods. 
114 10 +VE Gram-positive rods. 
115 11 +VE Long Gram-positive rods (S) 
116 11 +VE Gram-positive rods. 
117 12 +VE Small Gram-negative rods. 
118 12 +VE  Long Gram-positive rods (S) 
119 12 +VE Gram-positive rods with spores. 
120 13 +VE Gram-positive rods. 
121 13 +VE Long Gram-positive rods (S) 
122 14 +VE Gram-positive rods. 
123 16 +VE Long Gram-positive rods (S) 
124 18 +VE Long Gram-positive rods (S) 
125 19 +VE Long Gram-positive rods (S) 
126 21 +VE Long Gram-positive rods (S) 
127 22 +VE Long Gram-positive rods (S) 
128 22 +VE Long Gram-positive rods (S) 
129 PP +VE Gram-positive cocci. 
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Table A10: Catalase and Gram stains of the 17 APO isolated from Dawes Farm using potato starch 
agar. (S) indicates the presence of a potential Streptomyces spp. due to morphology and/or Gram 
stain, and hence those selected for further identification using DNA extraction, PCR and Gel 
electrophoresis. 
Isolate number Sample 
locations 
 
Catalase test Gram stain 
130 2 +VE Gram-positive rods 
131 4 +VE Gram-negative rods 
132 4 +VE Gram-negative rods 
133 6 +VE Long Gram-positive rods (S) 
134 6 +VE Long Gram-positive rods (S) 
135 6 +VE Gram-positive rods with spores 
136 7 +VE  Gram-negative rods 
137 9 +VE Long Gram-positive rods (S) 
138 10 +VE Gram-positive rods with spores 
139 11 +VE Long Gram-positive rods (S) 
140 12 +VE Long Gram-positive rods (S) 
141 12 +VE Long Gram-positive rods (S) 
142 14 +VE Gram-positive rods with spores 
143 18 +VE Long Gram-positive rods (S) 
144 18 +VE Long Gram-positive rods (S) 
145 19 +VE Gram-positive rods with spores 
146 22 +VE Long Gram-positive rods (S) 
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Table A11: The concentration and purity of the DNA extracted in duplicate, from the 11 Dawes 
Farm APO originally isolated using oat agar, with similar characteristics to the Streptomyces genus. 
Isolates with either low concentration of DNA and or poor quality detailed as inconclusive (-). 
Isolate Number Concentration (ng/ µl) A260/A280 A260/A230 
107 - - - 
107 - - - 
109 168 2.182 2.100 
109 167 2.227 2.400 
115 119 1.991 1.008 
115 142 1.844 1.029 
118 - - - 
118 - - - 
121 - - - 
121 - - - 
123 184 1.353 0.320 
123 163 1.304 0.392 
124 - - - 
124 - - - 
125 - - - 
125 - - - 
126 - - - 
126 - - - 
127 - - - 
127 - - - 
128 - - - 
128 - - - 
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Table A12: The DNA concentration and purity results of isolates, with characteristics similar to that 
of the Streptomyces genus, and initially cultivated from Dawes Farm soil samples, using potato 
starch agar. 
Isolate number Concentration (ng/ µl) A260/A280 A260/A230 
133 413 1.721 1.144 
133 361 1.719 1.003 
134 444 1.776 1.251 
134 301 1.824 1.400 
137 180 1.667 0.811 
137 155 1.685 0.876 
139 42 1.673 2.154 
139 62 1.588 1.148 
140 62 2.196 4.667 
140 65 1.892 1.697 
141 141 2.104 1.880 
141 150 2.113 2.000 
143 93 2.255 2.290 
143 83 2.096 1.976 
144 396 1.616 0.747 
144 368 1.614 0.732 
146 104 1.733 2.925 
146 133 1.705 1.198 
 
 
Table A13: The susceptibility profiles of MRSA, E. coli, and P. mirabilis, that were clinically isolated, 
and used for further APO testing in the perpendicular screening method. Susceptibility was 
determined using EUCAST clinical breakpoint tables for antimicrobial susceptibility (EUCAST, 2017). 
Susceptibility is indicated as Sensitive (S), Intermediate (I) or Resistant (R).  Antibiotics used were 
as follows; Ciprofloxacin (5 µg) (CIP5), Erythromycin (5 µg) (E5), Oxytetracycline (30 µg) (OT30), 
Gentamycin (10 µg) (CN10), Cefoxitin (30 µg) (FOX30), Amoxicillin and Clavulanic acid (30 µg) 
(AMC30), Imipenem (10 µg) (IPM10), Cefotaxime (5 µg) (CTX5). Oxytetracycline susceptibility 
profiles were not found, but were kept in tables for reference. 
Methicillin- resistant S. aureus 
sensitivity 
E. coli sensitivity P. mirabilis sensitivity 
Antibiotic 
disc: 
Diameter 
of 
inhibition 
(mm) 
Susceptibility Antibiotic Diameter 
of 
inhibition 
(mm) 
Susceptibility Antibiotic Diameter 
of 
inhibition 
(mm) 
Susceptibility 
CIP5 25 S AMC30 13 R AMC30 28 S 
E5 10 R IPM10 30 S IPM10 30 S 
OT30 8 - CTX5 25 I CTX5 31 S 
CN10 20 S CIP5 30 S CIP5 32 S 
FOX30 25 S CN10 6 R CN10 21 S 
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Figure A1: The NMR results of antibacterial compound 1, extracted using the solvent dichloromethane, with an original Rf value of 1 (see table 3.8). The 
work and data was collected by Dr Adam LeGresley and Mr Rob Warren. 
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Figure A2: Supplementary NMR results of antibacterial compound 1, extracted using the solvent dichloromethane, with an original Rf value of 1 (Table 
3.8). The work and data was collected by Dr Adam LeGresley and Mr Rob Warren. 
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Figure A3: NMR data for compound 2, extracted using dichloromethane, with a resulting Rf value of 0.68 (Table 3.8). The work and data was collected by 
Dr Adam LeGresley and Mr Rob Warren. 
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Figure A4: Supplementary NMR data for compound 2, extracted using dichloromethane, with a resulting Rf value of 0.68 (Table 3.8). The work and data 
was collected by Dr Adam LeGresley and Mr Rob Warren. 
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Figure A5: NMR data for compound 1, extracted using the solvent acetonitrile, and separated using TLC plate 1. This compound had an Rf value of 1 (See 
Table 3.9). The work and data was collected by Dr Adam LeGresley and Mr Rob Warren. 
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Figure A6: Supplementary NMR data for compound 1, extracted using the solvent acetonitrile, and separated using TLC plate 1. This compound had an Rf 
value of 1 (See Table 3.9). The work and data was collected by Dr Adam LeGresley and Mr Rob Warren. 
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Figure A7: NMR data for compound 1, extracted using the solvent acetonitrile, and separated using TLC plate 2. This compound had an Rf value of 1 (See 
Table 3.9). The work and data was collected by Dr Adam LeGresley and Mr Rob Warren. 
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Figure A8: Supplementary NMR data for compound 1, extracted using the solvent acetonitrile, and separated using TLC plate 2. This compound had an Rf 
value of 1 (See Table 3.9). The work and data was collected by Dr Adam LeGresley and Mr Rob Warren. 
